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Abstract
In work directed towards the purification of a liver microsomal
cytochrome P-450 species capable of supporting cholesterol 7a-hydroxylase
activity in a reconstituted system, the use of the detergent Renex 690
for the solubilisation of microsomal protein resulted in an unacceptable
inhibition of cholesterol 7ct-hydroxylation. This confirmed previous
work, showing that Nonidet P42 is the optimum choice of solubilising
agent for this purpose. DEAE-cellulose chromatography of microsomal
protein solubilised with Nonidet P42 was confirmed to be a suitable
first step in the purification of liver microsomal cytochrome P-450,
since there is a good separation of this species from NADPH cytochrome c
reductase activity. However, the recovery and purification of total
cytochrome P-450 was low. Dithiothreitol, 4-phenyl-imidazole, diethyl-
dithiocarbamate and glycerol, by themselves or in combination with each
other, were shown to be useful agents in liver microsomal cytochrome
P-450 purification. It was further demonstrated that increasing the
recovery of cytochrome P-450 gave a concomitant improvement in its
purification. Chromatography on quaternary aminoethyl-Sephadex or on
carboxymethylcellulose did not result in any purification of cytochrome
P-450. Hydroxyapatite chromatography of cytochrome P-450 - containing
fractions from the DEAE-cellulose eluate gave a further small purification
of cytochrome P-450. The use of chemical donors of "active oxygen"
in the reconstitution of cholesterol 7a-hydroxylase activity with liver
microsomal cytochrome P-450 was shown to be limited by the rapid
destruction of the cytochrome by these agents.
An assay for cholesterol esterification by liver microsomal
preparations was developed. This assay measured the fractional
14-i
conversion of exogenous L4- Cj-cholesterol to cholesterol ester in the
presence of coenzyme A and ATP, and therefore represents the combined
activities of acyl-coenzyme A synthetase and acyl-coenzyme A:cholesterol
acyltransferase. This activity was not a linear function of protein
concentration, so the protein concentration used in subsequent experiments
had to be maintained within a narrow range. The rate of esterification
was linear up to twenty minutes and then declined. Esterification
required the presence of coenzyme A, but the esterification rate was
independent of coenzyme A concentration over a wide range. The
coenzyme A analogues N-acetyl-cysteine and N-acetyl-cysteamine were
not able to support cholesterol esterification. Perturbations of the
rate of fatty acid desaturation by microsomal preparations had no effect
on the rate of cholesterol esterification. Newly synthesised cholesterol
ester sedimented with microsomes rather than forming a floating lipid
layer. Butanol extraction or detergent solubilisation of microsomes
resulted in large losses of cholesterol esterification activity.
The assay of acyl-coenzyme A:cholesterol acyltransferase throughout
a twenty-four hour period indicated that this enzyme exhibited a small
diurnal variation of activity with the maximum and minimum activities
occurring three hours after the middle of the dark and light periods,
respectively.
In the twenty-four hours after occlusion of the bile duct the
plasma concentration and, by implication, the hepatic content of bile
salts increased, as did the liver microsomal cholesterol content.
There was no difference either in the size of the substrate pool for
cholesterol 7a-hydroxylase or in the cholesterol 7a-hydroxylase activity
between sham operated and bile duct ligated animals. The diurnal
variation in cholesterol 7a-hydroxylase activity and in the size of
its substrate pool persisted after bile duct occlusion. There was
no difference in the size of the substrate pool for acyl-coenzyme A:
V.
cholesterol acyltransferase between sham operated and bile duct ligated
animals. After twenty-four hours the acyl-coenzyme A:cholesterol
acyltransferase activity of bile duct ligated animals was greater than
that of sham-operated controls. Plots of these enzyme activities
against substrate pool size are consistent with the hypothesis that
under these circumstances these enzymes are not saturated with substrate,
and there is therefore a linear relationship between the amount of
substrate accessible to the enzyme and the rate of conversion of substrate
to product.
Feeding rats a diet containing 10% olive oil resulted in no
detectable changes in either whole liver or liver microsomal free or
esterified cholesterol contents. Feeding a diet containing 10% olive
oil, 1% cholesterol gave a small increase in whole liver or liver
microsomal free cholesterol and large increases in liver and liver
microsomal cholesterol ester. The withdrawal of the cholesterol from
the diet resulted in a rapid return of cholesterol ester contents to
basal levels. Free cholesterol contents also returned to basal levels,
but more slowly. The activity of acyl-coenzyme A:cholesterol acyl-
or the olive o'iL
transferase increased on feeding either the olive oil^plus cholesterol
diet, but the rise in activity in the latter case started earlier and
was more sustained. No increase in cholesterol 7a-hydroxylase was
detected on feeding 10% olive oil, 1% cholesterol, despite an increase
in the size of the substrate pool for this enzyme.
Acetone-extracted liver microsomes combined with liposomes made
from microsomal lipid supplemented with increasing amounts of cholesterol
exhibited increasing activities of acyl-coenzyme A:cholesterol acyl¬
transferase. Saturation was not apparently achieved within the range of
cholesterol content used.
vi.
Cholesterol-enriched serum was used to enrich liver microsomes with
cholesterol. This resulted in an increase in acyl-coenzyme A:cholesterol
acyltransferase activity, but no change in cholesterol-7a-hydroxylase
activity.
The problems associated with the assay of enzymes that are membrane-
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1.1 The metabolic and structural roles of cholesterol - an introduction
Cholesterol is found in varying amounts in all mammalian tissues.
It is derived either from the diet, or by synthesis from simple two-
carbon precursors (Figure 1.1). The absorption of cholesterol from the
diet depends on various factors, a major influence simply being the
amount of cholesterol in the diet (1). All tissues examined have the
ability to synthesise cholesterol (2,3), but this activity is closely
controlled by the supply of cholesterol (3,4) .
In the absence of dietary cholesterol an adequate supply of
cholesterol for the entire organism can be maintained by synthesis in
the liver and the cells of the small intestine (3,5). The rate of
cholesterol synthesis in the liver is determined by the dietary
cholesterol intake (3,5,6), and the synthetic rate in all other tissues
is normally maintained only at low levels (3,6). Such an arrangement
has the advantage that the cholesterol metabolism of the whole organism
is centrally controlled, but requires the export of cholesterol into
the plasma, and a complex centrifugal transport system to carry the
cholesterol from its sites of synthesis and absorption to the tissues
where it is required (Section 1.2).
Cholesterol can be taken up into the cells of peripheral tissues
both by non-specific exchange or diffusion processes (7-10) and by
highly specific receptor-mediated transport mechanisms (Section 1.3).
The advantage of the latter system is that it allows control of the
quantity of cholesterol entering the cells of a tissue. Thus, once the
cholesterol has entered the cells of its target tissue not only does it
inhibit the rate of cholesterol synthesis in that tissue, but it also may
inhibit the synthesis of the receptor required for its uptake.
In addition, the conversion of cholesterol to cholesterol ester
(presumed to act as an inert storage form of cholesterol) may be stimulated.
Figure 1.1






















Each arrow in the sequence of metabolic conversions shown can represent
one or more enzyme-catalysed reactions. The primary site of feedback
regulation of cholesterol synthesis is indicated thus: ——
Secondary sites of regulation, exhibiting a decreased enzyme activity
on prolonged cholesterol feeding are indicated thus: *.
(Adapted from reference 3).
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This concerted control of cholesterol uptake, synthesis and storage has
been best characterized for the fibroblast and has been embodied in the
"low density lipoprotein receptor hypothesis" (Section 1.3).
In all tissues cholesterol is an essential structural component in
both intracellular and extracellular membranes. The cholesterol content
of membranes is critical in determining many of their properties such as
structure, fluidity, transition temperature and enzyme activities
(Sectiorsl.5 and 1.6).
In addition to this structural role which cholesterol fulfils in
all tissues, in certain organs it serves specific metabolic purposes.
In steroid hormone-producing tissues cholesterol is stored in the form
of its ester. On the appropriate hormonal signal this ester is rapidly
hydrolysed to free cholesterol and this is converted to steroid hormone
(11-16). In the liver cholesterol can be converted to bile acids
(Section 1.4). After conjugation with the bases glycine or taurine
the resultant bile salts are secreted, with phospholipid and cholesterol,
as bile. Finally, as has already been mentioned, the cholesterol may be
esterified by combination with a fatty acid. Intracellularly, this
fatty acid is derived from fatty acyl-coenzyme A, the enzyme being
acyl-coenzyme A cholesterol acyltransferase (Sections 1.3 and 1.4);
in plasma the fatty acid involved in esterification of cholesterol is
derived from lecithin, the reaction being a transesterification
catalyzed by the enzyme lecithin:cholesterol acyltransferase (Section
1.2(b)). The resultant cholesterol ester is the form in which
cholesterol accumulates when it is present in excess. The site of this
accumulation varies in different species, being the liver in rats,
and is presumably the result of the relative activities of acyl-coenzyme A:
cholesterol acyltransferase in each tissue and of lecithin:cholesterol
acyltransferase.
4.
The only major route for catabolism of cholesterol leads to the
bile acids (Figure 1.2), and this occurs exclusively in the liver (17-21).
In addition to the centrifugal cholesterol transport systems already
mentioned there is therefore a need for a centripetal transport system
to transfer excess cholesterol from peripheral tissues to the liver
for catabolism and excretion (Section 1.2(b)).
From the foregoing outline of cholesterol transport, metabolism and
function it can be concluded that the liver plays a central coordinating
role, since it is capable of cholesterol synthesis, storage and
catabolism, can secrete cholesterol into the blood and the bile, and
can absorb cholesterol from the blood. This thesis examines some aspects
of two of these processes - the first and rate-limiting step in the
metabolism of cholesterol to bile acids, and the conversion of
cholesterol to cholesterol ester. These reactions, however, must be
considered in the context of overall cholesterol metabolism, transport
and function described in the following paragraphs.
1.2 Cholesterol transport
(a) Lipoprotein composition and structure
Like other lipid molecules cholesterol is transported in the blood
by the serum lipoproteins, a heterogeneous class of particles composed
of varying amounts of lipid (mainly triglyceride, phospholipid and
free and esterified cholesterol) and protein. These proteins comprise
three groups designated apoprotein A, apoprotein B and apoprotein C
(apoA, apoB, apoC). Further subdivision of these apoprotein groups is
denoted by a roman numeral suffix.
The lipoproteins are subdivided on the basis of their centrifugation
characteristics into four main classes: chylomicrons, very low density
lipoproteins (VLDL), low density lipoproteins (LDL), and high density
Figure 1.2
The metabolism of cholesterol to bile acids
Pathways for formation of bile acids. I, cholesterol; II, 7a-hydroxycholesterol
(5-cholestene-3/?, 7a-diol); III, 7a-hydroxy-4-cholesten-3-one; IV, 5/i-cholestane-3a. 7a-diol;
V, 7a. 12a-dihydroxy-4-cholesten-3-one; VI, 5/f-cholestane-3a. In. 12a-triol; VII, 5/3-
cholestane-3a. 7a, 12a. 26-tetrol; VIII, 5/I-cholestane-3a. 7a, 26-triol; IX, 3a. 7a. 12a-tri-
hydroxy-5/i-cholestanoic acid; X, 3a. 7a-dihydroxy-5/i-cholestanoic acid; XI, cholic acid;
XII, chenodeoxycholic acid; XIII, deoxycholic acid; XIV, lithocholic acid. reactions
catalyzed by liver enzymes; —reactions catalyzed by microbial enzymes.
(From reference 20).
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lipoproteins (HDL). The size and composition of these species is
summarised in Table 1.1 (22-25).
The structure of all the lipoproteins is such that non-polar
molecules, or portions of molecules, are in the interior of the particle,
shielded from the aqueous environment by a layer of polar molecules or
parts of molecules. Thus, chylomicrons and VLDL have the structure of
a large hydrophobic core of triglyceride (with some cholesterol ester,
when present) surrounded by a monolayer of phospholipid and free
cholesterol, the apoproteins being associated with this monolayer (22-25).
LDL has a micellar structure, with an apolar core of cholesterol ester
and triglyceride, surrounded by a monomolecular shell of phospholipid,
free cholesterol and apoprotein (23). The structure of HDL will be
discussed below, with the role of HDL in cholesterol transport,
(b) Lipoprotein metabolism
When a fat-containing meal is ingested, the lipid (mainly triglyceride)
is hydrolyzed to free fatty acids and monoglycerides in the lumen of
the small intestine and absorbed into the mucosal cells of the intestinal
wall. These newly absorbed lipid components are used in the synthesis
of triglyceride and phospholipid, which, with cholesterol and protein,
are assembled into chylomicrons (23,26). VLDL synthesis uses fat
derived from the diet and, in larger quantities, from endogenous
synthesis, and occurs in the liver and the small intestine (27-30).
These two lipoprotein species are usually considered to be assembled
in a similar way, with lipid synthesis occurring in the smooth
endoplasmic reticulum, protein synthesis in the rough endoplasmic
reticulum, and the essentially completed lipoprotein then being
transported to the Golgi apparatus and secreted by processes dependent
on microtubules (31-42). Experiments performed to investigate the
degree of interdependence of these various stages in synthesis and
Table1.1
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secretion, using inhibitors of protein synthesis, perturbations of lipid
synthesis rate and microtubule disrupting agents have tended to give
equivocal results (43-46).
The intestinal triglyceride-rich lipoproteins are secreted into the
lymph system and drain into the systemic blood circulation via the
thoracic duct. The hepatic VLDL is secreted directly into the blood.
When first secreted the intestinal particles do not have their full
complement of apoC (29,44), but rapidly gain it from HDL, when in the
blood (47,48).
Components of these lipoproteins are hydrolyzed by the action of
lipoprotein lipase, an enzyme whose primary action is the hydrolysis of
triglyceride, and which is situated on the luminal surface of capillary
endothelium, being readily released into the circulation by heparin.
Lipoprotein lipase is activated by apoC-II (48-50). Newly secreted
chylomicrons and VLDL are therefore poor substrates for this enzyme
until they have received apoC-II from HDL. The precise mechanism of
action of lipoprotein lipase is not understood. In particular, it is
not clear how it acts on triglyceride which is situated in the hydrophobic
core of these lipoproteins, surrounded by a layer of polar lipid.
However, it is known that the removal of triglyceride occurs in a
number of steps, with repeated binding of lipoprotein to lipoprotein
lipase, followed by enzyme activity with consequent loss of some
triglyceride, and release into the circulation (51-53). This means that
at any given time there will be circulating a spectrum of products of
different sizes.
Over the range of chylomicron and VLDL concentration normally
encountered in_ vivo, the lipoprotein lipase of the capillaries of heart
muscle will be saturated with substrate, since it has a low K for the
m
substrate, whereas the enzyme in the vessels of adipose tissue will not
7.
be saturated, having a relatively high K (51). This has important
m
consequences for the fate of triglyceride from triglyceride-rich
lipoproteins. At all concentrations there will be a priority clearance,
at a constant rate, of fatty substrate into tissues which require it
for immediate utilization, while clearance into adipose tissue will be
proportional to the concentration of circulating triglyceride.
This lipolysis results in the removal of lipid from the apolar
core of the lipoprotein, with a resultant surplus of surface components.
These must be removed if the particle is to remain stable. Various
mechanisms have been proposed to achieve this removal. In vitro
lipoprotein lipase exhibits some phospholipase activity towards the
surface phospholipids of these lipoproteins (54,55), and this would
have the desired effect of removing material from the external layer
of the lipoproteins. However, this process has not been demonstrated
in vivo. HDL plays an important role in the other mechanisms involved.
Firstly, as triglyceride hydrolysis proceeds, chylomicrons and VLDL
lose apoC peptides, and these return to HDL (47,48). Thus, in effect
the plasma apoC pool cycles between HDL and triglyceride-rich lipoproteins,
with the result that the fractional catabolic rate of VLDL apoC is
considerably lower than that of apoB (24). In consequence these
particles, as they lose their triglyceride content, eventually become
sufficiently depleted in apoC-II that they cease to be effective
substrates for lipoprotein lipase (48,56).
Secondly, it is well known that cholesterol can readily transfer
between lipoprotein classes, and HDL, in conjunction with the activity
of lecithin:cholesterol acyltransferase is particularly suited to
remove cholesterol from particles or membranes where it is in excess
(see below).
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Thirdly, as the lipolysis of triglyceride-rich lipoproteins proceeds,
there is a rapid appearance of phospholipid and protein (primarily apoA
proteins) from these species in HDL-containing plasma fractions (57-60).
Two mechanisms have been suggested to explain this observation. These
species could be transferred to pre-existing HDL (57-60), the movement
of phospholipid perhaps being facilitated by phospholipid exchange
proteins (59). Alternatively, or in addition to this mechanism, there
is the possibility that these compounds could themselves be a source of
new HDL (61). Thus, VLDL lipolysis by the perfused rat heart yields
particles very similar to discoidal HDL (58) in addition to the major
product, triglyceride-depleted VLDL; selective delipidation of the
chylomicron core results in the appearance of lamellar aggregates of the
surface components similar to particles which appear in the HDL fraction
shortly after the injection of chylomicrons into rats (62); finally,
after in_ vitro lipolysis of chylomicrons it is possible to observe
protruding folds from the surface of the resulting particles presumably
caused by a puckering of the surface layer as triglyceride is removed
from the interior of the particle (63).
The depletion of the triglyceride content and the removal of
surface components from chylomicrons and VLDL described above results
in the formation of smaller lipid-containing particles known as remnants.
Remnant particles derived from chylomicrons compare in size and
composition with remnants derived from VLDL (sometimes referred to as
intermediate density lipoprotein (IDL)), but are not metabolised in the
same way in all species.
In all species investigated chylomicron remnants are rapidly
cleared by the liver (64-66). Thus, following administration of labelled
chylomicrons to rats, 80% of the cholesterol ester, but only 10% of the
triglyceride is recovered in the liver (64). Also, in the intact rat
9.
chylomicron remnants are not detected after the absorption of a fat-
containing meal, but if the rat is hepatectomised before the intragastric
administration of fat, or the intravenous injection of previously
purified chylomicrons, remnants accumulate (64). The evidence suggests
that the remnants are taken up intact (67), and by a high affinity,
high specificity, saturable pathway (67-69). The recognition factor(s)
for this uptake and for the discrimination between chylomicrons and
chylomicron remnants are not known, but appear not to be particle size
or composition (67,69). Finally, and in important contrast to the uptake
of LDL by fibroblasts (see Section 1.3), the uptake of remnants into
the liver is not in any way a function of the hepatic rate of
cholesterogenesis (68,70).
In the rat remnants formed from VLDL lipolysis are also rapidly
taken up by the liver in a manner similar to chylomicron remnants (71-73),
only 10% of VLDL apoB remaining in the circulation, in LDL. By contrast,
in the human VLDL remnants (or IDL) are not taken up by the liver, and
there is a precursor-product relation between VLDL and LDL (74,75),
with more than 90% of VLDL apoB being eventually recovered in LDL.
The amount of apoB per particle remains relatively constant in the
VLDL - IDL - LDL system, suggesting that it persists as a constant
structural component in all the particles of this series. The remodelling
of IDL to LDL primarily requires the removal of further triglyceride,
and it can be speculated that this may be the function of hepatic
lipase, an enzyme similar to lipoprotein lipase but situated on the
endothelial surface of the hepatic blood vessels.
In the human the catabolism of VLDL can apparently account for all
LDL synthesis (74), although alternative sources of LDL cannot be excluded.
However, in the rat a further route must exist for LDL synthesis,
and it is not clear where this route occurs (75). No LDL release has
10.
been observed in the perfusate of the isolated liver, although the
secretion of VLDL and HDL is readily detected (29,30,76). Nascent VLDL
can be demonstrated in the rat liver Golgi apparatus (37,38), but no
LDL-like particles can be seen. However, this does not exclude the
possibility of direct hepatic LDL synthesis, since a relatively slow rate
of synthesis could contribute significantly to the size of the plasma
LDL pool because of the relatively slow turnover time of this lipoprotein.
LDL contains cholesterol, mainly as cholesterol ester, as a major
component and is presumed to be the lipoprotein species responsible for
the transport of cholesterol to extra-hepatic tissues. Thus, although
uptake of cholesterol from LDL into the liver can be detected (70,77-79),
in the pig hepatectomy does not result in an increase in the rate of
removal of LDL from the plasma (80). Furthermore, the existence of a
well characterised, highly specific pathway for LDL uptake and degradation
in a variety of cells in culture (Section 1.3) strongly suggests that
LDL is largely catabolized in the peripheral tissues. This therefore
results in a net transfer of cholesterol from the organs of absorption
(the intestine) and synthesis (the liver and the intestine) to tissues
that require it either as a structural component or as a steroid hormone
precursor.
There is much suggestive evidence that the role of HDL is to act
in an opposite sense to LDL, to bring about the centripetal transport
of cholesterol from the peripheral tissues to the site of cholesterol
catabolism, the liver. Thus, there is strong negative correlation
between plasma HDL cholesterol concentration and the size of the pools
of tissue cholesterol both in normal and hyperlipidaemic man (81).
There is an inverse relationship between the plasma HDL concentration and
mortality from cardiovascular disease (81,82). Low levels of HDL
predispose towards atherosclerosis (as do high levels of LDL (83,84)),
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and high levels of HDL protect against it (81,82,85). In Tangier disease
(HDL deficiency) there are cholesterol deposits in reticuloendothelial
and other tissues (86). HDL cholesterol appears to be secreted in the
bile in preference to LDL cholesterol (87). Finally, many studies in_ vitro
have shown that HDL has the ability to remove cholesterol from cells
(88-91), from other lipoproteins and from cholesterol-rich lipid
dispersions.
The ability of HDL to act in this way is intimately associated both
with HDL structure and with the activity of lecithin:cholesterol
acyltransferase. In addition to the possibility, mentioned above, that
HDL arises from the excess surface components of chylomicrons and VLDL,
HDL is synthesised by the liver (29,30,76) and by the intestine (28,29).
Nascent HDL is a disc-shaped particle, apparently composed of a bilayer
of phospholipid and free cholesterol, with apoA around the hydrophobic
edge of the bilayer (61,76,92,93). This structure is analogous to that
of the water-soluble lipid particles found in the bile, where the
hydrophobic edges of the phospholipid-cholesterol bilayers are surrounded
by bile salts. Thus, apoA (in particular, apoA-II) has a solubilising
role, similar to that of bile salts. Unlike HDL isolated from plasma,
these nascent HDL particles contain no cholesterol ester, and are
relatively deficient in free cholesterol (61,76,93).
Cholesterol is known to readily exchange between different
lipoprotein classes, cell membranes and phospholipid bilayers (7-10),
presumably via the transient formation of a collision complex.
The direction and extent of this transfer depends on the relative
cholesterol concentrations of the particles involved. The relatively
low concentration of free cholesterol in the surface layer of HDL
(or the lipid bilayer of nascent HDL) is therefore particularly suited
to promoting the movement of cholesterol onto HDL.
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If cholesterol was only transported by the plasma lipoproteins as
free cholesterol the carrying capacity of these particles would be
severely limited by their surface area, since this is the thermodynamically
favoured area for free cholesterol to occupy. (It is noteworthy that the
bulk of the cholesterol in LDL, presumed to be the main transporter of
cholesterol to the peripheral tissues, is present as cholesterol ester,
which is situated within the core of the particle.) In the particular
case of HDL and its ability to remove cholesterol from other particles
or membranes, an equilibrium would rapidly be reached where the polar
lipid layer was saturated with free cholesterol and was therefore unable
to accept more cholesterol from potential donors.
The effectiveness of HDL in this function is considerably enhanced
by the activity of lecithin:cholesterol acyltransferase (94,95).
This is a plasma enzyme, synthesised in the liver (93,96), that transfers
a fatty acid from the C-2' position of lecithin to cholesterol, giving
lysolecithin and cholesterol ester. Lecithin:cholesterol acyltransferase
is activated by apoA-I, one of the major apoproteins of HDL, and HDL
is accordingly a particularly effective substrate (97).
The products of this reaction, lysolecithin and cholesterol ester,
are no longer suited to the environment they occupied as substrates.
Lysolecithin is removed as a complex with serum albumin. Cholesterol
ester retreats from the polar surface of the particle into its
hydrophobic core, and hence the disc-like nascent HDL is eventually
converted to the spherical HDL observed to occur in plasma. This
change of shape can be observed during the in_ vitro incubation of
lecithin:cholesterol acyltransferase with nascent discoidal HDL
(obtained from rat liver perfusions performed in the presence of an
inhibitor of lecithin:cholesterol acyltransferase (93)).
As well as resulting in this change of shape as HDL matures, the
esterification of cholesterol has the effect of maintaining a low
concentration of free cholesterol at the surface of the particle.
The ability of HDL to accept cholesterol from cholesterol-rich sources
is thus prolonged. It should also be noted that as the other enzyme
substrate, lecithin, becomes depleted it can be replenished by transferral
of the surplus surface components generated during the lipolysis of the
triglyceride-rich lipoproteins, possibly through the mediation of
phospholipid exchange proteins, as described above.
HDL has been shown to be taken up and degraded by the liver
(77,78,98-100). However, measurements of the rate of accumulation of
cholesterol in liver cells, from HDL, indicate a plasma half-life for
HDL cholesterol ester considerably shorter than that for HDL apoproteins
(98,99). Various mechanisms could account for this. Firstly, HDL
could circulate through the plasma, acquiring cholesterol from extrahepatic
tissues and delivering this up at the liver without the uptake of the
complete HDL particle. This process might occur several times before
finally the entire particle was degraded. Secondly, the cholesterol
ester-rich HDL particle might deliver its cholesterol to remnant
lipoproteins derived from chylomicron or VLDL lipolysis. Two mechanisms
might be envisaged for this. The process might be mediated by cholesterol
ester exchange proteins, known to facilitate the transfer of cholesterol
ester from HDL to VLDL or LDL, probably in exchange for triglyceride
(101-103). Alternatively, HDL might give up some of its complement of
apoA-I in the formation of new HDL from the excess of surface components
of VLDL and chylomicrons. As this occurs the apoA-I-deficient HDL
would become less stable in its aqueous environment, and would be likely
to fuse with another lipoprotein (61). The fusion of this unstable
HDL species with chylomicron remnants would provide a route for the
transfer of HDL cholesterol ester to the liver.
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In species such as man, where little or no cholesterol is secreted
into lipoproteins as cholesterol ester, these mechanisms for ester
transfer from HDL to other lipoproteins may be a major source of these
lipoproteins' cholesterol ester content (104). In particular, the
cholesterol ester of LDL may be derived directly by transfer to it, or
indirectly by transfer to VLDL or its remnant. This is in addition to
any low level of activity lecithin:cholesterol acyltransferase may
display towards these particles. In the rat there is some evidence that,
in addition to any plasma cholesterol ester generated by lecithin:
cholesterol acyltransferase, there is some secretion of cholesterol
ester in newly synthesised lipoproteins (105). This cholesterol ester
is presumably synthesised by the intracellular enzyme acyl-coenzyme A:
cholesterol acyltransferase.
1.3 The cellular uptake of cholesterol
Cholesterol can be taken up from the plasma lipoproteins into cells
by at least two mechanisms. Firstly, cholesterol is relatively free to
exchange between the lipoproteins and cell membranes. This exchange
process is non-specific, and any net transfer of cholesterol depends
solely on the existence of a difference in cholesterol concentration
between the species concerned. Secondly, specific mechanisms exist for
the high affinity, high specificity binding and internalisation of
certain lipoproteins in certain tissues. Such mechanisms exist for
the uptake of chylomicron remnants (and probably, in the rat, VLDL
remnants), and possibly HDL, in the liver, and for LDL in extrahepatic
tissues.
Of these specific systems, the clearance of chylomicron remnants
has been studied to the extent of determining the kinetic
characteristics and substrate preference of the mechanism (67-69).
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Work on the uptake of LDL by tissue culture cells, however, has yielded
information not just on the actual uptake mechanism, but also on the
metabolic consequences to the cell. These results are usually presumed
to be of general significance in the understanding of how individual
cells regulate their cholesterol content to meet changing demands for
cholesterol in the presence of a potentially fluctuating cholesterol
supply. These observations have been embodied in the so-called
"LDL receptor pathway" (83,106-109) which is briefly described below.
On the surface of cultured human fibroblasts there is a protein or
glycoprotein receptor (110,111), which binds LDL with high specificity
and high affinity (110,112,113), and which can be saturated (112,113).
The binding requires apoB to be present in the lipoprotein (112,113) and
probably involves an ionic interaction. The LDL-receptor complex then
enters the cell by a process resembling endocytosis (112,114-116), and
the endocytotic vesicles fuse with lysosomes with subsequent degradation
of their components (113,117,118). This results in the release of amino
acids into the culture medium (113) and the accumulation of free
cholesterol within the cell, largely associated with cell membranes
(108,117). This cholesterol can be used in any cellular requirement for
the synthesis or regeneration of membranes.
In addition, the accumulation of free cholesterol has a regulatory
effect on two endoplasmic reticulum enzymes, suppressing 3-hydroxy-3-
methylglutaryl-coenzyme A reductase activity and activating acyl-
coenzyme A:cholesterol acyltransferase (119-123). The former enzyme
is the rate-limiting enzyme in cholesterol synthesis, and the decrease
in its activity accordingly results in the cessation of cellular cholesterol
production. The latter enzyme catalyzes the esterification of cholesterol,
and thus any free cholesterol not immediately required in membrane
synthesis is converted to cholesterol ester which accumulates in the form
of cytoplasmic lipid droplets (121-124).
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A final, and most important, consequence of this binding and uptake
of LDL is the suppression of LDL binding to receptors, apparently due
to a decrease in the number of receptors on the cell surface (125-128).
This is probably due to a suppression of the synthesis of receptor
molecules (125,128).
Conversely, when this cholesterol-loaded cell experiences a demand
for cholesterol, the cholesterol esters stored as cytoplasmic lipid
droplets can be hydrolysed (83). These therefore act as a buffer in
the cells' cholesterol metabolism. Once this supply is exhausted, the
LDL receptor can again be synthesised to take advantage of any cholesterol
supply from the extracellular medium, and a stimulation of 3-hydroxy-3-
methylglutaryl-coenzyme A reductase activity can result in an increase
in the intracellular production of cholesterol.
In the normal steady state in_ vivo it appears that most extra-
hepatic tissues do not synthesise cholesterol (129-132), but rely
instead for a supply delivered through the circulation from the diet or
from the central organs of cholesterol synthesis (Section 1.2). The
control of extra-hepatic cellular cholesterol content may well therefore
be achieved by adjustments in the amount of the LDL receptor.
Although all the features of this pathway have been elaborated
following work with the cultured human fibroblast, a similar mechanism
operates in cultured human lymphoblasts (133) and aortic smooth muscle
cells (134) and in circulating human lymphocytes (135) and in cultured
mouse Y-l adrenal cells (136) .
1.4 The functions of the hepatic endoplasmic reticulum in the metabolism
of cholesterol
The roles of the liver in cholesterol metabolism were described
within the context of whole body cholesterol metabolism in Section 1.2,
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and are diagrammatically shown in Figure 1.3. Section 1.3 outlined the
pathway by which an alternative cell type controls its cholesterol
uptake and metabolism, and at least some of the features of this system
might be expected to be exhibited by the liver cell.
To summarise, those processes that might result in a net gain in the
cholesterol content of liver cells are the synthesis of cholesterol and
the uptake of lipoproteins from the bloodstream (in particular, the
uptake of chylomicron remnants, but also probably the remnants of VLDL
lipolysis and HDL and possibly even LDL). The uptake of lipoproteins
will yield initially both free and esterified cholesterol, but if
internalisation of lipoproteins is followed by lysosomal hydrolysis,
as occurs in the uptake of LDL by fibroblasts, and as in some cases
at least, also seems to occur in the liver (68,73,98,100,137,138), any
cholesterol ester will be converted to free cholesterol before release
into the cell.
Those processes resulting in no net change in cellular cholesterol
content are cholesterol esterification and the hydrolysis of cholesterol
ester. In the rat cholesterol esterification occurs both in the
accumulation of cholesterol ester-rich cytoplasmic lipid droplets, and
also contributes to the cholesterol ester content of lipoproteins.
Whether cytoplasmic cholesterol ester can be used in the assembly of
lipoproteins without prior hydrolysis and re-esterification is not known.
In addition to lysosomal cholesterol ester hydrolysis, probably concerned
exclusively with the uptake and disposal of lipoproteins from the plasma,
this reaction can be catalysed by various other subcellular fractions
of the liver, including microsomes, but the function of these other
cholesterol ester hydrolases is at present not clear.
Processes resulting in a net loss of cholesterol from liver cells
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containing varying proportions of free and esterified cholesterol,
the conversion of free cholesterol to bile acids, and the secretion of
bile, containing bile acids and cholesterol. Figure 1.3 diagrammatically
summarises all these hepatic functions in the metabolism and transport
of cholesterol.
These functions can alternatively be divided into two major
categories. First, metabolic transformations of cholesterol, such as
synthesis, esterification and catabolism. Second,processes resulting in
packaging or movement such as storage of lipid droplets, assembly and
secretion of lipoproteins and bile, and uptake and degradation of
lipoproteins.
Central to the metabolism of cholesterol by the liver are those
processes occurring within the endoplasmic reticulum. These include
the rate-determining reactions in the synthesis and catabolism of
cholesterol, as well as many of the other enzymic steps in these pathways,
cholesterol esterification, and the assembly of lipoproteins.
The endoplasmic reticulum is a heterogeneous subcellular organelle
largely recovered, on homogenisation and centrifugation, in the microsomal
fraction (139-144).
This thesis concerns two of the processes described above as
"metabolic transformations", namely the endoplasmic reticulum reactions
catalysed by the cytochrome P-450-dependent enzyme cholesterol
7a-hydroxylase(145-147) (the rate-limiting reaction in bile acid synthesis)
and by acyl-coenzyme A:cholesterol acyltransferase. However, although
the work described concerns only these reactions and their control,
implicit in it are the rates of synthesis of cholesterol, and the activity
of the processes described as "packaging or movement", since, by analogy
with the LDL receptor pathway, it can be expected that many of these
systems will be regulated in a coordinated manner. The level of under¬
standing of the regulation of these systems varies considerably.
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Little is known about the production of cell surface receptors for
the lipoproteins recognised by the liver. It can be speculated that the
rate of production of these receptors will not be regulated because of
the following observations. Firstly, the role of the liver as the major
organ of cholesterol catabolism and the only organ of cholesterol
excretion would perhaps preclude any regulation of the rate of hepatic
cholesterol uptake from other tissues via the plasma. Secondly, the
important part the liver plays in the adjustment of the whole body's
cholesterol metabolism in sympathy with the cholesterol supply probably
also suggests that any prevention of cholesterol uptake would be
undesirable. Thirdly, the rate of clearance of chylomicron remnants by
the liver does not appear to be a function of the hepatic rate of
cholesterogenesis (68,70). Finally, when there is an excess supply of
cholesterol to the liver, because of the ingestion of a cholesterol-rich
diet, there is a considerable accumulation of cholesterol ester within
the liver (148,149). In this respect, then, the hepatocyte appears to
differ, or to be likely to differ, from the fibroblast.
Like the fibroblast, however, the hepatocyte does regulate its
rate of cholesterol synthesis in accordance with the cholesterol supply
(150-153). However, the function of the hepatocyte in the cholesterol
transport system means that it senses the demands of all other tissues
for cholesterol, in addition to taking account of its own requirements.
Thus, when there is a surplus of cholesterol in the extrahepatic tissues,
transfer of this excess cholesterol to HDL, and hence to the liver,
will be high. Conversely, when there is a deficit in the cholesterol
content of the extrahepatic tissues this transfer will be low. In addition,
the uptake of LDL by extrahepatic tissues is dependant on their cholesterol
content, being depressed when the content is adequate, and stimulated
when cholesterol is required for membrane or steroid hormone synthesis
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(Section 1.3). Since LDL uptake by the liver has been detected (70,77-79),
it can be speculated that, under circumstances where the extrahepatic
cholesterol supply is adequate and hence the extrahepatic removal of LDL
from the plasma is low, excess LDL may be cleared by the liver.
Therefore, by one or both of these mechanisms, the rate of return of
cholesterol from the periphery to the liver reflects the cholesterol
content of the peripheral tissues. Furthermore, the liver is the site
for the clearance of chylomicron remnants, and also possibly VLDL remnants,
from the plasma, and hence the hepatic uptake of cholesterol also reflects
the intestinal absorption, and perhaps also the intestinal synthesis,
of cholesterol. To summarise, these mechanisms mean that under
circumstances of dietary intake of cholesterol and/or of adequate
peripheral cholesterol content the supply of cholesterol to the liver
will be high. When there is no dietary intake of cholesterol and/or
there is a requirement for cholesterol in extrahepatic tissues the
supply of cholesterol to the liver will be low. Cholesterol synthesis
is particularly susceptible to feedback regulation, being strongly
supressed in the presence of cholesterol (3,4,129,154-161). Thus,
unlike the fibroblast which simply adjusts its cholesterogenesis to
take account of its own requirements for, and supply of, cholesterol,
the liver is in a position to regulate its cholesterogenesis in the
light of the cholesterol supply and demand of the whole body.
The major site for the regulation of cholesterol synthesis is
usually acknowledged to be at 3-hydroxy-3-methylglutaryl-coenzyme A
reductase (3,4,154,155,162), although there is evidence for the
coordinate regulation of other enzymes in the pathway. Mechanisms for
the short term regulation of the enzyme involving feedback inhibition
by cholesterol (149), phosphorylation/dephosphorylation (162-167), and
the influence of the fluidity of the endoplasmic reticulum membrane
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(168,169, and Section 1.6) have been proposed. The long term regulation
of the activity of this enzyme is at the level of enzyme synthesis
(4,155,170).
In the fibroblast, the accumulation of cholesterol ester in the
presence of a rich supply of cholesterol is known to be accompanied by
an increase in the activity of the cholesterol esterifying enzyme,
acyl-coenzyme A:cholesterol acyltransferase (121,122). In the rat liver
an increase in cholesterol supply is accompanied by an increase in the
hepatic cholesterol ester content (148,149), but no reports of changes
in acyl-coenzyme A:cholesterol acyltransferase activity had appeared
at the time the work described here (Sections 6.4(a) and 6.4(b)) was
undertaken.
Unlike fibroblasts, which have no specific mechanisms for cholesterol
export other than passive loss from the membrane (presumably to HDL when
in vivo), the liver cell loses cholesterol in lipoproteins, by conversion
to bile acids, and, in association with phospholipids, in the bile.
Little is known about the control of the cholesterol content of
either lipoproteins or bile (171). There is however a considerable
body of information on the response of the rate of bile acid synthesis
and cholesterol 7cc-hydroxylase activity to a wide variety of experimental
manipulations (Section 6.1).
Thus, the supply of a large amount of cholesterol to the liver of
the rat tends to result in a stimulation of the rate of cholesterol
conversion to bile acids (172,173), although the effect on cholesterol
7a-hydroxylase is disputed (147,161,174-176, and see Sections 6.1, 6.4(c)
and 8.4(a)). Also, a high proportion of the bile salts secreted into
the duodenum are re-absorbed in the terminal ileum and return to the
liver through the hepatic portal circulation (177). The concentration
of these returning bile acids is another determining factor in the rate
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of bile acid synthesis and cholesterol 7a-hydroxylase activity. Thus,
if this enterohepatic circulation is broken by the cannulation of the
bile duct, or by feeding the bile acid-binding resin cholestyramine,
the rates of bile acid synthesis and cholesterol 7a-hydroxylase activity
both increase (147,174,178-182). The conversion of cholesterol to bile
acids is thus largely determined by, among other factors, the presence
of both the substrate and the end-product of this pathway.
However, despite the fact that the response of this pathway and
cholesterol 7a-hydroxylase to these, and other, conditions are well known,
the mechanisms by which these effects are mediated are still not clear.
1.5 The function of cholesterol in biological membranes
Natural membranes are complex associations of lipids and proteins,
and in the study of the structure and function of membranes the use of
simple models has frequently been of use. These models have included
monolayers of lipid spread on water, black lipid membranes, and single
or multiple walled liposomes, and these have been made of either single
lipid species or of natural and artificial mixtures of lipids. Techniques
used in the examination of membrane characteristics include x-ray
crystallography, nuclear magnetic resonance, electron paramagnetic
resonance, differential scanning calorimetry and the measurement of
membrane permeability (183-189) .
The result of this work is that membranes are now recognised to
exist as bilayers of phospholipid arranged such that the fatty acid
side chains of the lipid molecules are approximately aligned with each
other and occupy the hydrophobic interior of the membrane, shielded
from the aqueous environment by the polar head groups. Cholesterol is
positioned with its hydroxyl group oriented towards the exterior polar
layer while its nucleus and tail are sited within the hydrophobic interior.
Protein molecules are embedded to varying degrees in the membrane,
interacting with the different parts of the lipid environment by the
appropriate hydrophobic or polar forces.
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The single bonds of the fatty acid side chains of the phospholipids
can exist in either the trans or the gauche conformation, and there can
thus exist a degree of fluidity in the hydrophobic membrane interior.
There is a gradient of probability of trans-gauche conformation changes
within the membrane, and a corresponding fluidity gradient, the most
fluid region being in the middle of the bilayer (190,191). In model
membranes containing only one phospholipid species there is a characteristic
transition temperature below which the fatty acid side chains exist in
a rigid pseudo-crystalline state, with all trans conformation, and
above which the lipids exist in a more fluid state (187). The change
from pseudo-crystalline to fluid state is a co-operative phenomenon,
with all the phospholipid molecules changing state simultaneously.
The transition temperature is a function of phospholipid type, and fatty
acid side chain length and saturation (192). In a simple mixture of
lipids each lipid type condenses out at its own transition temperature,
where these are sufficiently different from each other, and thus
relatively extensive domains of rigid and fluid lipids can coexist
(193-196).
The cholesterol molecule interacts with phospholipid in a non-
stoichiometric fashion (188,197), with the hydroxyl group in the polar
region of the membrane and the nucleus and the tail in the hydrophobic
interior (188,198,199). Models of phospholipid-cholesterol complexes,
incorporating highly specific interactions between the molecules, have
been suggested (188,197-199), but not proved. However, various
features of the cholesterol molecule have been demonstrated to result
in an optimal interaction with phospholipids, including a planar nucleus
(20O) and tail length (201-203).
Addition of cholesterol to a lipid at a temperature below its
phase transition temperature increases the probability of gauche
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conformations and hence fluidity (184,187,204). Conversely, above the
phase transition temperature cholesterol exerts a constraining effect,
increasing the number of trans conformations, and decreasing the fluidity
(184,187,204). Cholesterol thus induces the formation of a phase of
fluidity intermediate between the pseudo-crystalline and liquid phases
(187). In the presence of cholesterol it is not possible to detect a
lipid phase transition temperature by differential scanning calorimetry
(205), but laser Raman spectrometry suggests that a phase transition
does occur, but is non-cooperative and is spread over a wide range of
temperature (206,207).
Mixtures of phospholipids that differ sufficiently in their
transition temperatures (for saturated phosphatidylcholine species this
requires a difference in chain length of four or more carbons) show
phase separation behaviour, as mentioned above. If cholesterol is added
to such a mixture it is found to preferentially interact with the more
fluid phospholipid (193). Thus, the non-random distribution of phospho¬
lipid can result in a non-random distribution of cholesterol. As well
as depending on the fatty acid chain length, as in the above example,
the distribution of cholesterol can depend on phospholipid type.
Cholesterol tends to destabilize bilayers of phosphotidylethanolamine
(208), and it is suggested that the phosphatidylethanolamine content
of a membrane or of parts of a membrane may influence the cholesterol
content of that membrane and its distribution within it.
1.6 The control of the activity of membrane-bound enzymes
The activity of membrane-bound enzymes can presumably be controlled
by the same mechanisms that have been proposed for water-soluble enzymes.
In addition, there is the possibility that some control may be exerted
through the influence of membrane characteristics on enzyme activity
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(209-212). Thus, in reconstitution studies many of these enzymes are
inactivated on removal of lipid, activity being restored by the addition
of lipid to the lipid-free preparation (213-216). Further, in intact
preparations Arrhenius plots of enzyme activity as a function of the
absolute temperature often show breaks at or near the lipid phase
transition temperature (217-221). In the past these observations have
been interpreted in terms of fluidity changes. It now appears that a
better explanation may be in terms of lateral phase separations
occurring at temperatures close to the transition temperature (211) .
These observations have seldom been satisfactorily explained but
possible roles for lipid in the mechanisms of action of membrane enzymes
include the maintenance of enzyme configuration in an active form by
binding the hydrophobic portions of the protein structure; ensuring
the correct interaction of separate protein subunits of the enzyme,
or the proximity of enzymes where more than one is required for overall
activity; allowing the correct approach of substrate to enzyme,
especially if the substrate partitions within the hydrophobic phase
provided by the membrane interior.
Despite the fact that many membrane-bound enzymes are not disputed
to either have an absolute requirement for lipid or to be influenced by
the physical characteristics of the lipid matrix in which they are sited,
there is little evidence for in_ vivo regulation of enzyme activity by
changes in membrane properties in mammals. However, the possibility of
such a control mechanism operating in the case of enzymes involved in
cholesterol metabolism is particularly interesting, since cholesterol
itself has such a profound influence on membranes' properties and hence,
potentially, on enzyme activity. Such a mechanism has been proposed
to operate in the case of the rate-determining enzyme of cholesterol
synthesis, 3-hydroxy-3-methylglutaryl coenzyme A reductase (168,169).
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Factors influencing the activities of membrane-bound enzymes are






2.1 Animals and diets
Female rats of the Wistar strain, in the weight range 150-250 g, were
used throughout. These were bred at the Edinburgh University Small Animal
Breeding Station. The rats were subjected to a controlled lighting
schedule with a dark period, unless stated otherwise, between 1900 and
0700.
In dietary experiments, the control/diet used was 70% wholemeal flour,
25% skimmed milk powder, 5% dried yeast. Experimental diets were made
up by mixing the required components into this base. These additional
components were the bile acid sequestering agent, cholestyramine, at a
concentration of 4% w/w, or olive oil, at a concentration of 10% w/w,
or cholesterol dissolved in olive oil, at final concentrations of 1% and
10% w/w respectively. When phenobarbital was given, to increase the
hepatic content of cytochrome P-450, this was administered as a 0.1%
solution in a 1% solution of glucose in the drinking water. Diets and
drinking water were available ad_ libitum.
2.2 Preparation of microsomes
Rats were anaesthetised with ether, a cannula was inserted into the
hepatic portal vein, and the liver was perfused with ice-cold 0.154 M
potassium chloride. This had the effect of reducing contamination by
haemoglobin and plasma enzymes, and also of rapidly cooling the liver.
The liver was removed, finely chopped with a pair of scissors,
and homogenised with three passes of a Potter-Elvehjem homogeniser to
give a 25% w/v homogenate in 0.154 M KC1. This was centrifuged at 8 000 x g
to remove cell debris, nuclei and mitochondria. The resultant supernatant
was subjected to further centrifugation at 105 OOO x g, to sediment
microsomes. This method is essentially that described by Ernster et al
(222) . When possible, fresh microsomes were prepared for each experiment.
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If microsomes were to be stored for future use, they were suspended in
a small quantity of distilled water, freeze-dried, and stored at -20°C.
2.3 Butanol extraction of rat liver microsomes
Extraction of microsomes with butanol results in a large reduction
of the lipid content, and especially the cholesterol content, of the
preparation, with only minimal losses in the activity of cholesterol
7a-hydroxylase (223-226). All apparatus and solvents were pre-cooled
to -20°C, and strictly anhydrous conditions were maintained throughout.
Freeze-dried microsomes were briefly homogenised in butanol and
centrifuged at 12 OOO x g for 2 minutes. The butanol was poured off,
and the surface of the pellet was gently washed with acetone to remove
excess butanol. The pellet was then resuspended in acetone, and the
suspension was centrifuged at 2 OOO x g for 30 s. The pellet was
stirred into 200 ml acetone, and the acetone was then removed by
filtration. The resultant powder was kept in the vacuum desiccator
for 1 hr, and then stored at -2o°0.
2.4 Solubilisation of microsomal proteins
For solubilisation of microsomal protein, a freeze-dried powder of
microsomes, or a butanol-extracted freeze-dried powder (a "butanol
powder"), was suspended in an appropriate buffer at approximately 10 mg
protein per ml. The buffer chosen depended on the starting conditions
for the following column chromatography step. Nonidet P42 was added
slowly to a final concentration of 4 pi per mg protein. After stirring
on ice for 20 minutes, the solution was centrifuged at 100 000 x g for
1 hr, and the resultant supernatant was used for subsequent chromatography
(225,226).
30.
2.5 Assay for cytochromes P-450 and iy
Difference spectra were recorded on a Unicam SP800 split beam
spectrophotometer. Cytochrome P-450 concentration was determined by
the method of Omura and Sato (227). A few grains of sodium dithionite
were added to approximately 6 ml of sample solution. This was divided
between two cuvettes and a base-line spectrum was recorded. Carbon
monoxide was bubbled through the sample cuvette for 30 s, and a recording
was then made of the "CO-reduced" minus "reduced" difference spectrum.
The cytochrome P-450 concentration was calculated from the absorbance
at 450 nm relative to 490 nm, using an extinction coefficient of
91 mM "*"cm Figure 2.1 shows a typical liver microsomal cytochrome P-450
spectrum.
Cytochrome b^ was estimated from a "reduced minus oxidised"
difference spectrum. Thus, after recording a base line spectrum, if
cytochrome P-450 and NADH-cytochrome c reductase were present, a few
grains of NADH were added to the sample, or in the absence of these
components a few grains of sodium dithionite were added, and a
difference spectrum was recorded. The cytochrome b^ content was estimated
from the difference in absorption at 424 nm and 409 nm, using an
extinction coefficient of 185 mM ^cm ^ (228) . A typical liver microsomal
cytochrome b^ spectrum is shown in Figure 2.2.
2.5 Assay for NADPH-cytochrome c reductase
1 ml of a solution of 0.4 mg cytochrome c, 1 mg glucose-6-phosphate,
0.3 mg NADP+ and 0.3 U glucose-6-phosphate dehydrogenase per ml 0.1 M
potassium phosphate buffer, pH 7.7, was added to a 1 ml cuvette, in a
o
water-jacketed cell-holder, maintained at 25 C in the Unicam SP800
spectrophotometer. Reaction was started by the addition of an appropriate
amount of flavoprotein - containing sample. The NADPH-cytochrome c
Figure 2.1
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(For method see text).
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reductase activity was determined by measuring the rate of change of
absorbance at 550 nm against a suitable blank, and using an extinction
coefficient for reduced minus oxidised cytochrome c at 550 nm of 19 mM ^
(229-231). The blank usually used was 1 ml of the assay solution
without the addition of the sample. However, when relatively large
volumes of turbid samples had to be used the blank used was 1 ml of
assay solution made up without glucose-6-phosphate dehydrogenase.
Equal volumes of the sample to be assayed were then added to the
reference and sample cuvettes.
2.7 Assays for protein
Protein was usually assayed by the method of Lowry et al (232),
or by the biuret method (233) . In the presence of KC1 or Nonidet P42,
a slight turbidity developed when the Lowry assay was used. The use of
suitable standard solutions containing appropriate concentrations of
these components, or centrifugation to clear the solutions, was shown
to allow accurate determination of protein concentration in these
samples. When interference was very strong, for example in the presence
of diethyldithiocarbamate, used in some column chromatography, an
alternative assay based on protein-binding to the dye Coomassie
Brilliant Blue G250 was used (234).
2.8 Lipid extractions
Where lipid contents of microsomal samples were to be measured,
lipids were extracted from the samples prior to assay by the method
of Folch et al (235), using a small aliquot of [4- c]-cholesterol to
assess the recovery of lipid through the extraction procedure.
2.9 Assay of phospholipid
Phospholipid was assayed by the method of McClare (236) . The assay
reagent was made up by dissolving 2.5 g ammonium molybdate in water,
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adding 20 ml perchloric acid, followed by 0.5 g ascorbic acid dissolved
in water, and making up to 250 ml with water. (The order of mixing
these compounds is important.) Perchloric acid (0.5 ml) was added to
o
the dried lipid extract, and heated to 200 C for one hour, to convert
all "lipid phosphate" (or organic phosphate) to free phosphate. After
cooling, 9.5 ml assay reagent was added, the resultant mixture was
o
incubated at 50 C for one hour, cooled to room temperature and the
absorbance at 825 nm was measured. A standard curve was constructed
using a standard solution of triphenylphosphine in ethanol. The assay
was used in the range of 0.02 to 0.1 jjmoles per assay tube.
2.10 Assays for cholesterol
Assays for cholesterol were usually enzymatic, using cholesterol
oxidase from Nocardia sp., and were either colorimetric (237) or
fluorimetric (238). Cholesterol oxidase releases hydrogen peroxide
as one of the products of its reaction:
cholesterol + 0^ -*■ cholest-4-en-3-one + ^2^2
This hydrogen peroxide can be estimated by its reaction, in the presence
of peroxidase, with a suitable oxygen acceptor to form a species that
can be detected either colorimetrically (in which case the reagent
employed was 4-aminophenazone) or fluorimetrically (when p-hydroxyphenyl-
acetic acid was used). Cholesterol ester contents were measured as the
difference in free cholesterol contents before and after hydrolysis
with 0.5 M KOH in 90% ethanol. Alternatively, during the mass
fragmentographic assay for cholesterol 7a-hydroxylase, cholesterol
contents were calculated from the total ionic current trace, which
corresponds to a conventional gas chromatographic assay, using cholestane
as an internal standard.
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2.11 Assays for cholesterol 7a-hydroxylase
The activity of cholesterol 7a-hydrcxylase was routinely assayed by
determining the percentage conversion of [4- ^c]-cholesterol to [4-^c]-
7a-hydroxycholesterol on incubation with microsomes and the necessary
cofactors. This assay has certain disadvantages, due to the dilution
of the added tracer by endogenous cholesterol, and to the compartmentation
of this endogenous cholesterol into pools of varying ability to act as
substrate for cholesterol 7a-hydroxylase (239, and see Sections 2.12,
2.13, 4.1, 7.4 and 8.2). These factors prevent the calculation, from
this assay, of enzyme activity in terms of actual production of 7a-
hydrcxycholesterol. However, this technique is convenient, requiring
no complex or expensive equipment. Furthermore, under most circumstances,
results obtained by this assay are in good agreement with results
obtained by the determination of 7a-hydroxycholesterol production
(240-242).
Assays which measure the actual production of 7a-hydroxycholesterol
use gas-liquid chromatography (202,240,243) or combined gas-liquid
chromatography and mass spectrometry (174,241,244) to directly measure
the mass of 7a-hydroxycholesterol. More indirectly, assay incubations
can be performed in the presence of [4-"'"^c]-cholesterol, enabling
7a-hydroxycholesterol (both labelled and unlabelled) to be readily
detected on separation from other sterols by thin layer chromatography.
The amount of this product can then be assessed by reaction with
[3H] -acetic anhydride of known specific radioactivity (245,246).
Of these methods, gas-liquid chromatography has not proved to be
reliable in this laboratory, apparently because of the breakdown of
the sterol (whether derivatized or not) at the column temperatures used
(Dr. I.F. Craig, personal communication); combined gas-liquid
chromatography-mass spectrometry is perhaps the most satisfactory assay
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of all, but requires very complex and expensive instrumentation, which
was only available for a few experiments, and not for routine use;
the use of [^H]-acetic anhydride in the assay of 7a-hydroxycholesterol
gives an assay which is extremely time-consuming to perform.
It was therefore decided that the use of the [4-^cl-cholesterol-
r 14-i
based assay, giving results in terms of per cent conversion to L4- CJ-
7a-hydroxycholesterol, was satisfactory for most experiments, provided
that the limitations of this technique were appreciated. The conditions
and method used were similar to those previously described by members
of this laboratory (225,226,227).
The assay incubations contained 12.5 mg glucose-6-phosphate, 3.75 mg
NADP+, 8 mg B-mercaptoethylamine, 1.0 U glucose-6-phosphate dehydrogenase,
approximately lO mg microsomal protein (or the equivalent of 1 g liver)
and 0.05 (iCi radioactive cholesterol added in 50 ji.1 acetone in a total
of 7 ml 0.1 M potassium phosphate buffer, pH 7.4. Reaction was started
by the addition either of the [4-14c]-cholesterol or of the NADP+,
glucose-6-phosphate, glucose-6-phosphate dehydrogenase mixture ("NADPH
generator"). After 60 minutes in a shaking water bath at 37°, reaction
was stopped by the addition of 5 ml methanol, and the solution was
transferred to a glass-stoppered tube with the help of a further 5 ml
methanol. Neutral lipid was extracted according to the scheme shown
(Figure 2.3).
The reaction products were separated from each other and from the
substrate by thin layer chromatography on silica gel, using a 7:13
mixture of benzene or toluene and ethylacetate as the solvent system.
Peaks of radioactivity were located by scanning with a Panax thin layer
radioactive scanner, and scraped directly into scintillation vails.
5 ml scintillant (4 g PPO, 30 mg POPOP per 1 toluene) was added, and
radioactivity was determined in a Packard Tri-Carb scintillation
spectrophotometer. Activity was expressed as the percentage of [4- 4cl-
cholesterol converted to [4-44c]-7a-hydroxycholesterol.
Figure 2.3
Lipid extraction scheme for cholesterol 7a-hydroxylase assay
Incubation medium
Supernatant


























In a few experiments, where the use of an assay giving activities
as per cent conversions was particularly unsatisfactory, assays were
performed using a mass fragmentographic procedure in collaboration with
Professor Galli of the Institute of Pharmacology and Pharmacognosy at
the University of Milan. For these assays, incubations were conducted
as usual, with 10 mg microsomal protein per incubation flask when
simultaneous radioactive assays were being performed on the same
incubation, or with 5 mg microsomal protein if only the mass fragmentographic
assay was to be performed. On stopping the reaction with methanol,
cholestane (10 (ig/mg protein) was added as an internal standard.
Lipid extraction was as normal. If a simultaneous tracer assay was
being performed, half the extract was then taken for thin layer
chromatography. The lipid extract for mass fragmentography was stored,
dry, in vials sealed under nitrogen.
A standard curve was prepared by pooling microsomal suspensions
from all groups of animals in the experiment (for experiments lasting
more than 12 hr, microsomes were stored frozen until the end of the
experiment, and then thawed and pooled), and aliquots containing 5 mg
protein were made up to a total of 7 ml with 0.1 M potassium phosphate
buffer pH 7.4. Varying amounts of standard 7a-hydroxycholesterol and
50 jug cholestane were added to each flask. Extraction and storage was
as above.
These vials were sent, or taken, to Milan for analysis. The
conditions used were as have been described (244). The extracts were
dissolved in ethyl acetate, and suitable aliquots were taken to dryness
under nitrogen. After silylation with a 3:1 mixture of N,0-bis-trimethyl-
silyl-trifluoroacetamide and pyridine, samples were injected into the
Varian MAT 112 S gas chromatograph-mass spectrometer. The glass column,
2 m x 3 mm, was packed with 3% SE-30 on 100- to 120-mesh Gaschrom P
(Applied Science, State College, Pa.). The oven temperature was 280°C
o
and the injector and detector were maintained at 290 C. The helium gas
flow was 15 yl/min. The electron energy was set at 70 eV, the emission
current at 1.5 mA, and the electron multiplier at 2.5 kV. The molecular
separator and the ion source were at 280°C. The ions at m/e 546
(M+ of di-trimethylsilylethers of cholestendiols) and at m/e 443 (M+ -15
of trimethylsilylether of cholesterol, corresponding to the molecular
fragment resulting from the loss of an angular methyl group) were
focussed. The instrument allowed continuous monitoring of the total
ionic current, and the ionic currents at m/e 546 and m/e 443. A typical
example of the trace obtained is shown in Figure 2.4.
Comparison of the peak, heights corresponding to cholesterol and
to cholestane in the sample and in a standard 1:1 mixture of cholesterol
and cholestane allows the calculation of cholesterol content. For the
standard curve, a regression line is calculated for the ratio of the
heights of the peaks at m/e 546 and m/e 443 against the ratio of the
known amount of added 7a-hydroxycholesterol to the measured amount of
cholesterol. Using the parameters of this regression line, for any
sample with an unknown content of 7a-hydroxycholesterol, the ratio of
the heights of the peaks at m/e 546 and m/e 443, and the measured
cholesterol content,allows the determination of the 7a-hydrcxycholesterol
content.
2.12 Assays for acyl-coenzyme A:cholesterol acyltransferase
The conditions used for the assay of acyl-coenzyme A:cholesterol
acyltransferase were essentially as described by Goodman et al (248)
and by Goodman (249). For a further discussion of the choice of assay
conditions see Section 4. The incubation mixture contained 2 mM ATP,
4 mM MgCl^/ 0.05 mM coenzyme A, 3.3 mM reduced glutathione and
Figure 2.4
Mass fragmentographic trace from cholesterol 7a-hydroxylase assay
(For sample preparation and running conditions see text.
The gain in the signal at m/e 546 was 333.3 times that
in the signal at m/e 443.)
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approximately 100 pg of microsomal protein, in a total volume of 3 ml
0.1 M potassium phosphate buffer pH 7.1. Although a considerable range
of protein concentration could be used for this assay, within any one
experiment protein concentrations were kept as similar as possible
because of the non-linearity of enzyme activity with protein concentration
(further discussed in Sections 4.2 and 8.2). Reaction was timed from
the addition of 0.05 |j.Ci [4-"'"^c]-cholesterol, and was stopped after
20 minutes in a shaking water bath at 37°c, by the addition of 5 ml
methanol. The mixture was brought briefly to the boil, and, after
cooling, 10 ml chloroform was added. The upper, aqueous methanolic,
phase was re-extracted with 20 ml of a 2:1 mixture of chloroform and
methanol. The upper phase was discarded and the two chloroform phases
were combined, taken to dryness, and subjected to thin layer chromatography
on silica gel, using as developing solvent a 70:30:1 mixture of
petroleum spirit, diethyl ether, acetic acid. The radioactive peaks
were located and quantified as for the cholesterol 7a-hydroxylase
r 14 i
assay. Activity was expressed as per cent conversion of L4- Cj-cholesterol
to [4-1^c]-cholesterol ester. This assay has the same drawbacks as the
equivalent assay for cholesterol 7a-hydroxylase activity, in that this
result cannot be converted to an actual rate of product formation, and
is dependent on both enzyme activity and on the distribution of
cholesterol between the various microsomal compartments.
In a few preliminary experiments, in order to measure ACAT activity
in absolute terms, [l-^cl-oleic acid was used as tracer instead of
[4-^^c]- cholesterol. In this case, 1 mg bovine serum albumin and 0.05
|uCi [l-^d-oleic acid was added per incubation and the reaction was
started by the addition of the microsomal suspension. Activity was
calculated from the radioactivity found as cholesteryl ester, and the
specific radioactivity of the added oleic acid, assuming negligible
dilution by endogenous fatty acids.
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2.13 The calculation of a maximal estimate of substrate pool size for
cholesterol 7g-hydroxylase or acyl-coenzyme A:cholesterol acyltransferase
There is evidence that not all microsomal cholesterol is available
to act as substrate for either cholesterol 7a-hydroxylase (174,245,250,251)
or acyl-coenzyme Archolesterol acyltransferase (251-254). Where assays
for these enzymes were performed both by measurement of the percent
conversion of exogenous labelled cholesterol to product and by absolute
measurement of the amount of product formed it is possible to obtain an
estimate of the maximum possible size of the pool of microsomal
cholesterol which acts as substrate (239,250).
If it is temporarily assumed that microsomal cholesterol exists as
a single homogeneous pool, and that all exogenous labelled cholesterol
partitions uniformly into this pool, it is possible to calculate an
absolute enzyme activity by multiplying the percent conversion of labelled
cholesterol to product by the total amount of microsomal cholesterol
present. This will overestimate the actual enzyme activity by the same
factor as that by which the total microsomal cholesterol is an over¬
estimate of the size of the substrate pool, as long as all the exogenous
tracer cholesterol is available to the enzyme. If the actual enzyme
activity is known by an independent absolute assay it is therefore
possible to calculate the fraction of the total microsomal cholesterol
that is in the enzyme's substrate pool. This estimate will always give
the maximum possible substrate pool size, since it relies on the assumption
that all exogenous tracer cholesterol enters the substrate pool, and the
fraction of the tracer cholesterol which actually does enter this pool
cannot be obtained.
This explanation of the justification for this calculation is an
alternative expression of the directly analogous argument presented by
Balasubramanian et al (250).
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The dependence of this estimate of substrate pool size on experimental
conditions and in particular on the vehicle used to add the cholesterol
label to microsomal incubations (174,250), has led to the usefulness of
the concept of the term "substrate pool" being questioned (174).
However, despite the impossibility of determining the actual size of
the substrate pool, the evidence suggests that such an entity exists,
and that as long as experiments are performed under carefully controlled
conditions, limited comparisons of estimated maximal substrate pool
size within any one experiment may be useful (239).
2.14 Assay for flavins
Flavin adenine dinucleotide and flavin mononucleotide were assayed
by the method of Faeder and Siegel (255).
2.15 Liposome preparation
Liposomes were prepared by the method of Bloj and Zilversmidt (256).
A solution of the required amount of lipid was made up in chloroform.
This was taken to dryness under nitrogen, and the last traces of organic
solvent removed by storing in the vacuum desiccator for one hour. Buffer
(chosen as appropriate for the remainder of the experiment) was added to
give a final concentration of lecithin of approximately 3 mg/ml. The
solution was then shaken with a vortex mixer for five minutes, to give
multilamellar liposomes. When single-walled liposomes were required
these were then subjected to sonication in an ice bath, either with the
wide probe, power setting 8, of the Ultrasonics Ltd Rapidis 150 sonicator,
output 20W, (2 minutes on, followed by 30 seconds off for 40 minutes),
followed by centrifugation at 100 OOO x g for 30 minutes to remove titanium
particles, or with a sonication bath (Dawe Instruments Ltd, Sonicleaner
Type 6443A) for 3-4 hours, until clear. These conditions have been well
characterised as giving single-walled liposomes (202,257).
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2.16 DEAE-cellulose
DEAE-cellulose for column chromatography was prepared, and linear
gradients of KC1 were generated according to Peterson and Soper (258).
2.17 Statistics
When estimating the significance of the difference of two results,
Student's t test was used unless specifically stated to the contrary.
2.18 Materials
All common reagents were purchased from BDH or Sigma and were of
Analar Grade.
+
Cytochrome c, glucose-6-phosphate, NADP, NADH, glucose-6-phosphate
dehydrogenase were obtained from Boehringer Mannheim GmbH, Mannheim.
Nonidet P42 was obtained from BDH Chemicals Ltd, Poole, England.
Renex 690 was obtained from Atlas Products, ICI United States, Inc.
PPO and POPOP were obtained from Koch-Light, England.
QAE - Sephadex was obtained from Pharmacia, Uppsala, Sweden.
DEAE-cellulose was obtained from Sigma.
CM-cellulose was obtained from Whatman, England.
Bio-Gel HTP (hydroxyapatite) was obtained from Bio-Rad, England.
Cholestyramine resin (Cuemid) and Kieselgel H (silica gel) were
obtained from Merck, Sharp and Dohme.
[4-14c]-Cholesterol and [l-^c]-oleic acid were obtained from the
Radiochemical Centre, Amersham. Before use, the [4-^cD-cholesterol
was purified by thin-layer chromatography on silica gel, using as the
developing solvent a 70:30:2 mixture of di-isopropylether, petroleum
spirit and acetic acid.
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Section 3
Approaches to the Purification of a Cytochrome P-450




(a) The requirement for a purified preparation of 7g-hydrcxylase
Much work has been done on the in vivo regulation of bile acid
synthesis and cholesterol 7a-hydroxylase activity. In order to extend
further some of the ideas developed from the results of these experiments
it will be necessary to examine the molecular mechanism of action of
cholesterol 7a-hydroxylase and its control. This demands the use of a
reasonably pure preparation of the enzyme. Among the reasons for this
requirement are the following.
Under various circumstances HMGCoA-reductase and cholesterol
7ct-hydroxylase, usually considered to be the rate-determining enzymes in
cholesterol and bile acid synthesis, respectively, are regulated in
coordination with each other (4,147,155,178,181,239,259-273). Since
there is some evidence that the preferred substrate for bile acid
production is newly synthesized cholesterol (174,250,274-276), it has
proved difficult to separate the effects of these enzymes on the
regulation of bile acid synthesis. The elucidation, at a molecular level,
of a mechanism for the control of cholesterol 7a-hydrcxylase in the
absence of HMGCoA-reductase may help to resolve this problem.
A number of cytochrome P-450 species with different substrate
specificities exist in the liver (277-283). At present there is no
unequivocal evidence for the existence of a cytochrome P-450 species
specific for cholesterol 7a-hydroxylase. Indeed, inducers of microsomal
cytochrome P-450 have not been convincingly shown to induce cholesterol
7a-hydroxylase (266,284-287), cholestyramine feeding or the creation of
a bile fistula results in an increase in cholesterol 7a-hydroxylase
activity while the microsomal cytochrome P-450 content remains unchanged
or decreases (146,266,287-289), and thyroxine treatment and thyroidectomy
have opposite effects on liver microsomal cytochrome P-450 contents and
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cholesterol 7a-hydroxylase activities (266-268). The reconstitution of
enzyme activity with separate, pure components might allow an investigation
of whether these results are best explained in terms of the existence of
a cytochrome P-450 species specific for cholesterol 7a-hydroxylase,
present in too small an amount for changes in its quantity to have a
significant effect on total microsomal cytochrome P-450 content, or
whether activity is dependent on some broad specificity cytochrome P-450,
possibly in conjunction with one or more inducible protein or non-protein
cofactors.
The reconstitution of drug hydroxylating activity from pure preparations
of cytochrome P-450 and NADPH-cytochrome c reductase requires the
presence of phospholipid (290), possibly to allow the correct interaction
of these two components so that electron transfer can occur (290,291).
There is some evidence that there is no such requirement for cholesterol
7a-hydroxylase activity (225). However, the enzyme preparations used
were not pure enough to be free of contamination by phospholipid or
detergent, especially since the solubilisation of microsomes by nonionic
detergents does not allow good separation of phospholipid from cytochrome
P-450, in contrast to the use of bile acid detergents (292,293).
Further, nonionic detergents are not easily removed from protein
preparations (294,295), and it is possible that detergent may substitute
effectively for phospholipid in maintaining enzyme activity (213).
The use of pure preparations of cholesterol 7a-hydroxylase might help
to show whether this enzyme also requires phospholipid for electron
transfer. It has been suggested that substrate binding to cytochrome P-450
is mediated by membrane lipids (195,296). The use of isolated enzyme
components should demonstrate whether phospholipid is also required for
the binding of cholesterol, an endogenous membrane component.
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It is possible that cholesterol 7a-hydroxylase can respond to
changes in the amount of its substrate in its environment, either because
it is operating at substrate levels below saturation, or through some
more subtle effect of cholesterol either directly on the enzyme, or
through the mediation of changes in membrane fluidity. A particularly
satisfactory way of investigating this would be to reconstitute the
enzyme in liposomal membranes of varying cholesterol content.
Finally, by direct analogy with other microsomal cytochrome P-450-
dependent enzymes, studies could be made of the substrate-binding,
oxygen-binding and electron-accepting steps in the enzyme mechanism,
of the interactions and stoichiometry of the cytochrome and its reductase,
of the possible involvement of cytochrome b^ in the enzyme mechanism,
of the nature of the active site and many other unresolved problems.
Since there is evidence that the specificity for cholesterol 7a-
hydroxylase activity resides in cytochrome P-450-containing fractions
rather than NADPH-cytochrome c reductase-containing fractions in
preliminary resolution experiments (225) , the approach adopted in this
laboratory has been to attempt to fractionate cytochrome P-450 for
subsequent recombination with NADPH-cytochrome c reductase purified by
published methods.
(b) Purifications of microsomal cytochromes P-45Q reconstitutively active
in hydroxylations of substrates other than cholesterol
Several groups of workers have now published schemes for the
purification of cytochrome P-450 from the microsomes of livers of rats
(297-301), rabbits (302-305), and mice (306) and the lungs of rats (307)
and rabbits (308). Much of this work has been well summarised by Lu and
Levin (292) . Several important general points have emerged from this
work.
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Firstly, it is important to prevent extensive degradation of
cytochrome P-450 to cytochrome P-420. Since the discovery that certain
thiols and polyols promote the conversion of cytochrome P-420 to
cytochrome P-450 (309), this has usually been effectively accomplished
by the inclusion of glycerol, and frequently also dithiothreitol in
buffers used in the purification of cytochrome P-450 (297,308,310).
Secondly, the choice of detergent used for the solubilisation of
the microsomal membranes is crucial. The majority of detergents will
inhibit hydroxylations to some extent, and some detergents are extremely
inhibitory to some reactions. The degree of this inhibition needs to be
established for any reaction of interest, with a wide variety of
detergents. Ionic detergents, such as sodium cholate or deoxycholate,
tend to have little inhibitory action on microsomal hydroxylations, and
to allow a good separation of cytochrome P-450 from phospholipid, but not
from NADPH-cytochrome c reductase. These detergents can be largely
removed from protein preparations by extensive dialysis. Nonionic
detergents are more likely to inhibit enzymic reactions and cannot
easily be removed from the purified preparation because of their low
critical micellar concentration, and large micelle size. However, in the
presence of nonionic detergents the separation of cytochrome P-450 from
NADPH-cytochrome c reductase is much improved.
An example of the use of sodium cholate for cytochrome P-450
preparation is offered by the early stages of the scheme reported by
Lu and Levin (1972) (311) . After solubilisation of microsomes with
cholate, the resultant solution was fractionated with ammonium sulphate.
Cytochrome P-450-containing fractions were redissolved, adsorbed to calcium
phosphate gel and eluted with increasing concentrations of phosphate
buffer. This gave a three-fold purification, with contamination by
cytochrome b and NADPH-cytochrome c reductase, but with low levels of
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phospholipid. A similar preparation has been reported for rabbit liver
cytochrome P-450, but with fractionation by polyethyleneglycol 6000
preceeding that by ammonium sulphate (312).
The exclusive use of nonionic detergents for cytochrome P-450
preparation has been reported by Miyake et al (Lubrol WX) (293), Fujita
et al (Triton N-101) (313), and Sato et al (Emulgen 911) (314) .
The specific content of these preparations was not more than three to
four times that of the starting material, although contamination by
NADPH-cytochrome c reductase was low. However, where reported,
phospholipid levels were high.
It has usually proved most satisfactory to use a combination of
detergents for cytochrome P-450 purification. After solubilisation
with a bile acid detergent and an initial fractionation with ammonium
sulphate or polyethylene glycol, the resultant fractions are redissolved
in a nonionic detergent-containing buffer before chromatography.
Detergents used include Renex 690 (315,316), Emulgen 911 (299,311) and
Nonidet P40 (305).
Most cytochrome P-450 purification schemes, after the initial
fractionation and replacement of ionic with nonionic detergents, have
involved some combination of chromatography on DEAE-cellulose with
elution with increasing KC1 concentrations, and adsorption to calcium
phosphate gel, with elution by increasing concentrations of phosphate
buffer (298,305,306,310,315,316). Some workers have found the use of
octylamino-Sepharose to be satisfactory (303,307,308,317), and the use
of lauric acid affinity chromatography has been reported (301).
It is of interest to note that the usually low overall recovery
of cytochrome P-450 and the length of time involved in purification
procedures consisting of many steps has recently resulted in increased
attention to improving recoveries of cytochrome P-450 in the initial
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steps of purification schemes. The use of affinity chromatography at
a relatively early stage of a purification is often a particularly
satisfactory solution to these problems.
(c) Purification of a cytochrome P-450 preparation capable of supporting
cholesterol 7a-hydroxylation in a reconstituted system
(i) Procedures used in this laboratory
Dr. Hattersley, of this laboratory, tried many techniques, in various
combinations, in attempts to purify preparations of cytochrome P-450
capable of supporting cholesterol 7a-hydroxylase activity in the
presence of NADPH-cytochrome c reductase (225). Perhaps the most
satisfactory preparation involved the solubilization of butanol-
extracted microsomes with 4 pi Nonidet P42 per mg protein followed by
centrifugation at 105 OOO x g for 1 hour. This solubilised preparation
was applied to a DEAE-cellulose column pre-equilibrated with 20 mM
potassium phosphate buffer pH 7.7, 0.4% Nonidet P42. Cytochrome P-450
was eluted from this column unadsorbed in one major and two subsidiary
peaks, largely separated from cytochrome b^ and NADPH-cytochrome c
reductase, which could be eluted by increasing the concentration of KC1
in the elution buffer. Fractions containing cytochrome P-450 were
pooled, diluted with glycerol to 20%, and added to a suspension of
hydroxylapatite pre-equilibrated in 10 mM potassium phosphate pH 7.7.
A batch-wise elution was carried out with increasing concentrations of
potassium phosphate buffer pH 7.7, 20% glycerol, 1% Nonidet P42.
Typically, the DEAE-cellulose chromatography gave less than a 50%
recovery of cytochrome P-450 with a purification of 1.0- to 1.5-fold.
About 80% of the cytochrome P-450 added to the hydroxylapatite was
recovered, in a rather broad elution profile, with approximately half
of this purified two-fold. This scheme therefore gives an overall
purification of cytochrome P-450 of between two- and three-fold, with
a recovery of about 15%.
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Various aspects of this scheme are worth noting. Firstly, butanol-
extracted microsomes were used. Butanol removes much of the phospholipid
and, more especially, cholesterol from microsomal preparations.
Since this low level of substrate might be helpful in various types of
experiment, for example in reducing dilution of added radioactive
cholesterol in cholesterol 7a-hydroxylase assays, and since these
preparations retain activity well when stored at -20°C, butanol-extracted
microsomes were rountinely used for all this work.
Secondly, the microsomal protein was solubilised with Nonidet P42.
Most cytochrome P-450 purification schemes have involved an initial
solubilisation with sodium cholate or deoxycholate, even if this is
replaced by a nonionic detergent at a later stage of the preparation.
These bile acids proved, perhaps unsurprisingly, to act as powerful
inhibitors of cholesterol 7a-hydroxylase activity. The use of Nonidet
is the only method of the many which have been tried that solubilises
cholesterol 7a-hydroxylase without a substantial .inhibition of its
activity (225).
Thirdly, although the DEAE-cellulose chromatography gave no
purification and relatively low recoveries of cytochrome P-450,
the fairly good separation of cytochrome P-450 from cytochrome b^ and
NADPH-cytochrome c reductase makes this a useful first step in a
purification scheme, and allows some investigations of the requirements
for the reconstitution of enzyme activity to be done, even with such a
relatively impure preparation (225,226,318).
(ii) Procedures reported by other laboratories
In 1974 the reconstitution of cholesterol 7a-hydroxylase activity
from partially purified cytochrome P-450 and NADPH-cytochrome c reductase
was reported by I. Bjorkhem, H. Danielsson and K. Wikvall (318).
However, sodium cholate was used for the microsomal solubilisation,
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although at a concentration three-fold less than that usually used,
and this had a strong inhibitory effect on enzymic activity. Attempts
at subsequent purification were generally unsuccessful, especially
when involving the use of chromatographic procedures. It was possible
to fractionate with polyethylene glycol or ammonium sulphate, but the
extent of purification was low (319).
Since the work reported in subsequent parts of this Section was
performed, Hansson and Wikvall have published schemes for the preparation
of cytochrome P-450 active in 7a-hydroxylation, from rats and rabbits,
to specific contents of 8.1 and 3.7 nmoles per mg protein, respectively
(320). These procedures are summarised in Figure 3.1. It should be
noted that Renex 690 was used for the solubilisation of rat liver
microsomes, at a concentration of 1 pi per mg protein (see Section 3.2).
Nonidet P42 was used for the solubilisation of rabbit liver microsomes
at a concentration of 3 pi per mg protein.
3.2 The use of Renex 690 as a solubilising agent
Renex 690 has been much used in cytochrome P-450 purification work,
usually after initial solubilisation by sodium cholate or deoxycholate
(315,316), but also as the initial microsomal solubilising agent (320).
A 10% solution of Renex 690 was added to suspensions of butanol-
extracted microsomes (lOO mg protein per 8.7 ml, in centrifuge tubes)
at detergent:protein ratios equivalent to 0.1 to 1.0 pi undiluted Renex
690 per mg protein. After 20 minutes on ice, with occasional shaking,
these tubes were centrifuged at 105 OOO x g for 1 hour. The supernatant
was assayed for cytochromes P-450 and b^. These results were expressed
as a percentage of the concentrations in the original suspension
(Figure 3.2). The decrease in the amount of cytochrome P-450 solubilised
at higher detergent concentrations was at least partly due to a large
conversion to cytochrome P-420.
Figure 3.1(a)
Purification of cytochrome P-450 from liver of cholestyramine-
treated rats
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The effect of Renex 690 on cholesterol 7a-hydroxylase activity was
investigated by adding various concentrations of the detergent to
enzyme assay incubations. The results are shown in Figure 3.3.
The presence of 0.5 jal Renex 690 per mg protein depressed cholesterol
7a-hydroxylase activity to less than 50% of control values.
It was concluded that Renex 690 was not a useful detergent for
cholesterol 7a-hydroxylase or cytochrome P-450 solubilisation.
3.3 DEAE-cellulose chromatography
(a) General description
Microsomes prepared from rats fed on 4% cholestyramine for one
week were freeze-dried and extracted with butanol at -20°C as described
in the methods section. This butanol powder was suspended at a
concentration of 50 mg/ml in buffer and solubilised by the addition of
4 pi. Nonidet P42 per mg protein. After centrifugation at 105 000 x g
for 1 hour, a suitably-sized sample was applied to the DEAE-cellulose
column, which had been pre-equilibrated by washing with at least 5
column volumes of a solution of 0.4% Nonidet P42 in the buffer used
for suspension.
The column was then washed with three column volumes of this
equilibration buffer. This eluted cytochrome P-450 in one large unbound
peak, and a smaller, slightly retarded, subsidiary peak, which usually
appeared as a shoulder on the major peak.
The remaining monooxygenase components were usually eluted with a
linear gradient of KC1 in the range of 0-0.4 M in the equilibration
buffer. This eluted first cytochrome b,. in a fairly broad band, followed
by, and overlapping with, NADPH-cytochrome c reductase. These components
were alternatively occasionally eluted by stepwise increases of the
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were chosen such that the first increase would hopefully elute any
cytochrome P-450 still adsorbed to the column, uncontaminated by
cytochrome b,. (in fact, no cytochrome P-450 was ever detected in such
a fraction), the second would elute cytochrome b,_ largely uncontaminated
by NADPH-cytochrome c reductase, and the third would elute the
reductase largely free of cytochrome b,_.
The appearance of cytochromes from the column was often conveniently
monitored by the absorbance of the eluate at 419 ran, the wavelength of
their Soret absorption band. The concentrations of monooxygenase
components and of protein were determined either in each fraction or in
suitably pooled groups of fractions, and recoveries and purifications
were calculated.
(b) Control conditions
In control experiments the buffer used for suspension of the
butanol powder was 20 mM potassium phosphate pH 7.7, and the DEAE-
cellulose column was pre-equilibrated with 20 mM potassium phosphate
pH 7.7, 0.4% Nonidet P42. A typical elution profile of a column
eluted with a linear gradient of KC1 concentration is shown in
Figure 3.4.
For five experiments, the mean recovery of cytochrome P-450 was 43%,
and the mean purification (the ratio of nmoles cytochrome P-450 per mg
protein in the pooled cytochrome P-450-containing fractions to that
in the applied sample) was 1.1-fold, and in some of the experiments
actually fell to values less than 1.0. Contamination of this fraction
by NADPH-cytochrome c reductase was frequently undetectable, and at
most represented less than 5% of the total activity applied to the
column. The amount of cytochrome b in this cytochrome P-450-containing
fraction varied, and was typically 10%, but under some conditions could
be up to 35%, of the cytochrome b^ eluted from the column.
Figure 3.4
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(For microsomal protein solubilisation see Section 2.4.
The column volume was 15 ml; 39 mg microsomal protein
in a volume of 3 ml was applied to the column; elution
was with 30 ml 20 mM potassium phosphate, pH 7.7, 0.4%
Nonidet, followed by a 0-0.5 M potassium chloride gradient
in this buffer; 4.5 ml fractions were collected.)
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The main conclusions from this work were therefore that DEAE-
cellulose chromatography gives no increase in the specific content of
cytochrome P-450, and that less than 50% of the cytochrome P-450
applied to the column was detectable in the eluate. It was felt that
these facts were linked, and were likely to be a consequence of loss
of haem from the cytochrome to give a spectrally undetectable species,
and therefore that any attempts to raise the recovery of cytochrome
P-450 could be hoped to bring a concomitant increase in its
purification. It was considered worthwhile to look for conditions
resulting in this increase in recovery and purification, rather than
to try completely alternative techniques, since in principle DEAE-
cellulose chromatography is a good first step in a purification
scheme for cytochrome P-450, because of the satisfactory separation
from NADPH-cytochrome c reductase. For a first step in such a
scheme, however, the low recovery obtained was particularly unacceptable,
(c) The use of various protective agents
The results of these experiments are summarised in Table 3.1.
(i) Dithiothreitol
The effect of polyols and certain thiols in promoting the
reconversion of cytochrome P-420 to cytochrome P-450 is well known
(309). For this reason, many workers in the field of microsomal
cytochrome P-450 purification routinely add glycerol and/or a thiol,
commonly dithiothreitol, to the buffers used (297,308,310).
Dithiothreitol was therefore added to the buffers used for
solubilisation and chromatography, at a concentration of 0.1 mM.
Recovery and purification increased slightly, to 49% (probably still
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(ii) 4-Phenyl-imidazole
The cytochrome P-450 isolated from Psueodmonas putida grown in the
presence of camphor as the sole carbon source is extremely stable in
the presence of relatively low concentrations of its substrate, camphor,
presumably because of some conformational effect of having the substrate
binding site occupied. In the purification of the cytochrome P-450
species of bovine adrenal cortical mitochondria that is responsible
for the cleavage of the side-chain of cholesterol, the use of a
cytochrome P-450 ligand, 4-phenyl-imidazole, has proved to be of
considerable benefit, presumably because of a similar stabilising
action (Dr. R. Hume, personal communication).
Figure 3.5 illustrates the difference spectrum observed on the
addition of 4-phenyl-imidazole to a suspension of butanol-extracted
microsomes. The addition of increasing amounts of 4-phenyl-imidazole
allows the calculation of an apparent spectral binding constant, K^.
The variation of the value of this constant with cytochrome P-450
concentration is plotted in Figure 3.6.
In the range of cytochrome P-450 concentrations encountered in
column chromatography eluates (up to 1.5 nmoles/ml) the apparent Ks
varied up to about 20 pM. In order that the cytochrome should be
saturated with ligand at these concentrations (and also at the higher
concentrations used during solubilisation, when it should be noted,
however, there was little loss of cytochrome), 4-phenyl-imidazole was
added to all solutions used for solubilisation and chromatography to a
final concentration of 1.0 mM. This resulted in an increase in the
recovery of cytochrome P-450 to 70%, and an increase in the purification
to 1.9-fold.
Figure 3.5
CYTOCHROME P-450 DIFFERENCE SPECTRUM
OBTAINED WITH 4-PHENYL-IMIDAZOLE
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4-phenyl-imidazole concentration = 60 nmol/ml
Figure 3.6
The variation of the spectral binding constant of 4-phenyl-imidazole
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(iii) Diethyldithiocarbamate
In the preparation of the prostaglandin-synthesising cyclooxygenase
diethyldithiocarbamate has been used to increase enzyme recoveries (321).
This compound is a copper chelator, but its mode of action in increasing
recoveries of this enzyme is obscure, since the purified cyclooxygenase
contains no copper. It is possible to speculate that the removal of
trace amounts of copper from the enzyme solutions might prevent autoxidative
processes which might be promoted in the presence of some transition
metal ions. Alternatively, the particular combination of hydrophobic
properties and mercaptan groups may be involved.
The use of 10.0 mM diethyldithiocarbamate in the buffers used for
solubilisation and chromatography of microsomal protein gave a recovery
of cytochrome P-450 of 54%, and a purification of more than 2-fold.
Diethyldithiocarbamate was able to reduce cytochrome c, and in assays
for NADPH-cytochrome c reductase this background rate of reduction was
therefore subtracted from all reaction rates to obtain values for
enzymic reduction rates. The elution profile of apparent NADPH-
cytochrome c reductase activity was profoundly altered by the presence
of diethyldithiocarbamate, when a large peak of activity eluted with
cytochrome P-450. In an attempt to resolve whether this activity
was genuinely due to the presence of NADPH-cytochrome c reductase, or
was an artefact, the flavin content (flavin adenine dinucleotide plus
flavin mononucleotide) of pooled groups of fractions of eluate from
columns run in the presence and absence of diethyldithiocarbamate was
measured (Figure 3.7). This did not succeed in resolving the problem,
since a large peak of flavin elutes in the void volume of the column,
with cytochrome P-450, whether or not diethyldithiocarbamate is present.
There is, however, little apparent change in flavin elution profile,
which is suggestive that the change in the elution profile of apparent
Figure 3.7(a)
DEAE - cellulose chromatography





















(For microsomal protein solubilisation see Section 2.4.
The column volume was 30 ml? 84 mg microsomal protein
in a volume of 4 ml was applied to the column? elution
was with 60 ml 20 mM potassium phosphate, pH 7.7, 10% glycerol,
0.4% Nonidet, followed by a 0-0.5 M potassium chloride gradient
in this buffer? 4.2 ml fractions were collected.)
Figure 3.7(b)
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(Conditions were as specified for Figure 3.7(a), except all
buffers contained 10 mM diethyldithiocarbamate, and 89 mg
microsomal protein was applied to the column.)
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activity of NADPH-cytochrome c reductase is not the result of a change
in the elution pattern of the enzyme itself.
Further evidence, again inconclusive, for this statement is
offered by the results summarised in Table 3.2. In this experiment
1 ml 0.1 M potassium phosphate buffer pH 7.4 containing 0.4 mg cytochrome c,
1 mg glucose-6-phosphate and 0.3 mg NADP+ was pipetted into a cuvette,
followed by additions of 100 fj.1 10 mM diethyldithiocarbamate, 1.0 U
glucose-6-phosphate dehydrogenase, and 100 jj.1 of a 2.55 nmole/ml
solution of cytochrome P-450, as indicated in the table. (The cytochrome
P-450 solution was a partially purified sample of bovine adrenal
mitochondrial cytochrome P-450, kindly supplied by Dr. R. Hume, and
contained no detectable NADPH-cytochrome c reductase activity.) The rate
of reduction of cytochrome c was measured. It is apparent that
cytochrome c is reduced by diethyldithiocarbamate, and the rate of
this reduction is enhanced by the presence of cytochrome P-450.
The presence of glucose-6-phosphate dehydrogenase, and hence of NADPH,
makes little difference to the observed reduction rates.
These results demonstrate that a peak of NADPH-cytochrome c
reductase activity would be detected as coeluting with cytochrome P-450
in the presence of diethyldithiocarbamate, even if no enzyme was in
fact present. It was not, however, possible to demonstrate unequivocally
that the observed peak was not due to the presence of NADPH-cytochrome c
reductase.
(iv) 4-Phenyl-imidazole and diethyldithiocarbamate
When a combination of 1.0 mM 4-phenyl-imidazole and 10.0 mM
diethyldithiocarbamate was used in the solubilisation and chromatography
buffers the recovery and purification of cytochrome P-450 were 54% and
1.2-fold, respectively.
Table 3.2
Reduction of cytochrome c by diethyldithiocarbamate
Cytochrome c reduction rate
(nmoles/min)
Additions* No G6PDHt 1.0 U G6PDH
1.0 pmol DDCt 3.99 4.22
0.255 nmol P-450+ 0.44 1.55
1.0 (tmol DDC +
0.255 nmol P-450 7.33 7.77
*All cuvettes contained 0.4 mg cytochrome c, 1 mg glucose-6-
phosphate, 0.3 mg NADP in 1 ml 0.1M potassium phosphate buffer,
pH 7.4, with the specified additions.
tAbbreviations: G6PDH, glucose-6-phosphate dehydrogenase;
DDC, diethyldithiocarbamate; P-450, bovine adrenal
mitochondrial cytochrome P-450, free of detectable NADPH-
cytochrome c reductase activity.
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Some cytochrome b always elutes from a DEAE-cellulose chromatography
column with the main peak of cytochrome P-450, although the main peak of
cytochrome b^_ does not elute until the ionic strength of the eluting
buffer is increased. There is no evidence for a heterogeneous population
of cytochrome b in liver microsomes. In order to try to adsorb all the
cytochrome b to the DEAE-cellulose column while cytochrome P-450
eluted unadsorbed, and also, perhaps, to achieve a better separation of
the different cytochrome P-450 peaks, solubilisation and chromatography
were performed in buffers of reduced ionic strength. (It should be
noted that this approach makes the implicit assumption that adsorption
to the ion-exchange column is dependent on protein structure. Since
some lipid remains firmly bound to protein during chromatography,
protein adsorption could be due to charged groups on these lipid
molecules, and hence variations in adsorption could be caused by
differing numbers of lipid molecules bound to the protein.)
Butanol-extracted microsomes were suspended in 10 mM potassium
phosphate pH 7.7, 10 mM 4-phenyl-imidazole, 10.0 mM diethyldithiocarbamate
and chromatography was performed in a 0.4% solution of Nonidet P42 in
this buffer. The recovery of cytochrome P-450 was relatively low (26%) ,
but, since the amount of protein eluting in this first, unadsorbed,
peak was also low, the specific content of cytochrome P-450 was high
(2.3-nmoles/mg protein) and the purification was high (2.3-fold).
However, 8% of the cytochrome b applied to the column eluted with
the cytochrome P-450, and under these circumstances of low cytochrome
P-450 recovery this totalled a quantity greater than 65% of the amount
of cytochrome P-450 present in this fraction.
(v) Glycerol
Since the observation that the presence of polyols and certain
thiols promotes the reconversion of cytochrome P-420 to cytochrome P-450
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(309), many workers in the field of hepatic microsomal cytochrome P-450
purification have routinely added various concentrations of glycerol to
the buffers used in their purification schemes (297,308,309).
Solubilisation was performed in 20 mM potassium phosphate pH 7.7,
10.0 mM diethyldithiocarbamate, 10% glycerol, and DEAE-cellulose
chromatography was run in a 0.4% Nonidet solution in this buffer.
Recovery and purification were 46% and 0.86-fold, respectively.
These relatively low results could possibly be ascribed to the increased
running time of the column, because of the higher viscosity of the
buffers. It was noticeable, however, that cytochrome P-450 spectra
were more satisfactory, exhibiting only a small shoulder at 420 nm.
Because of this advantage of running the chromatography in a glycerol-
containing buffer a further attempt was made to find satisfactory
conditions for chromatography in the presence of glycerol. 20 mM
Potassium phosphate buffer pH 7.7, 10 mM diethyldithiocarbamate, 10% glycerol
1.0 mM 4-phenyl-imidazole was used for solubilisation, and a 0.4%
solution of Nonidet P42 in this buffer for chromatography. This gave a
39% recovery and a 1.1-fold purification.
(vi) 1% Nonidet P42
There is a possibility that the elution profile of solubilised
microsomal protein from a DEAE-cellulose column depends not only on
charged groups on the protein, but also on charged groups on the lipids
bound to the protein. If this is so, it might be possible to alter the
elution of microsomal proteins by performing solubilisation and
chromatography at raised detergent concentrations if this resulted in
a displacement of a greater number of charged lipids from the protein,
and their replacement by uncharged detergent molecules.
Butanol-extracted microsomes were therefore suspended in 20 mM
potassium phosphate buffer pH 7.7, 10.0 mM diethyldithiocarbamate,
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1.0 mM 4-phenyl-imidazole, 10% glycerol and solubilised with 5 jllI
Nonidet P42 per mg protein. Chromatography was carried out in a 1%
Nonidet P42 solution in the buffer used for suspension. This resulted
in the loss of 90% of the cytochrome P-450, principally to some
spectrally undetectable species, but also to cytochrome P-420.
3.4 Quaternary amino ethyl-Sephadex chromatography
Under all conditions used for DEAE-cellulose chromatography a
substantial proportion of the cytochrome b,_ applied to the column
elutes in cytochrome P-450-containing fractions. Because of the
controversy surrounding the possible role of cytochrome b^_ in microsomal
cytochrome P-450-dependent hydroxylations this is a particularly
undesirable contaminant. It was therefore decided to try the use of a
stronger anion exchanger, quaternary amino ethyl Sephadex (QAE-Sephadex),
as an alternative first step in cytochrome P-450 purification.
Butanol-extracted microsomes were suspended in 20 mM potassium
phosphate pH 7.7, 1.0 mM 4-phenyl-imidazole, 10% glycerol and solubilised
with 4 )il Nonidet P42 per mg protein. Chromatography was run in 0.4%
Nonidet P42 in the buffer used for suspension, with elution by a
linear gradient of KC1.
The elution profile of this QAE-Sephadex column was the same as
that of a DEAE-cellulose column, with cytochrome P-450 eluting unabsorbed,
followed by cytochrome b<_ and NADPH-cytochrome c reductase at raised
ionic strengths. There was a 38% recovery, the specific content of the
recovered cytochrome P-450 fell to O.7-fold that of the applied sample,
and 40% of the recovered cytochrome b,. eluted with cytochrome P-450.
3.5 Carboxymethylcellulose chromatography
Since cytochrome P-450 elutes unbound from a DEAE-cellulose column
it was decided to try the use of a cation exchange column as an alternative
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first step. Various cation exchanges were used under various conditions
by N.G. Hattersley, but always after DEAE-cellulose chromatography,
when no purification of cytochrome P-450 was observed{"2.ZS").
In 20 mM potassium phosphate pH 7.7, 10% glycerol, 0.4% Nonidet P42,
cytochromes P-450 and b^_ and NADPH-cytochrome c reductase eluted
together, unbound (Figure 3.8). All the cytochrome P-450 was recovered,
with a 1.3-fold increase in specific content. Similar results were
obtained when the buffer concentration was decreased to 5 mM.
When 5 mM potassium acetate, pH 6.2, 10% glycerol, 0.4% Nonidet P42
was used cytochrome P-450 bound to the column. When the ionic strength
of the eluting buffer was raised by means of a linear KC1 gradient
monooxygenase components again eluted together. The recovery of
cytochrome P-450 was low (25%) and its specific content was decreased
to 0.4 times that of the applied material.
3.6 Hydroxylapatite chromatography
In the light of the DEAE-cellulose experiments described above,
where increased detergent concentrations resulted in large losses of
cytochrome P-450 and the presence of glycerol tended to depress
recoveries even while minimising degradation to cytochrome P-420,
the requirement for performing hydroxylapatite chromatography in
phosphate buffers containing 20% glycerol and 1% Nonidet P42 was
investigated.
The cytochrome P-450-containing fractions from a DEAE-cellulose
column were pooled and stirred into a suspension of washed hydroxylapatite
in the first elution buffer, at a ratio of 1 g hydroxylapatite per 5 mg
o
protein. After lO minutes stirring at 4 C the hydroxylapatite was
sedimented by centrifugation, and resuspended in a volume of the next
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(For microsomal protein solubilisation see Section 2.4.
The column volume was SO ml; 71.4 mg microsomal protein
in a volume of 6 ml was applied to the column; elution
was with lOO ml 20 mM potassium phosphate, pH 7.7, 10% glycerol,
0.4% Nonidet, followed by a 0-0.5 M potassium phosphate gradient
in this buffer; 5.4 ml fractions were collected.)
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This procedure was repeated with the buffer concentrations specified
in Table 3.3.
The results of three experiments are given in Table 3.3, with some
results reported by N.G. Hattersley for comparison. The omission of
glycerol and reduction of Nonidet P42 concentration to 0.4% reduces the
total cytochrome P-450 recovery to 33%. In the absence of glycerol and
high concentrations of Nonidet P42 cytochrome P-450 bound much more
strongly to the hydroxylapatite, only being eluted at high concentrations
of potassium phosphate.
On increasing the concentration of Nonidet P42 to 1.0% the
cytochrome P-450 eluted at slightly lower phosphate buffer concentrations.
Recovery of cytochrome P-450 summed over all recovered fractions was
100%, and 55% of this recovered cytochrome P-450 was purified by more
than 5-fold. When glycerol was added to a total concentration of 10%
recovery of cytochrome fell to 65%. There was however a greater than
7-fold purification of 16% of the applied cytochrome P-450.
3.7 Iodosobenzene as a donor of "active oxygen" for cholesterol
7a-hydroxylation
These studies on the resolution of cholesterol 7a-hydroxylase
components have concentrated on cytochrome P-450, since there is
evidence that this is where the specificity of this enzyme resides
(225) . There is a need, however, to demonstrate that the cytochrome
P-450 preparations obtained are capable of supporting cholesterol 7a-
hydroxylase activity. One way of doing this involves the use of a
pure preparation of NADPH-cytochrome c reductase which would act by
reducing the cytochrome P-450-substrate-oxygen complex, and thereby
"activating" the oxygen to a species capable of reacting with the
substrate cholesterol.
Table3.3
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An alternative approach would be to use one of those compounds that
have been used to investigate the nature of the "active oxygen" species
involved in cytochrome P-450-catalysed reactions and which are able to
support reaction in the absence of molecular oxygen or NADPH (322-329).
The type of reaction mechanism by which these compounds are thought to
work is shown in Figure 3.9.
Iodosobenzene was synthesised and shown to be more than 98% pure,
with contamination by iodoxybenzene less than 0.5%. Persistent attempts
to demonstrate cholesterol 7a-hydroxylase activity supported by
iodosobenzene were unsuccessful, both under aerobic and anaerobic conditions,
and at times from 10 s to 1 hr. A low rate of NalO^-supported reaction
was detectable (1.5% conversion of tracer cholesterol to 7a-hydroxy-
cholesterol in 1 hr), but was concomitant with a high level of cholesterol
autoxidation, principally to 7-ketocholesterol.
It has been suggested that iodosobenzene-supported reaction
proceeds with destruction of cytochrome P-450 (328) . This observation
was confirmed by the present work, where a suspension of butanol-
extracted microsomes was placed in the sample and reference cuvettes
of the Unicam SP80O difference spectrometer. The addition of
iodosobenzene to the sample cuvette caused the appearance of a broad
trough in the difference spectrum, centred at approximately 420 nm.
This trough had completely formed within five minutes of adding
iodosobenzene, and the reaction was 60% complete after one minute,
and 80% complete after two minutes. This result was not affected by
the use of anaerobic conditions, or by the use of a solubilised
cytochrome P-450 preparation free of detectable NADPH-cytochrome c
reductase activity.
Figure 3.9
A reaction mechanism for cytochrome P-450 showing a possible site
























































All assays for acyl-coenzyme A:cholesterol acyltransferases follow,
with no or only minor modifications, that published by Goodman et al
(248), described in more detail by Goodman (249) . In this assay,
enzyme activity is measured by the conversion of exogenous radioactive
cholesterol to cholesterol ester in an in vitro incubation of microsomes.
These incubations can be performed in two ways. Fatty-acyl-coenzyme A
can be used as cosubstrate for the esterification, the activity thus
measured being a function of only one enzyme-catalysed reaction, that
catalysed by acyl-coenzyme A:cholesterol acyltransferase. Alternatively,
a combination of ATP, coenzyme A and potassium oleate can be used,
when a combination of two reactions is measured, the activation of fatty
acid to fatty-acyl coenzyme A, and the transfer of the fatty acid moiety
of this species to cholesterol. Since the point of interest of these
investigations was the rate of the net conversion of cholesterol to
cholesterol ester in rat liver endoplasmic reticulum, and this rate will
depend on both these reactions, this latter approach was adopted, with
the following modification. The measured activity in the presence of
ATP, coenzyme A and potassium oleate has been shown by Goodman et al
(248) to be slightly greater than in the absence of potassium oleate
r 14
(13.3% conversion of free L4- CJ-cholesterol to cholesterol ester rather
than 12.1% conversion). Since this stimulation as measured by these
authors is relatively small, and proved difficult to reproduce (results
not shown), potassium oleate was not added to incubations.
This approach to the assay of acyl-coenzyme A:cholesterol acyltrans-
ferase suffers from the same problems as the similar assay for cholesterol
7a-hydroxylase, discussed in detail in Sections 2.11, 2.13, 7.4 and 8.2
and elsewhere (174,245,250-253), namely (i) the insolubility of cholesterol
and hence the difficulty of delivering the exogenous radioactive
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cholesterol to the enzyme without the use of concentrations of either
detergent or organic solvent that raise the possibility that the enzyme
or its membranous environment is disturbed; (ii) the cholesterol of
microsomes exists in more than one compartment, and these compartments
are not necessarily equally accessible to the enzyme; (iii) added,
radioactive cholesterol does not necessarily partition into each of
these compartments to an equal extent.
It is in an attempt to avoid these problems, and to arrive at
absolute values for acyl-coenzyme A:cholesterol acyltransferase rather
than merely fractional conversions of exogenous labelled cholesterol,
that most of the published modifications of the original assay of
Goodman et al (248) have been used.
These modifications have involved the use of labelled fatty acyl-
coenzyme A (usually [l-44c]-oleoyl-coenzyme A (330,331), or [i-14c]-
palmitoyl-coenzyme A (3 32,333,334)) or of [l-^^c]-oleic acid in the
presence of ATP and coenzyme A (122,252,335). In each case the assumptions
are made that the added labelled substrate will exist in the incubation
as a single homogeneous pool, and that the amount of endogenous
unlabelled fatty acid or fatty acyl-coenzyme A is negligible. This
means that the exogenous labelled substrate will not be diluted to a
significant extent on addition to the incubation, and hence that the
specific radioactivity of cholesterol esters formed during incubation
will be the same as that of the substrate. Thus, an absolute rate of
cholesterol ester production can be calculated.
This approach was not adopted for the preliminary experiments on
acyl-coenzyme A:cholesterol acyltransferase for various reasons.
Among these reasons was the fact that activities were to be compared
with those of cholesterol 7a-hydroxylase under various conditions.
Since absolute activities for cholesterol 7a-hydroxylase are not
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readily obtainable, and it was desirable that the enzyme activities
should be expressed in a similar form, it was necessary to determine
activities for esterification in terms of a fractional conversion of
exogenous labelled free cholesterol to cholesterol ester. Also, it was
hoped that eventually estimates would be made of the size of the
cholesterol pool acting as substrate for esterification, and this
requires values for acyl-coenzyme A:cholesterol acyltransferase activity
expressed both in absolute terms and as a fractional conversion of
added tracer cholesterol to cholesterol ester.
4.2 The effect of variation of protein concentration
Varying amounts of microsomes from the pooled livers of three rats
fed cholesterol-rich diet for eight days were incubated for 1 hour at
37°, in the presence of 0.5 mM coenzyme A, 2 mM ATP, 4 mM MgCl^, 3.3 mM
r 14 -i
reduced glutathione and 0.05 (uCi L4- CJ-cholesterol in a total of 3 ml
0.1 M potassium phosphate buffer, pH 7.1. Figure 4.1 shows the observed
percentage conversion of [4-^4c]-cholesterol to [4-^c]-cholesterol ester,
both in absolute terms and per 100 p.g protein added.
The non-linearity of activity and the non-constancy of specific
activity when the enzyme concentration is varied illustrate well the
inherent problems in the assay of enzymes where changes in enzyme
concentration bring concomitant changes in endogenous substrate
concentration and hence variations in the dilution of exogenous tracer
substrate.
A further complication is introduced by the possibility that there
exist several microsomal cholesterol pools and that these are not
equally accessible to the action of acyl-coenzyme A:cholesterol acyl¬
transferase. Over the very wide range of microsomal protein concentration
used for this experiment it is quite possible that the exogenous tracer
Figure 4.1
The effect of protein concentration cn acyl-coenzyme A :
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substrate will equilibrate into these different cholesterol pools to
varying extents, providing a further reason for the observed non-linearity.
Another experiment was therefore performed to examine the effect
of the variation of protein concentration over a much smaller range.
Incubations were for 20 minutes at 37°, and contained 2 mM ATP, 4 mM
MgCl^, 3.3 mM reduced glutathione and 0.05 mM coenzyme A in a total
volume of 3 ml 0.1 M potassium phosphate pH 7.1 (Figure 4.2). Little
variation of percent conversion of [4-"^c]-cholesterol to [4-^^c]-
cholesterol ester was detected. This is as would be expected if
(a) the specific activity of the enzyme (i.e. the activity expressed
as moles of product produced per mg protein) was constant, (b) the
fraction of the total microsomal cholesterol in the cholesterol pool
preferentially used as the enzyme substrate was constant and (c) a
constant fraction of tracer cholesterol enters the enzyme substrate
pool.
If it is assumed that microsomal cholesterol exists as a single pool,
and exogenously added radioactive cholesterol equilibrates completely
into this pool, it is possible to calculate a specific radioactivity of
the substrate cholesterol and hence of the product cholesterol ester.
Thus, by multiplying the percentage conversion of [4-1^c]-cholesterol to
[4-"^c]-cholesterol ester by the amount of endogenous cholesterol
present in the incubation it is possible to obtain an estimate of the
absolute enzyme activity. This estimate will always consistently
overestimate the actual activity by factors related to the fraction of
total microsomal cholesterol in the substrate pool and the equilibration
of radioactive cholesterol into this pool. (This problem is discussed
in detail in Section 2.13.)
Figure 4.3 shows the results of Figure 4.2 reworked in this manner,
when a satisfactory straight line is obtained.
Figure 4.2
EFFECT OF VARIATION OF PROTEIN CONCENTRATION ON
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The main conclusion to be drawn from these experiments where protein
concentration was varied was that when acyl-coenzyme A:cholesterol
acyltransferase activities of a number of preparations were to be
compared it is desirable to keep the protein concentrations of all
samples as closely similar as possible, because of the non-linearity of
activity with protein concentrations.
4.3 Time-course of acyl-coenzyme A:cholesterol acyltransferase activity
Microsomes were prepared from the livers of rats fed cholesterol for
10 days. Incubations of 130 fig microsomal protein were performed at 37°
for varying lengths of time in the presence of 0.5 mM coenzyme A, 2 mM
ATP, 4 mM MgC^/ 3.3 mM reduced glutathione. The result is shown in
Figure 4.4. The rate of cholesterol ester production was linear and
relatively high up to 20 minutes, after which the rate declined.
This result is closely similar to that of Balesubramanian et al (252),
who interpret the break in activity at 20 minutes as indicating that the
cholesterol in the enzyme substrate pool has become sufficiently depleted
that enzyme activity becomes limited by the migration of cholesterol
into this pool from other pools within the microsomal membrane.
4.4 The effect of variation of coenzyme A concentration
Microsomes were prepared from rats fed a cholesterol diet for
o
8 days. Microsomal protein (100 jig) was incubated at 37 for 20 minutes
with 2 mM ATP, 4 mM MgCl^/ 3.3 mM reduced glutathione and various
concentrations of coenzyme A. Figure 4.5 demonstrates that there is no
significant variation in the activity of acyl-coenzyme A:cholesterol
acyltransferase over a wide range of coenzyme A concentration. As a
result of this experiment the concentration of coenzyme A routinely used
in assays was decreased from 0.5 mM to 0.05 mM.
Figure 4.4
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Section 5




Little work has been done to extend the original observations of
Mukherjee et al (336) and of Goodman et al (248) on hepatic acyl-
coenzyme A:cholesterol acyltransferase. These were principally the
demonstration of the requirement for ATP and coenzyme A, or alternatively
for fatty acyl-coenzyme A, if cholesterol esterification is to proceed
at significant rates and the investigation of the specificity of the
enzyme towards a series of free fatty acids of varying length and
saturation.
In work on the fatty acid synthetase enzyme complex the use of
coenzyme A analogues has proved very useful (337,338). These could be
substituted for coenzyme A for various types of study, though usually,
because of the low affinities of the enzyme for these compounds, the
concentrations used had to be many times higher than the concentration
of coenzyme A for similar reaction rates to be observed (338). One of
the most successfully used analogues has been N-acetyl-cysteamine, whose
structure, together with that of coenzyme A, is given in Figure 5.1.
The ability of N-acetyl-cyteamine and N-acetyl-cysteine to support
cholesterol esterification by microsomes in the presence of ATP was
therefore investigated.
Liver acyl-coenzyme A:cholesterol acyltransferase has a substrate
preference for fatty acids that are mono-unsaturated, oleic acid being
the optimum (248). In liver microsomes there exists a cytochrome b^-
dependent fatty acyl-coenzyme A desaturase system. Since very little
is known of the source of the fatty acid for cholesterol esterification,
the effect of a series of conditions designed to perturb the activity
of the desaturase on the rate of cholesterol esterification was
investigated. This was in the hope that, in the absence of exogenous
fatty acid, variations in the rate of the desaturase might alter the
Figure 5.1
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size of the endogenous microsomal fatty acid pool and hence the rate of
cholesterol esterification (Figure 5.2).
Acyl-coenzyme A:cholesterol acyltransferase is found in the rough
endoplasmic reticulum enzyme (339,340), and sediments with the microsomal
fraction when centrifuged at 105 OOO x g for 1 hour. However, in
cholesterol-fed rats, the cholesterol ester which accumulates as lipid
droplets in the liver does not sediment with the microsomes on
centrifugation, but forms a floating layer at the surface of the
supernatant.
Cholesterol ester is soluble in unilamellar egg yolk lecithin
liposomes to 5 moles per cent (341), probably in a "horseshoe"
structure with the ester linkage near the lipid-water interface and the
cholesterol and fatty acid moieties buried within the hydrophobic
membrane core (341). A small amount of cholesterol ester sediments
with microsomes, but the proportion of this ester dissolved within the
membrane in this manner, as opposed to being associated with proteins
within the lumen of the microsomal vesicles (for example, nascent
lipoproteins) is unknown. Indeed, it is possible that all of the
sedimented cholesterol ester is associated with protein rather than
with membrane lipid.
Two possibilities for the immediate fate of newly synthesised
cholesterol ester are therefore that it is dissolved within the
microsomal membrane, or that it is extruded into the intravesicular
space to become associated with a protein. A third, perhaps less likely,
alternative is that the cholesterol ester is extruded into the
extravesicular space. That is, in an intact cell the cholesterol
ester would be secreted directly into the cytoplasm to form lipid
droplets.
Figure 5.2
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As a preliminary investigation into these possibilities the
r 14 i
sedimentation behaviour of L4- CJ-cholesterol ester newly synthesised
from [4-14c]-cholesterol was observed.
5.2 The use of N-acetyl-cysteine and N-acetyl-cysteamine as coenzyme A
analogues
The use of N-acetyl-cysteine at concentrations ranging from 50 pM
to 50 mM in incubations of 186 pg microsomal protein from cholesterol-
fed rats in the presence of ATP, MgCl^ and reduced glutathione did not
r 14-i
produce detectable esterification of exogenous L4- CJ-cholesterol.
N-acetyl-cysteamine more closely resembles the structure of the
active thiol end of coenzyme A than N-acetyl-cysteine, and has been
shown to be a more satisfactory coenzyme A analogue in the work on the
fatty acid synthase system (337,338).
Figure 5.3 shows the effect of incubating 240 pg microsomal protein
from cholesterol-fed rats either with 0.05 mM coenzyme A, or with various
concentrations of N-acetyl-cysteamine, in the presence of ATP, MgC^ and
reduced glutathione. The radioactivity recovered in the area corresponding
to cholesterol ester from the thin layer chromatogram in the presence of
0.05 mM or 20 mM N-acetyl-cysteamine was not above the level of
background radioactivity, which will account for approximately 0.75%
of the total recovered radioactivity. The activity observed in the
presence of 0.5 mM and 5 mM N-acetyl-cysteamine, although resulting in
clearly observable cholesterol ester peaks in the radioactivity scans
of the thin layer chromatography plates was probably not significantly
above background levels.
This experiment suggests that, while it might have been expected
that high concentrations of N-acetyl-cysteamine would be required to
observe reaction rates comparable to those obtained in the presence of
Figure 5.3
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coenzyme A, further increases in concentration above 20 mM are unlikely
to increase activity above the low values detected at 0.5 mM. If N-acetyl-
cysteamine was to be used as an analogue for coenzyme A in the study of
acyl-coenzyme A:cholesterol acyltransferase the main requirement would
thus be the use of more sophisticated means for assessing whether
observed reaction rates were above background levels. However, in this
range the detection of small changes in enzyme activity would be
extremely difficult.
More fruitful approaches would probably be the use of analogues
likely to have a higher affinity for the active site of the enzyme.
These analogues could be designed to resemble a greater part of the
coenzyme A molecule than N-acetyl-cysteamine does - an example would
be the use of N-(3-alanyl)-cysteamine.
An alternative would be to investigate the ability of fatty acyl
thioesters of N-acetyl-cysteamine to support cholesterol esterification
in the presence of microsomes.
5.3 The effect of in vitro perturbations of fatty acyl-coenzyme A
desaturase activity on cholesterol esterification
Various approaches to altering microsomal fatty-acyl-coenzyme A
desaturase were used. These included bubbling either oxygen or oxygen-
free argon through the microsomal suspension both before and during the
enzyme incubation, intended to, respectively, stimulate the enzyme
activity (in the presence of NADPH) and inhibit it. These conditions
were not wholly satisfactory, since the measured acyl-coenzyme A:
cholesterol acyltransferase activity of all samples that had been bubbled
with gas was lower than that of controls. This was probably attributable
to problems associated with frothing of the samples.
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The more satisfactory approach was therefore to use a high
concentration of potassium cyanide (1 mM) to completely inhibit any
desaturatase activity (342), and to use an NADPH-generating system to
support activity. (The natural reducing agent for fatty-acyl-coenzyme A
desaturase is NADH, but there is a considerable degree of cross-
specificity for NADPH (342) .) It should be noted that the presence of
NADPH will allow cholesterol 7a-hydroxylase activity. The presence of
oxygenated sterols will not affect the actual measurement of
esterification activity, since, in the solvent system used for
chromatography, these polar cholesterol derivatives will migrate with
cholesterol. It is possible that an active cholesterol 7a-hydroxylase
may influence esterifying activity, perhaps by altering the amount of
cholesterol available for esterification. However, some preliminary
experiments suggest that this is not so (Dr. K.E. Suckling, personal
communication), and in the absence of cysteamine cholesterol 7a-
hydroxylase activity will anyway be limited.
Table 5.1 shows the results obtained on the addition of either
1.0 mM potassium cyanide or NADPH generator to a standard assay for
acyl-coenzyme A:cholesterol acyltransferase activity. It can be seen
that potassium cyanide had no inhibitory effect and NADPH no stimulatory
effect on esterification activity. Under these conditions, then,
agents chosen to perturb the activity of fatty-acyl-coenzyme A
desaturase in vitro have no effect on acyl-coenzyme A:cholesterol
acyltransferase activity. This suggests either that the product of
the desaturase does not directly enter the substrate pool for
esterification or that esterification activity is not limited by the
supply of its preferred substrate.
Table 5.1
The effect of in vitro perturbations of fatty-acyl-coenzyme A




ACAT activity (% conversion)/
Experiment 1 Experiment 2
None 11.3 (l)t 11.3 (5)
KCN 11.2 (3) 12.6 (3)
NADPH 10.0 (3) 9.4 (2)
*The incubation contained 2 mM ATP, 4 mM MgCl^/ 0.5 mM coenzyme A,
3.3 mM reduced glutathione and 350 |ag protein (experiment 1) or
460 jug protein (experiment 2) in a total of 3 ml 0.1M potassium
phosphate buffer pH 7.4. KCN was added to a final concentration
of 1.0 mM. The NADPH-generating system was made up as for
cholesterol 7a-hydroxylase assays, and was added to give,+
per incubation, 12.5 mg glucose-6-phosphate, 3.75 mg NADPH ,
1.0 U glucose-6-phosphate, dehydrogenase. Incubation was for
1 hour at 37°.
/ACAT = acyl-coenzyme A:cholesterol acyltransferase.
+The figure in brackets indicates the number of replicates
included in the reported mean.
5.4 The fate of newly synthesised cholesterol ester
Acyl-coenzyme A:cholesterol acyltransferase incubations were
performed using 460 pg protein and the usual concentrations of cofactors.
Incubations were started at various times such that a time-course of
activity could be obtained, with all incubations being stopped at the
same time. The microsomal suspension was added to the solution of
cofactors in the incubation flask and the flask put into the incubation
bath five minutes before incubation was due to start, in order to allow
temperature equilibration. Incubation was started by the addition of
[4-14c]-cholesterol. Reaction in all flasks was stopped simultaneously
by transferring the flasks to ice. The contents of the flasks were
transferred to centrifuge tubes, with washing with two 1 ml aliquots
of phosphate buffer. These tubes were centrifuged at 105 OOO x g for
1 hour.
There was no visible floating lipid layer at the end of centrifugation.
The supernatants were transferred by aspiration (in an attempt to prevent
any unseen floating lipid adhering to the sides of the centrifuge tubes)
directly into extraction tubes containing a 2:1 mixture of chloroform
and methanol. The tubes and the surfaces of the pellets were gently
washed with two 500 pi aliquots of buffer, which were also transferred
to the extraction tubes.
The pellets were then resuspended in 2 ml phosphate buffer with the
use of a vortex mixer, and the suspension transferred to extraction tubes
as above. This was repeated twice with 1 ml aliquots of phosphate buffer.
Extractions and chromatography were as usual in assays for acyl-
coenzyme A:cholesterol acyltransferase activity. The results are shown
in Table 5.2. These indicate that cholesterol ester newly synthesised
from exogenous radioactive free cholesterol is entirely associated with
the microsomal pellet, despite the fact that a considerable proportion
Table 5.2































*For method,see text. The results are the percent of the total
recovered radioactivity found as free cholesterol or cholesterol
ester in the supernatant and pellet after centrifugation, and are
the means of two incubations.
+ACAT = acyl-coenzyme A:cholesterol acyltransferase.
Activity is the percent of total recovered radioactivity
as cholesterol ester.
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of the added free cholesterol is found in the supernatant. This suggests
that newly synthesised cholesterol ester either is capable of dissolving
within the microsomal membrane, or becomes associated with protein
trapped within the microsomal vesicles.
5.5 Effect on the acyl-CoA:cholesterol acyltransferase activity of
microsomes of freeze-drying and treatment with organic solvents
A convenient source of enzyme for experiments on cholesterol 7a-
hydroxylase is a freeze-dried powder of microsomes, which can be stored
at -20°. Butanol extraction of this freeze-dried powder both lengthens
the time for which the powder can be stored, and helps the interpretation
of the results of certain experiments, where it is an advantage to have
minimum dilution of added radioactive cholesterol by endogenous
cholesterol.
The effect of freeze-drying and butanol extraction on microsomal
acyl-coenzyme A:cholesterol acyltransferase activity was therefore
investigated (Figure 5.4). Freeze-drying caused a loss of acyl-coenzyme A:
cholesterol acyltransferase activity to 60% of that of fresh microsomes.
Butanol extraction reduced activity to barely detectable levels (11% of
the activity measured in fresh microsomes, 17% of the activity of a
freeze-dried powder). If the argument described in Section 4.2 is used
to allow the calculation of actual enzyme activities, the lack of
activity of the butanol-extracted preparation is considerably emphasised,
since the cholesterol content of this sample is so low. Thus, the
activity of the butanol-extracted preparation is 0.50 ng cholesterol
converted to cholesterol ester per 100 jdg protein per 20 minutes,
compared to a control activity for the freeze-dried microsomes of 74 ng









































The effect of freeze-drying and butanol extraction
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(Acyl-coenzyme A:cholesterol acyltransferase assays were performed
as described in Section 2.12. Assays contained the following amounts
of protein: fresh microsomes 79.5 |ig; freeze-dried microsomes 186 jag;
butanol-extracted microsomes 15 3 (J.g.)
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Extraction of freeze-dried microsomes with acetone at -20° removes
considerably less lipid than extraction with butanol. The examination
of acyl-coenzyme A:cholesterol acyltransferase activities of freeze-dried
and acetone-extracted microsomes showed losses of enzyme activity on
acetone extraction, to 20-40% of control values. These results are
further discussed in Section 7.
5.6 The effect of Nonidet P42 on acyl-coenzyme A:cholesterol acyltransferase
activity
For many experiments it would be an advantage to use a reasonably
pure preparation of acyl-coenzyme A:cholesterol acyl transferase,
and for this purpose it is necessary to solubilise the enzyme, while
retaining enzyme activity.
Although no results have been published, it appears that the acyl-
coenzyme A:cholesterol acyltransferase of aortic microsomes has proved
difficult to solubilise with retention of enzyme activity. ("Attempts
to study the enzyme in isolation...have been unsuccessful." (343).)
Similarly, no work has been published on the preparation of the liver
enzyme. Since Nonidet P42 has been shown to be successful in the
solubilisation of another liver microsomal enzyme, cholesterol 7a-
hydroxylase, without loss of activity (226), its effect on acyl-
coenzyme A:cholesterol acyltransferase was investigated.
Table 5.3 shows the effect of adding varying amounts of Nonidet
to a suspension of microsomes on their acyl-coenzyme A:cholesterol
acyltransferase activity. At low detergent concentrations there
is a slight increase in enzyme activity but at higher detergent
concentration the measured activity rapidly falls off. When these
microsomal samples with varying detergent concentrations were centrifuged
at 105 OOO x g for one hour no enzymic activity was detectable in the
supernatants obtained.
Table5.3

















(After this experiment had been performed, Kaduce et al (344)
reported on the use of 2% Triton X-lOO in the solubilisation of acyl-
coenzyme A:cholesterol acyltransferase from Ehrlich ascites cell
microsomes. This resulted in the loss of enzyme activity to levels of
1-2% of the activity of untreated controls. Removal of detergent by
the use of SM-2 BioBeads restored activity to 40% of control values,
and this activity could be further enhanced by up to 2.5-fold, by
incorporating this solubilised protein into liposomes..)
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Section 6




The liver plays a central controlling role in cholesterol metabolism,
as discussed in Section 1. In particular, the rates of synthesis and
degradation of cholesterol, and the activities of the enzymes
catalysing rate-determining reactions in these processes (3-hydroxy-3-
methylglutaryl-coenzyme A reductase, and cholesterol 7a-hydroxylase)
display a diurnal variation (4,129,154,155,262,263,272,345,346), and a
response to cholesterol absorption (4,129,147,154,155,159-161,174,176,347)
and to the prevention of cholesterol and bile acid secretion into bile
by occlusion of the bile duct (160,348). In addition, in the rat the
liver is able to accumulate large quantities of cholesterol ester on
cholesterol feeding (148,149). Experiments were undertaken to
investigate some of these aspects of the control of liver microsomal
cholesterol metabolism.
Although cholesterol synthesis (and 3-hydroxy-3-methyl-glutaryl
coenzyme A reductase) and bile acid production (and cholesterol 7a-
hydroxylase) are known to vary during a twenty-four hour cycle, no
diurnal measurements of the other microsomal enzyme of cholesterol
metabolism (acyl-coenzyme Archolesterol acyltransferase) have been
reported. In this context, it has been shown that, if the cholesterol
synthesis rate in hepatocyte suspensions is forced to increase by the
addition of mevalonic acid, cholesterol esterification is stimulated
(349), though this is difficult to reconcile with the lack of effect
on ACAT activity in vivo when mevalonic acid is administered intravenously
(350). (It should be noted that while it is recognised that hepatic
ACAT activity and cholesterol ester accumulation increase after
intragastric administration of mevalonic acid or mevalonolactone (331,
350,351), this is likely to be due to an increased delivery of cholesterol
to the liver, after synthesis in the intestinal tract, rather than to
an increased local, intrahepatic, cholesterol synthesis (350).)
This report of a connection between cholesterol synthesis rate and
cholesterol esterification confirmed the need to investigate the
possibility that acyl-coenzyme A:cholesterol acyltransferase might
exhibit a diurnal variation on its activity. While this experiment
was being planned, a report appeared claiming that this enzyme shows
no diurnal variation of activity (252), but this conclusion was based
only on measurements at noon and midnight.
The liver secretes bile which contains cholesterol, phospholipid
and bile salts, by a poorly understood mechanism. If the bile duct is
occluded by ligation, during the following few days the hepatic contents
of free cholesterol and bile salts rise (352,353), there is an increase
in serum free cholesterol (353), an increase in the rate of hepatic
synthesis of cholesterol (160,353), a decrease in overall bile salt
synthesis (354), and a change in the pattern of bile salts synthesised
(348,352,355). There is a small decrease in cholesterol 7a-hydroxylase
activity in the first twenty-four hours after bile duct ligation, with a
large increase in the activity of this enzyme after two days (348).
It is not clear how this increase in activity accords with the observed
decrease in bile acid synthesis. No attempt was made in this report
to differentiate the relatively small changes in enzyme activity within
the first twenty-four hours from the expected diurnal rhythm in activity.
In addition the assays were performed by measuring the conversion of
exogenous labelled cholesterol to 7a-hydroxycholesterol, but the results
were reported in terms of actual production of 7a-hydroxycholesterol.
In view of the increase in hepatic cholesterol content, the probability
of a change in the size of the substrate pool for cholesterol 7a-
hydroxylase makes the validity of this practice dubious. An experiment
was therefore undertaken to measure cholesterol 7a-hydroxylase activity
by an absolute method and also, by simultaneously measuring the activity
by the conversion of labelled substrate to product, to obtain an estimate
of the size of the cholesterol pool accessible to the enzyme. This was
done for the twenty-four hour period after bile duct ligation, and the
observed changes in activity were differentiated from the normal diurnal
variation by the use of sham-operated control animals.
Hepatic acyl-coenzyme A:cholesterol acyltransferase has been shown
to be affected by the supply of cholesterol, as follows. Hepatic
cholesterol esterification increases on intragastric mevalonic acid
administration (331,350,351), and on cholesterol feeding (252,331,351),
and esterification in isolated hepatocyb es is stimulated by addition of
mevalonic acid (349). In addition, the stimulatory influence of an
increase in cholesterol supply on acyl-coenzyme/cholesterol acyltransferase
activity in fibroblasts (106,121,123), and in rat hepatoma Fu5AH cells
(333,356-358), has been well characterised. The response of hepatic
acyl-coenzyme A:cholesterol acyltransferase activity to the increase in
liver cholesterol content achieved by bile duct ligation was therefore
also investigated.
Because of the central controlling role played by the liver in
cholesterol metabolism it is reasonable to expect that hepatic cholesterol
metabolising enzymes will show adaptational responses to the large
increases in cholesterol absorption caused by feeding cholesterol-rich
diets. It is widely acknowledged that cholesterol feeding in the rat
leads to an increase in bile acid synthesis (172,173). However, the
position with regard to cholesterol 7a-hydroxylase activity is considerably
confused, with reports of no increase in enzyme activity (174,175), and
reports of a stimulation of enzyme activity (147,161,176). There has
also been a suggestion that increased cholesterol 7a-hydroxylase activity
in some circumstances may be due not to an increased amount or increased
intrinsic activity of the enzyme itself, but to an increase in the size
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of the enzyme's substrate pool (176). This observation is complicated by
the fact that these authors observed a variation in substrate pool size
at 1.0 a.m. and 1.0 p.m. that was in synchrony with the activity of
cholesterol 7a-hydroxylase, with high values of each at 1.0 a.m. in
cholesterol-fed rats (176); when they had previously measured enzyme
activity and pool size throughout one day in control diet-fed animals
the variations in each were out of phase, with the maximum enzyme activity
coinciding with the minimum size of substrate pool and vice versa (263) .
The relationship between cholesterol supply and cholesterol 7a-hydroxylase
activity in cholesterol feeding is thus by no means clear.
Cholesterol-fed rats have long been known to accumulate large
quantities of cholesterol esters in their livers (148,149). As briefly
mentioned above, there have been reports of a stimulatory effect of
cholesterol feeding on acyl-coenzyme A:cholesterol acyltransferase
activity (252,331,351). However, in one of these reports, animals were
killed after 12 hours of feeding diets of varying cholesterol contents
(252), and the others contain no mention of the fat content of the diet
(331,351). No reports attempt to correlate the rapid decrease in liver
cholesterol ester contents on withdrawal of cholesterol-rich diets
with changes in the activities of enzymes of cholesterol esterification
or cholesterol ester hydrolysis.
Three experiments were therefore performed to investigate the
effects of cholesterol-rich diets on the liver microsomal enzymes of
cholesterol metabolism and on the sizes of the pools of cholesterol
accessible to these enzymes.
6.2 The assay of acyl-coenzyme A:cholesterol acyl-transferase activity
through a twenty-four hour cycle
The rats for this experiment were divided into two groups one of
which was kept in the animal house where they experienced a lighting
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schedule with twelve hours light between 0800 and 2000. The other group
was kept in a light-proof cabinet with the lighting schedule altered to
give twelve hours light between 1700 and 0500. This cabinet was housed
within the same animal house room as the other group of rats to minimise
the effects of any other environmental influences. The rats were fed the
cholesterol-rich diet.
Pairs of rats were killed from each group throughout a twelve hour
period, microsomes were prepared immediately and resuspended in 20 ml
water. After assay for protein, suitable amounts of microsomal
suspension were taken for assay of acyl-coenzyme A:cholesterol acyltrans-
ferase activity.
In view of the non-linearity of this assay the amount of protein
was kept as constant as practicable, and was always between 175 |i.g and
250 p.g, a difference which might be expected to account for an increase
in activity of approximately 1% (see Figure 4.2).
The results are shown in Figure 6.1. In this figure the results
from both groups of rats have been plotted on a time-scale where the
lighting was on between 0800 and 2000. A peak of activity was obtained
at 0500 and a trough at 1700. These times are separated by twelve hours -
the duration of the light and dark periods - and can be hypothesised to
occur at the times of maximal feeding and maximal fasting, respectively
(D. Mathe, personal communication).
The significance of the difference of the results at 0500 and 1700
is P<0.01 (by Student's t test), or P<0.025 (by the Welch-Aspin test,
which does not assume two identical normal distributions). However,
the validity of the result of this experiment is cast in doubt when
protein concentrations are taken into account. The protein concentration
had been allowed to vary within the limits of 175 pg and 250 pg per
assay because of the relatively small difference in measured ACAT activity
Figure 6.1
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(For method see text).
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this would be expected to cause, as long as activity is measured in
terms of percent conversion of tracer substrate to product (see Figures
4.1 and 4.2). The result of plotting the acyl-coenzyme A:cholesterol
acyltransferase activities obtained in this experiment against the amount
of protein per incubation is shown in Figure 6.2. Here it can be seen
that much of the variation in measured acyl-coenzyme A:cholesterol
acyltransferase activity in this experiment can be accounted for by
variations in the amount of protein used. It is however apparent that
the values obtained at 0500 and 1700 do in fact lie furthest from the
line obtained from this plot, so the possibility remains that there is
indeed a diurnal variation in acyl-coenzyme A:cholesterol acyltransferase
activity, with the high and low values being obtained at these times.
This experiment has been repeated using the more satisfactory assay
based on [l-^c]-palmitoyl-coenzyme A, and the presence of a diurnal
variation in acyl-coenzyme A:cholesterol acyltransferase activity has
been confirmed (Dr. K.E. Suckling, personal communication).
It should be noted that, while contradicting the conclusions of
Balasubramanian et al (252) that there is no diurnal variation in the
activity of acyl-coenzyme A:cholesterol acyltransferase, these results
fully explain the observation of these authors, since they based their
deduction on assays performed only at midday and midnight. At these
times there is certainly no difference in observed activity.
6.3 Assay of acyl-coenzyme A:cholesterol acyltransferase and cholesterol
7a-hydroxylase activities during the twenty-four hours following bile duct
occlusion
Rats were prefed on a 10% olive oil 1% cholesterol diet for 10 days.
At 0900 four rats were killed. The remaining animals were divided into
two groups. The animals in one of these groups were anaesthetised and
their bile ducts were ligated proximally and distally. The animals in
Figure 6.2
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(The results of the acyl-coenzyme A:cholesterol acyltransferase
assays obtained throughout a 24 hour cycle are here plotted against
the amount of protein used per assay.)
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the other group were sham operated. At 2, 4, 8, 16 and 24 hours after
operation pairs of experimental rats and pairs of control rats were
killed.
In all cases samples of systemic blood were obtained and plasma
was assayed for conjugated cholic acid and conjugated chenodeoxycholic
acid by Dr. G.J. Beckett of the Department of Clinical Chemistry,
University of Edinburgh. Liver microsomes were prepared, and assayed
for acyl-coenzyme A:cholesterol acyltransferase and cholesterol 7a-
hydroxylase.
In order that estimates of the sizes of the substrate pools for
these enzymes could be obtained parallel sets of assays were performed.
Thus, acyl-coenzyme A:cholesterol acyltransferase was assayed using
both [4-^cl-cholesterol and [l- ^c]-oleic acid as the tracer substrate,
and cholesterol 7a-hydroxylase was assayed both in terms of percent
conversion of tracer substrate to product and by absolute measurement
of 7a-hydroxycholesterol production by combined gas chromatography -
mass spectrometry. This latter technique also provided an assay of the
cholesterol content of the microsomes.
Figure 6.3 shows the plasma concentrations of cholic acid and
chenodeoxycholic acid following bile duct ligation. Two hours after
ligation conjugated cholic acid and conjugated chenodeoxycholic acid
levels had increased by twenty-fold and three-fold respectively.
Eight hours after ligation the concentrations of conjugated cholic acid
and conjugated chenodeoxycholic acid were respectively one hundred and
thirty-fold and eight-fold greater than control values. These results
allow confidence that the ligations of the bile ducts were successful
in achieving its occlusion.
Figure 6.4 shows hepatic microsomal free cholesterol contents,
expressed relative to protein. Eight hours after operation the level of
Figure 6.3
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cholesterol in the experimental animals was 5.7 nmol^per mg protein
greater than in the controls, and this difference was significant
(P<0.025). At later times the difference between experimental and
control groups was approximately maintained, although the significance
levels declined somewhat.
Figure 6.5 shows the results of assays for cholesterol 7a-hydroxylase
activity, both in terms of percent conversion of exogenous tracer
cholesterol to tracer product, and in terms of actual production of
7a-hydroxycholesterol. In terms of the percent conversion assay
(Figure 6.5(a)), the enzyme activity of the ligated rats was significantly
less than that of the sham-operated rats after 4 hr (P<0.05), and
remained so for the duration of the experiment. The normal diurnal
rhythm in cholesterol 7a-hydroxylase activity was maintained, superimposed
on the change observed.
In contrast, absolute measurement of enzyme activity shows that at
no time during the experiment was there a significant difference between
the activities of microsomal preparations from ligated and sham operated
rats (Figure 6.5(b)). Again, the diurnal variation in activity can be
seen to persist.
Estimates of the maximum possible size of the substrate pool can
be derived from these results. Figure 6.6 shows substrate pool size,
both in absolute terms and as a fraction of total microsomal free
cholesterol, plotted against time. There is a suggestion that the
absolute size of the pool in the experimental animals may be elevated
above that in control animals, but this difference does not approach
significance, the greatest difference being after 8 hours (0.05<P<0.1).
The results of both absolute and percent conversion assays for
acyl-coenzyme A:cholesterol acyltransferase are shown in Figure 6.7.
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cholesterol ester declined steadily during the first 8 hours of the
experiment and thereafter remained approximately constant (Figure 6.7(a)).
There was no difference in activity between animals with occluded bile
ducts and sham operated controls.
When acyl-coenzyme A:cholesterol acyltransferase was assayed using
14
[l- c]-oleic acid there was little change in activity detectable
(Figure 6.7(b)). After 24 hours the enzyme activity of microsomes from
ligated animals was greater than the controls (P<0.01), although neither
of these activities was significantly different from that measured at
the beginning of the experiment.
Figure 6.8 shows the values derived for the maximum size of the
pool of substrate for acyl-coenzyme A:cholesterol acyltransferase,
both in absolute terms, and as a fraction of the total microsomal free
cholesterol. In neither case was there a significant difference between
the substrate pool size of ligated and sham operated rats. There was a
suggestion that substrate pool size increased somewhat with time, both
in actual size and relative to microsomal free cholesterol levels.
However, in no instance did this increase quite approach significance.
(For the difference between values at the beginning of the experiment
and after 24 hr, 0.05<P<0.1.)
6.4 The response of the activities of acyl-coenzyme A:cholesterol
acyltransferase and cholesterol 7g-hydroxylase to feeding cholesterol-
rich diets
Three experiments were performed. In the first one the response of
both enzymes to feeding and then withdrawing a cholesterol-rich diet
was investigated. Aspects of the response of each enzyme were investigated
in more detail in the subsequent two experiments. (For details of diets,
see Materials and Methods.)
Figure 6.8(a)
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(a) The hepatic effects of feeding and withdrawing a cholesterol-rich diet
Rats were fed for one week on a 10% olive oil diet. On Day 0 of
the experiment the diet was changed to 1% cholesterol, 10% olive oil,
and the animals were maintained on this diet until Day 13, when they
reverted to 10% olive oil. On the days shown in the diagrams pairs of
rats were killed. Samples of liver were homogenised in a small volume
of water and freeze-dried. Lipids were extracted from the freeze-dried
powder, using an aliquot of [4-^cl-cholesterol to assess recovery,
and free and total cholesterol were assayed. The rest of the liver was
used for the preparation of microsomes. These were assayed for
cholesterol 7a-hydroxylase and acyl-coenzyme A:cholesterol acyltransferase,
and samples were extracted as above for the assay of free and total
cholesterol.
The effect of cholesterol feeding on whole liver free and esterified
cholesterol contents is shown in Figure 6.9. Free cholesterol levels
increased moderately from about 2.1 |omol per g liver and appeared to
reach a new plateau value of about 3.1 pmol per g liver after 9 days of
cholesterol feeding. On withdrawing the cholesterol-containing diet
there was no fall in free cholesterol for at least 9 days, after which
free cholesterol returned to approximately the starting level within the
following 6 days. • On cholesterol feeding the cholesterol ester content
increased rapidly from its starting value of about 1.55 pmol per g liver,
and had reached 8.8 pmol per g liver and was still apparently increasing
when cholesterol feeding ceased. The decline in cholesterol ester on
removing the cholesterol-rich diet was similarly rapid, with a drop from
8.8 to 4.9 jrmol per g liver within one day, and a return to the basal
starting level within five days. There was a subsequent small increase
in hepatic cholesterol ester that was maintained over the following ten
days.
Figure 6.9
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Similar results were obtained for the microsomal contents of free
and esterified cholesterol (Figure 6.10). There was a relatively small
(15%) increase in free cholesterol that was probably non-significant.
After an initial drop on withdrawing the cholesterol-containing diet
there was a small but steady increase in microsomal free cholesterol
for the following eight days. There was no alteration in microsomal
cholesterol ester content from basal levels of 5.2 nmol per mg protein
for three days following the change to the cholesterol-rich diet,
but there was then a large (six-fold) increase up to 38.8 nmol per mg
protein. On returning to the cholesterol-free diet cholesterol ester
rapidly fell to low levels.
On the basis of a typical microsomal phospholipid content of 0.52
(jmoles per mg protein it is possible to estimate that the microsomal
cholesterol ester to phospholipid ratio increased from 1:101 to 1:13.4.
Studies with lipid model systems containing phospholipid, cholesterol
and cholesterol ester, but no protein, have shown that cholesterol ester
can pack into phospholipid layers at molar ratios of cholesterol ester
to phospholipid of from 1:50 to 1:20 (phospholipid bilayers of varying
degrees of hydration (359)) or 1:20 (unilamellar liposomes (341)).
It is thus possible that cholesterol feeding has resulted in microsomal
cholesterol ester levels in excess of those that might be accommodated
within the microsomal membrane. The location of this cholesterol ester
and its spatial and temporal relation to the cholesterol ester secreted
in lipoproteins and accumulated as cytoplasmic lipid droplets is not yet
clear.
Figure 6.11 shows the activities of cholesterol 7a-hydroxylase
and acyl-coenzyme A:cholesterol acyltransferase throughout this experiment.
There was no statistically significant change in cholesterol 7a-
hydroxylase activity as measured here by percent conversion of exogenous
Figure 6.10
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labelled cholesterol to 7a-hydroxycholesterol (see also Section 6.4(c)).
In contrast the activity of acyl-coenzyme A:cholesterol acyltransferase
increased from a starting level of less than 2% conversion of labelled
cholesterol to cholesterol ester per 400 mg protein per hour to a
maximum value of more than 15% conversion after nine days of cholesterol
feeding. This activity fell slightly to 12.6% by the last day of
cholesterol feeding (Day 13). The fall in activity on withdrawing the
cholesterol-rich diet was relatively small and slow compared with the
observed increase, and resulted in an activity of 10% after one day and
7% after five days. However, after this time there was a small rise
in activity for the rest of the experiment with a final activity of 10%
being measured.
Thus, although acyl-coenzyme A:cholesterol acyltransferase activity
was observed to increase on feeding the 1% cholesterol 10% olive oil diet,
the activity did not return equally rapidly to basal levels on returning
to the 10% olive oil diet. Various explanations were considered for this.
It is possible that during the feeding of the cholesterol-containing diet
there had been some cholesterol deposition in peripheral tissues.
On withdrawing the diet the rapid loss of cholesterol from the liver
might have been followed by a slower return of this peripheral cholesterol
to the liver and its subsequent excretion as neutral sterols or bile
acids. However, the evidence is that cholesterol feeding in the rat
results in little or no increase in carcass cholesterol and only a
slight increase in serum cholesterol and that the only organ showing a
large increase in cholesterol content is the liver (148).
Alternatively, failure of acyl-coenzyme A:cholesterol acyltransferase
to return to basal levels on removing the cholesterol-rich diet may be
related to the use of the 10% olive oil control diet. This possibility
was further investigated (See Section 6.4(b)).
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The possibility had been considered that on cholesterol feeding and
withdrawal the observed changes in the level of cholesterol ester might
be a result not just of changes in the supply of substrate for
esterification and the activity of acyl-coenzyme A:cholesterol acyl-
transferase, but also of concomitant changes in the activity of
cholesterol ester hydrolase. In particular, the rapid decline in hepatic
cholesterol ester content might have been associated with an increase in
the activity of this enzyme. On every occasion that animals were
killed during the course of this experiment samples of microsomes and
cytoplasm were assayed for cholesterol ester hydrolase activity by
Dr. A.M.S. Gorban of this laboratory. These assays showed no significant
change in activity.
(b) The effect of diet manipulation on hepatic cholesterol content and
acyl-coenzyme A:cholesterol acyltransferase activity
Rats were fed for one week on soft diet before the first group were
killed. After this first day of the experiment the remaining rats were
maintained on soft diet for a further five days. The animals were then
divided into two groups, one of which received soft diet supplemented with
10% olive oil, the other being given soft diet supplemented with 10%
olive oil and 1% cholesterol. After ten days these groups were each
further subdivided into two groups one of which continued to eat either
the olive oil diet or the cholesterol plus olive oil diet, as appropriate,
the other reverting to soft diet. This feeding regime is schematically
represented in Figure 6.12.
At each point indicated in the figures three rats were killed, their
livers were pooled and homogenised, and microsomes were prepared.
Lipid was extracted from duplicate samples of liver and microsomes,
and each lipid extract was assayed for total and free cholesterol in
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cholesterol acyltransferase activity. Each reported enzyme activity is
the mean of five assays.
The hepatic and microsomal free and esterified cholesterol contents
are shown in Figures 6.13 and 6.14. Because of the large number of
points error bars are not included, to avoid confusion, but, typically,
standard errors of the mean amounted to some 15% of the mean value.
Cholesterol feeding resulted in liver and microsomal free cholesterol
contents that were consistently greater than those of the olive oil-fed
rats, but the significance of this difference never exceeded P<0.1.
Cholesterol feeding resulted in a slow but steady increase in whole
liver free cholesterol. This increase was paralleled by a similar rise
from the fifth day onwards of olive oil feeding. Similar trends were
observed for microsomal free cholesterol.
The whole liver free cholesterol content of olive oil fed rats
showed little change when these rats reverted to eating the soft diet.
When the cholesterol-fed rats reverted to the soft diet the mean values
for whole liver free cholesterol declined to values similar to those
for rats fed no cholesterol, but again the drop was not statistically
significant. There was no change in the hepatic microsomal free
cholesterol level within the first five days of olive oil- or cholesterol-
fed animals reverting to the soft diet, but in the second five days
there was an apparent increase. This increase was confirmed by repeated
cholesterol assays on the same lipid extracts, but never attained
statistical significance.
The results of assays for esterified cholesterol were much more
clear cut. Feeding cholesterol resulted in an accumulation of cholesterol
ester. This seems to reach a plateau value of 38.8-46.5 nmol/mg protein
in microsomes, but accumulation continued for the duration of cholesterol
feeding for whole liver. When cholesterol-fed animals reverted to
Figure 6.13(a)
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eating the soft diet, cholesterol ester levels rapidly returned to
control values. Little or no cholesterol ester accumulated on olive
oil feeding.
The results of acyl-coenzyme A:cholesterol acyltransferase assays
are shown in Figure 6.15. Again, to avoid confusion, error bars are
not shown. (The average of the standard deviations for all assays
+
was - 1.8% conversion of exogenous labelled free cholesterol to
cholesterol ester.) This experiment again demonstrated that feeding
the 1% cholesterol 10% olive oil diet resulted in an increase in the
measured acyl-coenzyme A:cholesterol acyltransferase activity. However,
feeding 10% olive oil also resulted in increased values for esterification
activity, there being no statistically significant difference between
the activities of microsomes from oil-fed and cholesterol-plus-oil-fed
animals at ten and fifteen days of feeding. However, a lag in the
increase of acyl-coenzyme A:cholesterol acyltransferase activity on
olive oil feeding resulted in a significant rise in activity of
cholesterol-fed animals over olive oil-fed animals at five days of
feeding (P<0.0025). The difference between activities at twenty days
feeding was also significant (P<0.01).
No decrease in esterification activity was detected when animals
reverted to the soft diet. However, there was no further significant
increase of activity in animals that had been previously fed on
cholesterol, with a resultant significant difference between their
activity after ten da^s and that of animals that continued to eat the
cholesterol diet (P<0.005). On the other hand, when olive oil-fed
animals reverted to eating soft diet, there was a significant difference
between their esterification activity and that of animals that continued
on the 10% olive oil diet at five days (P<0.01), but not at ten days.
Figure 6.15
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In summary it thus appears that feeding cholesterol plus olive
oil resulted in an increase in cholesterol esterification activity,
but that this increase was only greater than that produced by feeding
olive oil alone at certain stages. One of these stages was defined
by the lag before any increase was detectable on feeding olive oil.
On reverting to low fat, low cholesterol diets there was no immediate
reduction in the ability of liver microsomes to esterify cholesterol.
The reasons for this stimulation of measured esterification activity
on olive oil feeding, and for the maintenance of high levels of activity
on the removal of the dietary stimuli initially causing them, are
unclear.
The failure of the liver to accumulate cholesterol ester under
these circumstances presumably is at least partly explained by the lack
of substrate cholesterol in the quantities available in cholesterol-fed
animals.
It has been shown that feeding high fat diets to rats results in a
stimulation of hepatic cholesterol synthesis (360,361). It is possible
that this will result in a perturbation of the relative sizes of
microsomal cholesterol pools and/or of the partitioning of exogenous
labelled cholesterol between these pools. This will influence the
activity of acyl-coenzyme A:cholesterol acyltransferase as measured by
esterification of exogenous labelled cholesterol. A comparison of
results obtained as in this experiment with results obtained using a
more sophisticated assay, which measured actual cholesterol ester
production, might therefore help to explain some of these problems by
enabling an estimate of maximal substrate pool size to be made.
Alternatively, there is some conflicting evidence for the role of
the cytoplasm in hepatic cholesterol esterification, with some reports
of a stimulation of microsomal cholesterol esterification on the inclusion
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of cytoplasmic protein in the assay incubations (362,363), and some
reports claiming no such stimulatory effect (248), and oomo roporto
claiming no ouoh otimulatory offoot (348) . Similarly, work with rabbit
aorta preparations has failed to demonstrate the presence of any
cytoplasmic inhibitory or stimulatory factors from normal or
atherosclerotic animals (332). It is thus possible that, if some
cytoplasmic factor is important for enzyme activity, by assaying
microsomes alone, in common with most other workers in this field,
a true assay of the ability of the liver to catalyse cholesterol
esterification is not being obtained.
Finally, the modification of microsomal membrane fatty acid
composition in_ vitro with rat liver microsomes (364) , or in_ vivo with
Ehrlich ascites microsomes (365) has been shown to influence acyl-
coenzyme A:cholesterol acyltransferase activity. It is not known what
influence the olive oil diet had on the microsomes prepared from the
livers of rats fed on it, but it is possible that part of the change in
esterification activity may have been caused by some change in microsomal
phospholipid fatty acid composition.
(c) The effect of cholesterol feeding on cholesterol 7g-hydroxylase
There are ambiguities inherent in measuring cholesterol 7a-hydroxylase
activity in terms of conversion of exogenous labelled cholesterol under
circumstances when it is likely that the total microsomal cholesterol
content or the size of the cholesterol pool accessible to the enzyme is
changing. Because of the reported confusion over the effect of
cholesterol feeding on the activity of this enzyme an experiment was
undertaken to measure cholesterol 7a-hydroxylase, both by fractional
conversion of tracer cholesterol and by absolute measurement of 7a-hydroxy-
cholesterol production, in the days following a change to a cholesterol-
rich diet.
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Rats were fed for ten days on the 10% olive oil diet. At the
beginning of the experiment the diet was changed to 10% olive oil,
1% cholesterol. On each day indicated in the Figures three rats were
killed, their livers were pooled, and microsomes were prepared.
Microsomal suspensions were assayed for protein. Triplicate incubations
were performed for the measurement of cholesterol 7a-hydroxylase both
in percentage and absolute terms. The gas chromatography traces
obtained during the absolute measurement of 7a-hydroxycholesterol
production allowed calculation of the microsomal cholesterol contents.
Mean values for cholesterol 7a-hydroxylase activities, measured
by both assays, indicated the possibility of a rise in activity after
one day with a subsequent steady decline over the following week
(Figure 6.16), a result similar to that shown in Figure 6.11. However,
as in that experiment, none of the assay results showed a significant
difference from that obtained before cholesterol feeding began.
A drop in microsomal cholesterol content after one day of cholesterol
feeding just attained significance (P<0.05) (Figure 6.17). This result
is unexpected, and possibly needs to be explained in terms of some
physiological response not controlled in the experiment. (An example
might be that the rats detected the substitution of the cholesterol-
containing diet for the control diet and had not yet adapted to this
change and were thus partially starved.) After fourteen days of
cholesterol feeding, microsomal cholesterol levels were significantly
greater than at the beginning of the experiment (P<0.05).
The maximal size of the substrate pool for cholesterol 7a-hydroxylase
was calculated, and its variation with cholesterol feeding is shown in
Figure 6.18. The substrate pool size, both in terms of actual size and
as a fraction of total microsomal free cholesterol, after an initial
delay, showed a steady increase to reach a size significantly greater
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Section 7
The Response of Cholesterol 7a-Hydroxylase and Acyl-
Coenzyme A:Cholesterol Acyltransferase to In Vitro
Alterations of Cholesterol Concentration
98.
7.1 Introduction
Increased delivery of cholesterol to rat liver is associated with
a decrease in microsomal 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase
activity (129,159,160), with an increase in microsomal acyl-coenzyme A:
cholesterol acyltransferase activity (252,331,349-351), and with an
increase in bile acid synthesis (172,173), although the effect on the
microsomal rate-limiting enzyme in this latter process, cholesterol
7a-hydroxylase, is not clear (147,161,174-176, and see Sections 6 and 8).
The possibility presumably exists that these effects could all be at
least in part mediated at the level of protein synthesis, by the induction
of, or repression of the production of, the enzyme or some protein or
non-protein cofactor.
However, in the case of 3-hydroxy-3-methylglutaryl-coenzyme A
reductase there is evidence that the phase of inhibition due to the
repression of enzyme synthesis is preceded by a phase of inhibition that
is independent of protein synthesis or its inhibition (170). Since
this phase is not accompanied by a change in the K of the enzyme (366),
it has been suggested that this effect is mediated not by a classical
allosteric inhibition but via a decrease in the fluidity of the
endoplasmic reticulum membrane caused by an increase in its free
cholesterol content (168,169,350). Such an effect of membrane lipid
composition on the activity and the control of a number of other
membrane-bound enzymes has been well documented (209-211). (Without
eliminating the possibility that such a mechanism may indeed operate,
it should however be noted that there has been increasing evidence for
the acute control of 3-hydroxy-3-methylglutaryl-coenzyme A reductase
activity by a mechanism involving phosphorylation and dephosphorylation
(162-167). In addition, the half-life of the enzyme is sufficiently
short (2-4 hours) (366) that quite rapid and fine control could be
exerted at the level of protein synthesis (166).)
In the case of another liver microsomal enzyme, the cytochrome P-450-
dependent drug hydroxylation system, the critical effect of membrane
fluidity on substrate binding (217,296,367), on the interaction of the
cytochrome P-450 species with NADPH-cytochrome c reductase, (213,218,368,
369), and on overall enzyme activity (214-216,218-221) is recognised,
as is the influence of membrane components on the cytochrome spin state
(370). It is possible that the cytochrome P-450-dependent cholesterol
7a-hydroxylase reaction may display a similar sensitivity to membrane
fluidity and that this may mediate any effects of increased cholesterol
concentration on the enzyme. A similar mechanism may operate for acyl-
coenzyme A:cholesterol acyltransferase.
In addition to this type of mechanism it is possible that neither
of these enzymes is saturated with substrate at the cholesterol to
phospholipid ratios encountered in physiological membranes. It has been
shown that when cholesterol is added to liver microsomes the estimated
substrate pool size (250), and the production of 7a-hydroxycholesterol
(174,250) both increase, but in these studies cholesterol was added by
means of organic solvents or detergents. These vehicles are unlikely
to mimic physiological means of cholesterol delivery to the endoplasmic
reticulum. It is, indeed, plausible that the vehicle used for cholesterol
addition, being either lipophilic or surface active, may have a
perturbing effect on the disposition of cholesterol between different
microsomal compartments.
However, these studies indicate that the size of the substrate pool
appears to be too small to saturate the enzyme, and saturation was not
achieved even at the highest amounts of exogenous cholesterol used
(174,250). Similar results have been demonstrated for the acyl-coenzyme A
cholesterol acyltransferase of normal and atherosclerotic aortas (254)
of Ehrlich ascites cells (344) and of Fu5AH rat hepatoma cells (333) .
loo.
It is important once more to emphasise that the lipids in both model
and biological membranes (193,208), and in particular in the membrane of
the endoplasmic reticulum (194-196), do not exist in a homogeneous state.
It has repreatedly been shown that not all the microsomal cholesterol acts
as substrate for cholesterol 7a-hydroxylase (174,242,250,275,371) and
there is evidence that this is also true for acyl-coenzyme A:cholesterol
acyltransferase (252,254). In addition, it appears that the composition
and structure of the membrane phospholipids in the vicinity of cytochrome
P-450 may differ from the remainder of the endoplasmic reticulum (217,372) .
This has various consequences. In particular, a change in overall
microsomal membrane properties need not necessarily be reflected by a
similar change in the vicinity of a particular microsomal enzyme, and,
conversely, the absence of a detectable change in the microsomal fraction
does not rule out the possibility of local changes around a particular
enzyme. Also, since cholesterol 7a-hydroxylase and acyl-coenzyme A:
cholesterol acyltransferase are located in different microsomal subfractions,
even if both enzymes were found to respond in a similar way to local
increases in membrane cholesterol levels, they need not respond in a
similar way to an increase in cholesterol supply to the endoplasmic
reticulum from any one particular source.
7.2 The effect of the recombination of acetone-extracted microsomes with
microsomal lipid liposomes on acyl-coenzyme A:cholesterol acyltransferase
activity
This experiment was simultaneously performed with rats fed on soft
diet and with rats fed on cholesterol-rich diet. Three rats from each
group were killed and liver microsomes were prepared and freeze-dried.
Aliquots of these freeze-dried powders (200 mg) were homogenised in 20 ml
o o
acetone at -20 C, and filtered rapidly on apparatus chilled to -20 C,
with the use of a further 100 ml acetone. After one hour in the vacuum
desiccator the acetone-extracted powders were stored at -20 C. The yield
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of each acetone powder was approximately 150 mg. The acetone filtrate
from each powder was taken to dryness on the rotary evaporator, dissolved
in chloroform, and divided into six equal aliquots. One of these aliquots
was used to prepare multilamellar liposomes and one to prepare unilamellar
liposomes, using 5 ml 0.1 M potassium phosphate buffer, pH 7.1
(see Section 2.14).
At the end of the liposomal preparation, 20 mg acetone powder was
added to each liposome suspension. After thorough vortexing the resultant
mixture was incubated in a shaking water-bath at 37°C for 45 minutes.
Controls were prepared by similarly suspending and incubating 20 mg of
freeze-dried powder and acetone powder in 5 ml buffer. All samples were
assayed for protein and acyl-coenzyme A:cholesterol acyltransferase
activity (Figure 7.1).
The freeze-dried microsomes retained cholesterol esterificaction
activity, and those prepared from cholesterol-fed animals had a greater
activity than those from soft diet-fed animals (P<0.0125). Acetone
extraction resulted in a fall in activity to 46% (soft diet-fed rats)
and 34% (cholesterol-fed rats) of the activities of the freeze-dried
microsomes. These activities were, however, still readily measurable,
and were greater than those obtained on butanol extraction (see Section
4.5, and Figure 4.6). There was no longer any difference in activity
between preparations from cholesterol-fed and control rats.
Recombining the acetone-extracted microsomal protein with the
microsomal lipid failed to restore the measured activity to the levels
observed for freeze-dried microsomes. When multilamellar liposomes
were used, there was a decrease observed in the activity of preparations
from soft diet-fed rats (P<0.05), and no change in that of preparations
from cholesterol-fed rats. The use of unilamellar liposomes gave
activities that were in both cases significantly lower than the activities
recorded with multilamellar liposomes (P<0.05 and P<0.0005 for soft
diet- and cholesterol-fed rats, respectively).
Figure 7.1
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The observation that the unilamellar liposome preparations gave lower
activities than the multilamellar preparations suggests that a major
problem for the interpretation of this experiment is posed by the creation
of additional compartments into which the exogenous labelled cholesterol
used for the assay can partition. Thus, although the multilamellar and
unilamellar liposomes were made from identical amounts of lipid, the
size of the lipid compartments immediately accessible to the cholesterol
label will be related to the amount of lipid in the outermost layer of
the liposomes. This will amount to essentially all the lipid for the
unilamellar liposomes, but only a fraction of it for the multilamellar
liposomes. Thus, in the systems reconstituted using unilamellar
liposomes the compartment into which the cholesterol label can rapidly
partition is larger than in the systems using multilamellar liposomes.
This will result in lower measured activities whether or not all of this
compartment is accessible to the enzyme, since there is the possibility
both of greater dilution of the tracer substrate, and of a proportion of
this substrate being sequestered away from the enzyme.
This suggestion will adequately explain the measured activity of the
preparations using unilamellar liposomes being lower than those using
multilamellar liposomes, and also means that the lack of observed
enhancement of activities to levels greater than those of the acetone
powders may be an artefact of the assay method.
However, despite these difficulties, the following results remain.
The difference in activities of the preparations from the two groups of
rats was abolished on lipid extraction. The addition of microsomal lipids,
as multilamellar liposomes, back to delipidated microsomal protein resulted
in no decrease in activity for preparations from cholesterol-fed animals
although there was a decrease in activity for preparations from soft
diet-fed animals. These observations tend to suggest that at least some
changes in the activity of acyl-coenzyme A:cholesterol acyltransferase
might be due to changes in the lipid fraction of microsomes (possibly
their cholesterol content) rather than to changes in the amount of protein.
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7.3 The effect of the recombination of acetone-extracted microsomes with
microsomal lipid liposomes supplemented with varying amounts of cholesterol
on acyl-coenzyme A:cholesterol acyltransferase activity
Freeze-dried liver microsomes were prepared from three rats fed the
cholesterol-rich diet for six weeks. An amount of this freeze-dried
powder equivalent to 20 g liver was extracted with acetone as described
in Section 7.2. Aliquots of the acetone filtrate equivalent to 2 g liver,
supplemented with 0, 250, 500 or lOOO pg cholesterol, were taken to
dryness and used in the preparation of unilamellar and multilamellar
liposomes in 1.0 ml 0.1 M Tris-chloride buffer, 0.15 M KC1, pH 7.4 at 4°C.
Freeze-dried microsomes and acetone-extracted microsomes were
suspended at a concentration such that 1.0 ml contained microsomal
protein derived from 2.0 g liver. When the preparation of the liposomes
was complete, 1.0 ml of the acetone powder suspension was added to each
sample of liposomes. Controls were prepared by the addition of 1.0 ml
of the freeze-dried and acetone powder suspensions to l.O ml buffer.
Thus, all preparations now contained protein equivalent to 2 g liver,
and all liposome-containing preparations contained lipid equivalent to
2 g liver with or without additional cholesterol, in a total of 2 ml.
All preparations were shaken for 2h hours at 4°C, transferred to
centrifuge tubes with the help of an additional 5 ml buffer, and
centrifuged at 105 OOO x g for 1 hr.
The resultant pellets were resuspended and assayed for protein and
acyl-coenzyme A:cholesterol acyltransferase activity. This assay was
performed using [l-^c]-oleic acid as tracer. Samples were taken for
organic extraction and measurement of cholesterol and phospholipid
contents (Figure 7.2 and Table 7.1).
It should be noted that after the very long exposure to the
cholesterol-rich diet both the activity of acyl-coenzyme A:cholesterol
Figure 7.2
ACETONE EXTRACTION OF FREEZE-DRIED LIVER MICROSOMES
AND REPLACEMENT OF EXTRACTED LIPID,
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AP = Acetone-extracted powder
O = Lipids not supplemented with
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acyltransferase and the free cholesterol to phospholipid ratio were high,
being elevated some two-fold and four-fold, respectively, over typical
values obtained after one week of cholesterol feeding.
Extraction with acetone once more caused a large decrease in
activity, to 15% of that of the freeze-dried microsomes. Recombination
of this acetone-extracted powder with liposomes with no additional
cholesterol caused a small increase (P<0.025) and a small decrease (P<0.0025)
in activity for multilamellar and unilamellar liposomes respectively.
The activities of preparations reconstituted using multilamellar
liposomes supplemented with varying amounts of cholesterol were greater
than when no additional cholesterol was present, but were closely
similar to each other. This is explained by the cholesterol to
phospholipid ratios of the final, washed preparation, which demonstrate
that these liposomes failed to take up the increasing amounts of
cholesterol that were used in their preparation.
In contrast, the cholesterol contents of the unilamellar liposomes
were found to reflect the increasing amounts used in their preparation.
As the amount of cholesterol in these liposomes increased, their
esterification activity increased. This is best shown in the plot of
activity against cholesterol to phospholipid ratio in Figure 7.3.
This shows that there is a relationship between the amount of cholesterol
in membranes accessible to acyl-coenzyme A:cholesterol acyltransferase
and the rate of esterification. In particular, an apparent saturation
is not reached at the cholesterol concentrations normally found in the
endoplasmic reticulum, or even at the very high cholesterol concentration
found in this particular group of rats which had been fed on a cholesterol-
rich diet for an extensive period.
However, supplementing the cholesterol content of these preparations
failed to restore esterification activity to levels observed in
Figure 7.3
ACETONE-EXTRACTED LIVER MICROSOMAL ACYL-COENZYME A :
CHOLESTEROL ACYLTRANSFERASE ACTIVITY ON RECONSTITUTION
WITH VARYING AMOUNTS OF CHOLESTEROL
Cholesterol : phospholipid ratio
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preparations which had not been subjected to the relatively harsh
procedure of organic solvent extraction. Thus, despite the advantages
of this system (e.g. the ability to readily examine the effects of
cholesterol concentrations lower as well as greater than usual, and
the ease with which the method could have been extended to explore the
effect of different phospholipid fatty acids) it was felt that
alternative methods based on the use of cholesterol-enriched serum should
be investigated.
7.4 Acyl-coenzyme A:cholesterol acyltransferase and cholesterol 7a-
hydroxylase activities in microsomes supplemented with cholesterol using
cholesterol-enriched serum
Rats were fed on soft diet, 1% cholesterol diet or 4% cholestyramine
diet for one week. Three rats from each group were killed and liver
o
microsomes were prepared. The microsomal pellet was incubated at 4 C
for three hours suspended in normal horse serum, in horse serum enriched
in vitro with cholesterol (373), or in 0.1 M tris-chloride buffer pH 7.4,
at a concentration of 5 mg microsomal protein per ml. At the end of this
incubation the microsomes were sedimented by centrifugation at 105 OOO x g
for one hour, and washed free of any adherent cholesterol-containing
serum particles by resuspending and resedimenting a further twice.
The microsomes were finally suspended in 0.1 M tris-chloride buffer
pH 7.4. Aliquots were taken for assays for protein, acyl-coenzyme A:
cholesterol acyltransferase and cholesterol 7a-hydroxylase and for
organic solvent extraction and subsequent assay for cholesterol and
phospholipid. (In these experiments the incubation of microsomes with
the cholesterol-enriching and the control media and the assays for
protein, cholesterol, and phospholipid were performed by Dr. K.E. Suckling
and Mr. H.A.F. Blair.)
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Various experiments were undertaken to ensure that the additional
cholesterol detectable in the preparations incubated with the cholesterol-
enriched serum was indeed actually within the microsomal membrane rather
than being due to cholesterol-rich particles adsorbed to the membrane.
These particles could be hypothesised to be cholesterol-rich serum
lipoproteins or even cholesterol crystals formed as an artefact during
the preparation of the cholesterol enriched serum. Electron micrographs
of thin sections of glutaraldehyde-fixed cholesterol-enriched and control
microsomes (provided by Dr. A. Whyllie, Department of Pathology,
University of Edinburgh) showed no difference in appearance (Figure 7.4).
The physical state of a membrane can be investigated by means of a
suitable lipid-partitioning paramagnetic molecule, such as the fatty
acid derivative 5-doxyl stearate. Electron paramagnetic resonance
spectroscopy then allows the measurement of an order parameter for this
molecule, which in turn reflects the ordering of the membrane. When
cholesterol is incorporated into membranes an increase in the order
parameter for such a molecule can be detected. The order parameter of
5-doxyl stearate added to microsomes incubated with cholesterol-
enriched serum showed an increase over values obtained for microsomes
incubated with control serum. This is consistent with the suggestion
that at least some of the additional cholesterol detectable in these
preparations is located within the membrane (Dr. K.E. Suckling,
unpublished results).
The results of a typical experiment are shown in Figure 7.5 and
Table 7.2. Incubation of microsomes with control serum resulted in
small increases in both cholesterol and phospholipid contents expressed
relative to protein, the increase in cholesterol being slightly greater
than that in phospholipid as demonstrated by the increase in cholesterol
to phospholipid ratio. Incubation with cholesterol-enriched serum
Figure 7.4
Electron micrographs of microsomal preparations
Magnification = 75,000 x
(a) Fresh microsomes
(b) Microsomes incubated with control serum
(c) Microsomes incubated with cholesterol-enriched serum.
(The preparations were fixed in glutaraldehyde and stained with
uranyl acetate and lead nitrate.)
Figure 7.5
THE ACTIVITIES OF CHOLESTEROL 7a-HYDROXYLASE AND ACYL-COENZYME A
CHOLESTEROL ACYLTRANSFERASE OF LIVER MICROSOMES INCUBATED WITH
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s = Microsomes incubated with control serum
fx] = Microsomes incubated with cholesterol-enriched serum
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resulted in little or no further increase in the phospholipid content of
the microsomal preparations, but a large (five-fold or more) increase in
the cholesterol content.
When enzyme activities were measured by the fractional conversion
of labelled cholesterol to product, there was little difference between
the activities measured after incubation with the control serum and the
cholesterol-enriched serum, but these activities were somewhat less than
those of preparations incubated in the absence of serum. The interpretation
of this finding is considerably complicated by the varying cholesterol
contents of these preparations. Also, since there is some evidence that
cholesterol 7a-hydroxylase and acyl-coenzyme A:cholesterol acyltransferase
exist in different microsomal subfractions (253), the same explanation
need not apply to both enzymes.
Explanations of this finding are illustrated diagrammatically in
Figure 7.6 and are as follows. The first possibility is that the
additional serum-derived cholesterol entered a pool within the microsomal
preparation not accessible to the enzyme, and which therefore does not
act as a substrate for the enzyme. Two alternative suggestions could
then be put forward to explain the observed lack of change in conversion
of labelled cholesterol to labelled product. Firstly, the added tracer
entered the enzyme's substrate pool to give the same specific radioactivity
in each case (that is, the additional serum-derived cholesterol caused
no dilution of the added cholesterol label within the substrate pool)
(Figure 7.6(b) (i) ) . In this case, the unchanged per cent conversion
between preparations incubated with control serum and cholesterol-enriched
serum would reflect an unchanged enzyme activity. Alternatively,
the added tracer entered the substrate pool to a greater or lesser extent
than in the unsupplemented case (Figure 7.6(b) (ii) and (iii)) .
(It could be suggested that more labelled cholesterol might be available
Figure 7.6
Diagrammatic representation of microsomal cholesterol enrichment
experiments
Left hand compartment = pool of cholesterol available to act as
enzyme substrate




(b) Additional cholesterol enters non-substrate pool
(i) No change in substrate specific radioactivity
* ★ ★ * *
* * *
(ii) Decrease in substrate specific radioactivity
★ ★ ★
★ ★ *
(iii) Increase in substrate specific radioactivity
★ *
* *
(c) Additional cholesterol enters substrate pool
(i) No change in substrate specific radioactivity
* ★ ★ ★ *
***
(ii) Decrease in substrate specific radioactivity
1* *
r*
(iii) Increase in substrate specific radioactivity
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to enter this pool because of the "saturation" of membranes elsewhere
with the additional cholesterol, or that less might be available because
of the creation of a new alternative pool into which some of the tracer
might be diverted.) If the resultant specific radioactivity of the
substrate was greater than in the preparations not supplemented with
cholesterol, a decreased enzyme activity would be necessary to account
for the similar per cent conversion in each case. Conversely, if the
specific radioactivity of the substrate was less than in the unsupplemented
case, an increased enzyme activity would be needed to explain the
observed results.
The second possibility is that the additional cholesterol entered
the enzyme's substrate pool to a greater or lesser extent and hence
caused an expansion in its size. If, then, the amount of tracer
cholesterol entering this pool increased similarly, such that the
specific radioactivity of the substrate remained approximately constant
(Figure 7.6(c)(i)), the unchanged per cent conversion of labelled
substrate to product would reflect no change in actual enzyme activity.
If, however, an approximately similar amount of tracer cholesterol
entered the substrate pool in the control and the cholesterol-enriched
preparations, or at least if the tracer in the substrate pool is diluted
to a greater extent than in the unsupplemented preparation, the unchanged
per cent conversion suggests an increased enzyme activity (Figure 7.6(c)(ii)).
In summary, so long as the addition of the unlabelled serum-
derived cholesterol caused a decrease in the specific radioactivity of
the cholesterol in the substrate pool of the enzyme, it was necessary
to postulate an increase in the actual activity of the enzyme in order
to explain the absence of a decrease in the observed per cent conversion
of labelled cholesterol to labelled product. In view of the five-fold
increase in the cholesterol content of preparations incubated with
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cholesterol-enriched serum and the relatively lengthy incubation and
washing procedure involved, it was felt most likely that an equilibrium
would be reached when the size of all cholesterol pools within the
preparation would be increased to a greater or lesser extent. This would
then imply that there would have to be an increase in enzyme activity
in order to obtain the observed result.
It is therefore of interest to calculate enzyme activities from
the product of the observed per cent conversion of labelled cholesterol
to cholesterol ester or 7a-hydroxycholesterol and the microsomal free
cholesterol content (Figure 7.7). It should be noted that the results
thus obtained require the assumption that all the added cholesterol
tracer was accessible to the enzyme, and will then be overestimates of
the true activity by the same factor as that by which the total microsomal
free cholesterol is an overestimate of the substrate pool size.
These results then, while overestimating the actual activities in all
cases, give an indication of the relative size of increase that will
occur on cholesterol enrichment, so long as the proportion of the total
cholesterol that is in the substrate pool remains constant. If the
fraction of the total cholesterol that is in the substrate pool increases
or decreases when the overall cholesterol content increases, then this
calculated relative increase in enzyme activity will be respectively an
overestimate or an underestimate of the actual relative increase in
enzyme activity.
Because of the large number of uncertainties involved, too much
importance should not be placed on these calculations. However, some
preliminary results, described below, have indicated that the actual
activity of acyl-coenzyme A:cholesterol acyltransferase does indeed
increase when the microsomal cholesterol content is increased, although
the position for cholesterol 7a-hydroxylase is not yet clear.
Figure 7.7
THE CALCULATED ACTIVITIES OF CHOLESTEROL 7a-HYDROXYLASE AND ACYL-COENZYME A
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The result of an experiment where acyl-coenzyme A:cholesterol
acyltransferase was assayed in microsomes incubated with control and
with cholesterol-enriched serum, using the [l-^c]-oleic acid-based
assay, is shown in Table 7.3. This shows that despite a 34% decrease
14
in the enzyme activity measured by the [4- C]-cholesterol-based assay
on cholesterol enrichment, there was a two-fold increase in the activity
measured by cholesterol ester production from [l-^4c]-oleic acid.
On the basis of these results it is possible to calculate that the
maximum estimate of the enzyme's substrate pool size increased three-fold,
while the proportion of the total microsomal cholesterol that it
constituted fell from 19% to 7%.
After this experiment was performed, a similar experiment was
reported (374) , showing that incubation of rabbit liver microsomes with
cholesterol-rich lipoproteins resulted in an increase in acyl-coenzyme A:
cholesterol acyltransferase activity, and that this activity correlated
well with the microsomal free cholesterol content.
During the assay of cholesterol 7a-hydroxylase activity in the
experiment summarised in Figure 7.5 and Table 7.2, at the end of the
incubation with the cofactors required for cholesterol 7a-hydroxylase
activity, an aliquot of cholestane was added to assess recovery, lipids
were extracted, and the lipid extract was divided in two. One of these
lipid samples was subjected to thin-layer chromatography for the
14
conventional [4- c]-cholesterol-based assay of cholesterol 7a-hydroxylase
activity. The other sample was stored under nitrogen for eventual
assay of 7a-hydroxycholesterol production by coupled gas chromatography-
mass spectrometry.
However, problems were encountered in the assay of 7a-hydroxy-
cholesterol because of the large amount of cholesterol present.
The peaks due to cholesterol (on the total ionic current channel of the
Table 7.3
The assay of acyl-coenzyme A:cholesterol acyltransferase
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*Mean of three assays measuring the % conversion of exogenous [4-^c]-
cholesterol to cholesterol ester.
tMean of three assays measuring production of cholesterol ester from
[l- c]-oleic acid.
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instrument (equivalent to the gas chromatography trace) and at m/e 443
(the major fragmentation product derived from cholesterol)) were
asymmetrical due to overloading of the gas chromatography column.
This made the measurement of the cholesterol concentration (required for
the eventual calculation of the 7a-hydroxycholesterol concentration)
unreliable, and also affected the peak at m/e 546 (the principal
fragmentation product from 7a-hydroxycholesterol) which has a similar
retention time (see Figure 2.4).
In order to reduce the amount of cholesterol present all samples
were taken to dryness, and, after a known amount of tritiated cholesterol
was added to assess recoveries, applied to columns of 0.5 g silicic
acid (Biosil A, 100-200 mesh), and cholesterol was partially eluted
using 8 ml of an 80:20mixture of petroleum spirit (60°-80°) and diethyl
ether. The remaining sterols were eluted with 10 ml ethyl acetate.
Samples were taken up in ethyl acetate, radioactive recoveries were
measured, and a C^g sterol was added as a new internal standard.
The assay then proceeded as normal.
After the number of experimental manipulations involved in these
measurements, without the possibility of preliminary assessments of the
techniques involved, the errors in the final results were high, with
large disagreements between duplicates (Table 7.4). Insofar as it is
possible to tell from these results, there was no increase in enzyme
activity when the microsomal cholesterol content was increased,
although in each case the enzyme's apparent substrate pool size in the
cholesterol-enriched microsomes was enlarged, compared to the native
microsomes. The results obtained for the soft diet-fed rats' microsomes
incubated with control serum, and for the cholestyramine-fed rats'
microsomes whether native or incubated with control serum, are anomalous
in that the calculated maximal substrate pool size is greater than the
Table7.4































































total free cholesterol present. This could be due to the breakdown of
the assumption required in the calculation of maximal substrate pool
sizes, that all added tracer cholesterol is accessible to the enzyme.
However, in this experiment the possibility remains that this problem
is due to experimental error.
The repetition of these experiments by Dr. K.E. Suckling has
confirmed these results, showing that the incubation of microsomes
with cholesterol-enriched serum results in an increase in acyl-coenzyme A:
cholesterol acyltransferase activity and no change in cholesterol 7a-
hydroxylase activity. Further, if microsomes are incubated with serum
enriched with [la, 2a(n)-^H]-cholesterol in proportions that allow
cholesterol exchange but no net increase in its microsomal concentration,
and then enzyme assays are performed, radioactivity can be recovered as
cholesterol ester, but relatively little is found in 7a-hydroxycholesterol.
This is despite the similar activities of these two enzymes. This
result tends to support the idea that these two enzymes are present in
different microsomal subtractions. In addition, it appears that the
sub-fraction containing acyl-coenzyme A:cholesterol acyltransferase is
better able to accept cholesterol from cholesterol-rich lipoproteins
than that subfraction which contains cholesterol 7a-hydroxylase.
7.5 The activity of ethylmorphine N-demethylase in microsomes supplemented
with cholesterol using cholesterol-enriched serum
Microsomes were prepared from two groups of rats fed on soft diet
for one week, one of these groups having received 0.1% phenobarbitone,
1% glucose in their drinking water. These microsomes were incubated
with control serum and cholesterol-enriched serum and washed as described
above (Section 7.4). Assays were performed for cytochrome P-450,
NADPH-cytochrome c reductase, protein, cholesterol and phospholipid
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(Table 7.5), and for ethylmorphine N-demethylase (time-course shown in
Figure 7.8, and results calculated on the basis of the first five
minutes of activity in Table 7.5). The relatively large sample size
required for the ethylmorphine N-demethylase assay and the relatively
small amount of microsomes that could be treated at one time with the
serum preparations meant that only one assay could be performed per
preparation. However, replicate assays performed on another sample
of microsomes indicated that the standard error of the mean of five
assays was typically - 10% of the mean value.
These results showed a small increase in NADPH-cytochrome c
reductase activity on cholesterol enrichment. The observed small
decrease in ethylmorphine N-demethylase activity was not significant
at the proposed standard errors.
Table7.5

































































The work described in this thesis was performed with the intention
of elucidating some of the mechanisms involved in the short and long
term regulation of cholesterol-metabolising processes of the rat liver
endoplasmic reticulum, and in particular the responses of these processes
to alterations in the supply of cholesterol.
Although many details in the mechanism have still to be worked out,
the activity of endoplasmic reticulum 3-hydroxy-3-methylglutaryl-
coenzyme A reductase and the overall rate of hepatic cholesterol synthesis
are acknowledged to be closely controlled by the availability of
cholesterol. Attention was accordingly focussed on the activities of
cholesterol 7a-hydroxylase and acyl-coenzyme A:cholesterol acyltransferase,
and, by implication, on the processes of cholesterol excretion and
cholesterol storage.
Perhaps the ideal way to perform a study on any membrane-bound
enzyme, whose activity is likely to be influenced by the properties of
the membrane in which it is situated, is to at least partially purify
the detergent-solubilised enzyme. This preparation can then be recombined
with lipids of known composition in order to unambiguously investigate
the effects of varying lipid composition on enzyme activity. Such an
approach would be especially useful for enzymes, such as the two under
consideration here, where the enzyme substrate is an integral membrane
component, and, until there is evidence to the contrary, can be
presumed to be likely to approach the enzyme's active site from within
the membrane.
Cholesterol 7a-hydroxylase activity depends on at least two membrane-
bound proteins, cytochrome P-450 and NADPH-cytochrome P-450 reductase,
the interaction of which is required for enzymic activity of the analogous
drug hydroxylases. Overall cholesterol esterification by the endoplasmic
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reticulum similarly requires the activity of two enzymes, acyl-coenzyme A
synthetase and acyl-coenzyme A:cholesterol acyltransferase. At present
there is no evidence to suggest a close relationship between these two
enzymes of cholesterol esterification. The interaction between the
components of cholesterol 7a-hydroxylase, and any possible interaction
between the enzymes involved in cholesterol esterification, are likely
to be influenced by membrane properties. Again, such effects are
conveniently studied by the recombination of resolved, lipid-free,
preparations with lipid of known composition.
Such in vitro studies are most usefully performed if the experimental
conditions used are chosen in the light of the results of in vivo
experiments. Accordingly, the experiments performed were intended to
further purify a cytochrome P-450 species able to support cholesterol
7a-hydroxylase activity in a reconstituted system (Section 3), to
establish and characterise an assay for acyl-coenzyme A:cholesterol
acyltransferase (Section 4), to investigate the possibility of preparing
purified acyl-coenzyme A:cholesterol acyltransferase (Section 5.6),
to determine the activities of cholesterol 7a-hydroxylase and acyl-
coenzyme A:cholesterol acyltransferase in in vivo conditions where the
delivery of cholesterol to the liver and/or the lipid composition of
the endoplasmic reticulum were likely to be altered (Section 6), and,
finally, to investigate the effects on the activities of these enzymes
of in vitro perturbations of the cholesterol content of their membrane
environment (Section 7).
In all of this work an appreciation of the practical and theoretical
problems associated with the assay of these enzymes is essential.
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8.2 The assay of the activity of enzymes that are membrane-bound and/or
have lipophilic substrates
The interpretation of many of the experiments described has been
considerably complicated by the nature of the enzymes being assayed
(375-379). Firstly, these enzymes are membrane-bound. This is
presumably mediated by the insertion of a hydrophobic portion of the
protein structure into the membrane bilayer (380-382), and thus not
only can the membrane exert an influence on the enzyme (213-221,296,
.367-370), but also the enzyme can affect, at least locally, the membrane
characteristics (217,372,384). Secondly, these enzymes act on a
lipophilic, membrane-soluble substrate that is, furthermore, an essential
membrane component whose concentration has a profound influence on
membrane characteristics (184).
The types of problems that arise in the interpretation of the
results of assays of these enzymes are broadly divisible into two main
categories. The first set of problems is associated in particular with
the use of assays based on the measurement of the conversion of radioactively
labelled substrate to product. These difficulties arise from the large
amount of endogenous substrate, and from the existence of this substrate
not in one homogeneous pool, but in a series of pools of differing
ability to act as enzyme substrate (174,242,250,252,254,275,371).
Thus the radioactive substrate is diluted by non-radioactive substrate,
and the specific radioactivity of the substrate pool directly accessible
to the enzyme cannot be known. This means that this most straightforward
of assays cannot give activities in terms of an amount of substrate
converted to product, and, further, that the results obtained are a
function not only of enzyme activity but also of the amount of endogenous
substrate, and its distribution among the various compartments in which
it exists. These difficulties can all be circumvented by the use of
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assays which measure the actual amount of product formed. However,
these assays are technically more difficult and, so long as the drawbacks
of the simple radioactive tracer-based assay are appreciated, satisfactory
conclusions can often be obtained. (These points have been mentioned or
discussed in more detail in Sections 2.11, 2.12, 2.13, 4.1 and 7.4 and
are implicit in many of the experiments described in Sections 6 and 7.)
There is a further set of problems in the assay of these enzymes
that is not so amenable to solution by the use of more sophisticated
assay techniques. Thus, there is a difficulty in how best to express
concentrations, especially of substrate. These problems are of two
kinds. Firstly, membrane-bound enzymes acting on lipophilic substrates
are operating within an essentially two-dimensional system, and the
expression of concentration in terms of bulk volume units is accordingly
inappropriate. However, the most suitable and practicable expression of
concentration is by no means clear. One possibility would be in terms
of the membrane surface area, but this measurement would present
considerable difficulties. Also, in these terms the concentration
of all components would be apparently temperature-dependent, undergoing
an abrupt change where there is a well-defined membrane transition
temperature, or a more gradual change in complex mixtures of membrane
lipids. Thus, even if this measurement were readily available, its
use would be fraught with difficulties. Because of this perhaps a
more satisfactory alternative would be to use the mole fraction of
substrate in the membrane phase. Again, this is not a quantity that
lends itself to simple experimental determination, especially in membranes
such as the endoplasmic reticulum where there is a relatively large
amount of protein. However, if phospholipid is taken to constitute the
matrix of the membrane and is present in large amounts, then perhaps a
relatively acceptable alternative to the mole fraction of substrate
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would be the substrate to phospholipid ratio. Alternatively, where the
protein-to-phospholipid ratio remains constant, the substrate concentration
could be expressed per unit weight of protein.
Secondly, even if satisfactory units for substrate concentration
are found, there are doubts about the adequacy of statistical averages
of numbers of molecules in expressing substrate concentrations for
enzymes acting at interfaces or within membranes, because of the
probability that these enzymes are operating within a microenvironment
differing in its characteristics from the bulk solution or from the
rest of the membrane. In particular, there is evidence that membrane-
bound enzymes sequester around themselves an annulus of lipids differing
in their characteristics and composition from the membrane in general
(217,372,384); membrane lipids can undergo lateral phase separation,
resulting in areas with concentrations of particular lipids different
from their overall average concentration (193-196,208); microsomes
contain more than one pool of cholesterol, and the cholesterol pools are
not equally accessible to cholesterol 7a-hydroxylase and acyl-coenzyme A:
cholesterol acyltransferase (174,242,250,252,254,275,371);
finally, if the diffusion of substrate within the membrane is relatively
slow compared to enzyme activity, substrate concentrations in the
vicinity of the enzyme could be affected (see below).
These discussions of the problems involved in the expression and
use of concentrations in the context of these enzyme systems have so
far been concerned with lipophilic components that will be expected
to partition into the membrane bilayer. In addition to these, the
concentration of charged species and in particular the pH, at the
phospholipid-water interface will not be the same as the concentration
in the bulk solution and the water concentration within the membrane
bilayer will be far removed from that of an aqueous solution.
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Both protons and water participate in the reactions of hydroxylation and
esterification as either substrates or products, and the local
concentration of these components in the vicinity of the enzymes
(as distinct from the overall concentration) is therefore of interest.
In addition to these difficulties associated with the determination
of local concentrations in complex membranes, there is the possibility
that the movement of substrate from distant sites within the membrane
to the vicinity of the enzyme may be slow relative to the enzyme activity
rate. This will result in a concentration gradient of substrate within
the membrane with lower concentrations of substrate in the vicinity of
the enzyme than in the rest of the membrane. Conversely, if the rate of
product diffusion is slow relative to the reaction rate, there will be
a gradient of product concentration with a high concentration around
the enzyme.
In the case of an enzyme which is saturated with substrate at low
substrate concentrations the reaction rate will then depend on the
diffusion rate of the substrate within the membrane. For enzymes not
saturated at endogenous substrate concentrations the relationship between
reaction rate and diffusion rate will be more complex, since the reaction
rate and the diffusion rate will both be among the determinants of the
substrate concentration close to the enzyme, and this in turn will
affect the reaction rate.
The product diffusion rate becomes important when the enzyme is
inhibited by the product (as is cholesterol 7a-hydroxylase (146)).
In this case, if the relative rates of product production and diffusion
are such that a concentration gradient is formed, the enzyme activity
will be in part determined by the inhibition constant of the product
and its local concentration which in turn depends on the rates of product
formation and diffusion. (In vivo, the relative activities of
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cholesterol 7a-hydroxylase and the following enzymes in the pathway of
bile acid synthesis are such that 7a-hydroxycholesterol is unlikely to
accumulate to any appreciable extent. However, the in_ vitro assay for
cholesterol 7a-hydroxylase of necessity does not include the NAD+
required for the activity of the 38-ol dehydrogenase whose substrate
7a-hydroxycholesterol is. The amount of 7a-hydroxycholesterol formed
during an assay for cholesterol 7a-hydroxylase (1-10 nmol per mg protein)
is just sufficient to achieve a detectable inhibition of enzyme activity
(146) .)
The foregoing discussion seeks to establish that, for enzymes such
as the ones under consideration, the measured enzymic activity whether
actual (measured by product formation) or apparent (measured by fractional
conversion of radioactive substrate to product) is determined not only
by the intrinsic enzymic activity but also by the disposition of
substrate between different parts of the membrane and its rate of
movement between these sites. Factors affecting these will therefore
influence the measured enzymic activity. Examples of such factors
include temperature, the presence of organic solvents or detergents
(one or other of these is usually used in the addition of radioactive
substrate to such enzymes for their assay), and the lipid composition
of the membrane. This last category is of particular importance,
since cholesterol is not only the substrate of the two enzymes of
interest, but is also a membrane component whose concentration has a
marked influence on membrane characteristics including transition
temperatures and fluidity (184).
(It should be noted that these effects of the membrane on membrane-
bound enzyme activity are quite distinct from any direct effect of
membrane lipid on enzymic activity - for example, the frequent
requirement of purified membrane-bound enzymes for lipid if activity
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is to be detected (209-211,213), or the influence of the membrane on the
interaction of different protein molecules required for overall enzyme
activity (215,219,385-387).)
8.3 The preparation of a cytochrome P-450 species reconstitutively
active in cholesterol 7a-hydroxylation
(a) The existence of a cytochrome P-450 species specific for cholesterol
7a-hydroxylation
The existence of a cytochrome P-450 species specific for cholesterol
7a-hydroxylation has yet to be conclusively proved. In particular there
is no clear correlation between hepatic microsomal cytochrome P-450
content and cholesterol 7a-hydroxylase activity (266-268,286-289).
One possible explanation for this observation might be that there exists
some protein or non-protein cofactor for the cholesterol 7a-hydroxylase
system whose induction or repression, rather than that of cytochrome P-450,
controls enzyme activity. An alternative hypothesis, which does not
require the postulation of an entity for which there is no experimental
evidence, suggests that hepatic microsomal cytochrome P-450 exists in
multiple forms (277-283) and that the form specific for cholesterol
7a-hydroxylase only represents a relatively small fraction of the total
microsomal cytochrome P-450 content. This would then mean that changes
in this species sufficient to account for observed changes in cholesterol
7a-hydroxylase activity would be difficult to detect against the large
background cytochrome P-450 content. Conversely, the large inductions
of drug hydroxylation-specific cytochrome P-450 that can be observed on
pre-treating animals with appropriate drugs would not be expected to
have any effect on cholesterol 7a-hydroxylase.
A simple calculation can demonstrate that such a suggestion is
reasonable. In a purified, reconstituted system the activity of
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benzphetamine demethylase is 50 nraol per minute per nmol pure, specific
cytochrome P-450 (299). In experiments reported in this thesis
cholesterol 7a-hydroxylase activities in the range of 1-10 nmol per hour
per mg protein were observed, the lower values being obtained on feeding
the control or the cholesterol-containing diets, and the higher values
on feeding the 4% cholestyramine diet. On the basis of a typical
microsomal cytochrome P-450 content of 0.5 nmol per mg protein, this
activity is approximately in the range 0.05-0.5 nmol per minute per nmol
total microsomal cytochrome P-450. Therefore, if the two enzymes were
to operate at the same rate per nmol of specific cytochrome P-450,
cholesterol 7a-hydroxylase-specific cytochrome P-450 need only account
for 0.1-1% of the total microsomal cytochrome P-450. It is quite
possible that the intrinsic activity of the cholesterol 7a-hydroxylase
system is lower than that of drug hydroxylations. However, even if the
cholesterol 7a-hydroxylase operated at a rate lO-fold slower than drug
hydroxylases, it need still account for no more than 1-10% of the total
microsomal cytochrome P-450 in the uninduced and induced examples,
respectively.
The resolution of microsomal cytochrome P-450 into several fractions
which vary in their ability to support cholesterol 7a-hydroxylase
activity in a reconstituted system (320, and S. Ozasa, personal
communication) tends to confirm the existence of a cholesterol 7a-
hydroxylase-specific cytochrome P-450. However, these observations do
not unambiguously prove the existence of such a cytochrome P-450 species,
since it is possible that a cytochrome P-450 of more general specificity
could be co-purifying with some further protein subunit capable of
conferring specificity for cholesterol 7a-hydroxylation.
The suggestion that there is a cytochrome P-450 specific for
cholesterol 7a-hydroxylation and that this is present as a relatively
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small fraction of the total microsomal cytochrome P-450 has two important
consequences. Firstly, at each stage of a purification procedure it is
necessary to use any cytochrome P-450 fraction(s) obtained to reconstitute
cholesterol 7a-hydroxylase activity, to ensure that this activity has
been retained, and to test whether any fraction shows an enhanced
ability to support this activity. Secondly, if there is only a small
amount of the specific cytochrome P-450 in the microsomal fraction even
in animals where enzyme activity has been induced by feeding cholestyramine,
it is desirable that as little of the cytochrome should be lost as
possible, especially in the initial stages of the purification.
(b) The use of donors of "active oxygen" to reconstitute cholesterol
70t-hydroxylase activity
It was felt that a particularly convenient approach to the
reconstitution of hydroxylating activity with a series of cytochrome P-450
fractions would involve the use of one of the chemical donors of "active
oxygen" which have been demonstrated to support a variety of cytochrome
P-450-catalysed drug and steroid hydroxylations in the absence of
NADPH or molecular oxygen (322-329). The experiments performed
(Section 3.7) showed that it was not possible to detect any cholesterol
7a-hydroxylation catalysed by a microsomal suspension in the presence of
iodosobenzene under a range of experimental conditions, and only a
very low rate of NalO^-supported activity was observed.
At least part of the reason for the former result was the rapid
destruction of cytochrome P-450 by iodosobenzene which occurs concomitantly
with activity (328, and Section 3.6). Such an effect may be tolerable
in the study of enzyme activities where there are sensitive assays for
the enzymic reaction product, so that the initial rate of reaction can
be measured during the first few minutes of incubation, but poses a
considerable problem for the assay of cholesterol 7a-hydroxylase activity.
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An approximate calculation demonstrates the problems involved.
A typical cholesterol 7a-hydroxylase assay incubation contains 4 nmoles
microsomal cytochrome P-450. If it is assumed that 5% of this is specific
for cholesterol 7a-hydroxylation, and that each cytochrome molecule turns
over once, and in doing so produces one molecule of 7a-hydroxycholesterol
and is itself destroyed, then 200 pmoles 7a-hydroxycholesterol will be
produced during the course of the incubation. This amount of oxygenated
sterol is within the detection limits of the gas chromatography-mass
spectrometry assay, but this was not available for routine use. If the
problems introduced by the possibilities of cholesterol compartmentation
are ignored this production of 7a-hydroxycholesterol represents a
0.00005% conversion of endogenous cholesterol if native microsomes
were used, or a 0.001% conversion if a butanol-extracted preparation
was used. Such conversions are not detectable by the [4-^cl-cholesterol-
based assay.
The use of KIO^ was judged to be unsatisfactory because of the
large amounts of 7-ketocholesterol produced even in the presence of
3-mercaptoethylamine. 7-Ketocholesterol is a potent inhibitor of
cholesterol 7a-hydroxylase.
(c) The effect of increased recovery of cytochrome P-450 on its
purification
Because of the small amounts of putative cholesterol 7a-hydroxylase-
specific cytochrome P-450 that are likely to be present in microsomes
and the low recoveries of total microsomal cytochrome P-450 that were
obtained on DEAE-cellulose chromatography, it was considered that a
search for methods to improve the recovery of cytochrome P-450 at this
initial step would be useful. Furthermore, it was considered that if
the recoveries of cytochrome P-450 could be improved a more satisfactory
purification might result.
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The results obtained with a series of protective agents in various
combinations are tabulated in Table 3.1. Increasing the detergent
concentration or decreasing the buffer concentration caused large
losses of cytochrome P-450. The purifications of total cytochrome
P-450 obtained on using the various combinations of protective agents
in 20 pM potassium phosphate pH 7.7, 0.4% Nonidet are plotted against
recoveries in Figure 8.1. This demonstrates that this approach did
indeed tend to achieve improved purifications of cytochrome P-450 with
increased recoveries. On the basis of these results it would appear
that the use of 10 mM diethydithiocarbamate, with or without the
additional use of 10 mM 4-phenyl-imidazole, is a useful precaution in
any further work aimed at preparing cytochrome P-450.
8.4 The in vivo response of the liver to changes in its cholesterol supply
(a) Hepatic cholesterol metabolism during a twenty-four hour cycle,
and during cholesterol feeding
The most straightforward way of rationalising the diurnal changes
in hepatic cholesterol metabolism is to relate them to the periods of
maximum intake of food. Thus, rats feed most actively during the dark
phase of a twenty-four hour cycle, and the cholesterol metabolism of
the animal has to be controlled, largely in the liver, to take account
of this.
During the period of maximum food ingestion, in order to ensure
absorption of fat, the rat must increase its synthesis of bile acids
in order that bile salts can be secreted into the intestinal tract.
This requirement for enhanced bile acid synthesis is a direct consequence
of the absence of any storage capacity for bile in the rat. As would
therefore be expected, bile acid synthesis, and the activity of cholesterol
7a-hydroxylase, increase at times approximately coinciding with the
Figure 8.1
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times of maximum food intake (176,263,272,346). (It is of interest to
note that cholesterol 7a-hydroxylase is the only cytochrome P-450-
,k.hovJn
dependent enzyme activity^to exhibit such a variation.)
The relation between this fluctuation in cholesterol 7a-hydroxylase
activity and the variations detected in the size of the microsomal
cholesterol pool which preferentially acts as substrate for the enzyme
is not simple. When rats are fed a cholesterol-free diet, the fluctuations
in these quantities are directly out of phase with each other, with a
peak in enzyme activity during the dark period coinciding with a trough
in substrate pool size (263). This result raises the possibility that
the activity of cholesterol 7a-hydroxylase may itself be one of the
determining factors for the size of the cholesterol substrate pool for
bile acid synthesis, by controlling the rate of efflux from the pool.
On the other hand, when a cholesterol-rich diet is fed, the fluctuations
in cholesterol 7a-hydroxylase activity and in the size of its substrate
pool are in phase with each other, with maxima in both being detected in
the middle of the dark phase (176). This observation can perhaps be
rationalised in terms of the large absorption of cholesterol occurring
at this time resulting in an increase in hepatic microsomal cholesterol,
and, in particular, in an increase in the amount of cholesterol in the
pool that can act as substrate for cholesterol 7a-hydroxylase.
This increased delivery of cholesterol into this pool could be envisaged
to overwhelm the previously observed decrease in pool size which was
perhaps due to an increased efflux of cholesterol from the pool.
When the diet contains no cholesterol, the liver can make use of
the increased supply of dietary substrates that occurs during the dark
phase for the de_ novo synthesis of cholesterol, and, accordingly, peaks
of cholesterol synthesis and 3-hydroxy-3-methylglutaryl-coenzyme A
reductase activity can be detected (4,129,154-158,262,263,272,345,346).
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This newly synthesised cholesterol can be used to supply the body's
needs for this compound via lipoprotein (principally VLDL) synthesis
and export, or, since at this time there is a potential drain on the
body's cholesterol supply because of active bile acid synthesis, can act
as the preferred substrate for cholesterol 7a-hydroxylase (174,250,274,275).
Under these conditions the supply of cholesterol from intrahepatic
synthesis can be matched to cholesterol loss, and there is unlikely to
be any accumulation, temporary or long term, of free cholesterol in the
liver. If it is postulated that one of the functions of hepatic acyl-
coenzyme A:cholesterol acyltransferase activity is to deal with excess
free cholesterol by converting it to cholesterol ester for storage,
then there is no need for an enhancement of this enzyme's activity at
any time. However, in the rat, as well as this function, hepatic acyl-
coenzyme A:cholesterol acyltransferase probably synthesises some of the
cholesterol ester present in very low density lipoprotein (VLDL) (388,
389). If there is a diurnal variation in the rate of VLDL synthesis,
it is possible that the activity of acyl-coenzyme A:cholesterol acyl¬
transferase may vary in synchrony with this.
If, on the other hand, the rat was to eat a cholesterol-rich diet,
there would be an uncontrollable entry of cholesterol into this system,
and, furthermore, this entry would occur in a cyclic fashion, with
maxima at, or shortly after, times of maximum food intake. Known
responses to this are an inhibition of 3-hydroxy-3-methylgutaryl coenzyme A
reductase and a reduction in the rate of cholesterol synthesis (4,129,
154-162,262,347), and an enhanced rate of bile acid synthesis (172,173).
The effect on cholesterol 7a-hydroxylase is disputed, with reports of
an increased activity and of no change in activity (147,174,175, and
see Sections 6.4(a), and 6.4(c)). However, if this enzyme was not
saturated with substrate an enhanced conversion of substrate to product
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will result from the increase in substrate supply, in the absence of any
stimulation of activity (176, and see Sections 7 and 8.4(a)).
It could be envisaged that if the diet only contained a small
amount of cholesterol these mechanisms could be sufficient to prevent
cholesterol accumulation. However, if the cholesterol delivery is in
excess of the amount that can be converted to bile acids, it is apparent
that there will be a net increase in whole body cholesterol, and it is
well known that in the rat this increase occurs almost exclusively in
the liver, and in the form of cholesterol ester (148,149). (The tissue
localisation of this accumulated cholesterol does not concern the present
work, but is probably a result of a complex interaction between the
amounts of the different classes of lipoproteins, the activity of plasma
lecithin:cholesterol acyltransferase, and the activity of acyl-coenzyme A:
cholesterol acyltransferase in the liver and the peripheral tissues.)
On the basis of the foregoing discussion, it might be predicted that
this increase in cholesterol ester might occur in a cyclical fashion,
with maxima at, or shortly after, times of maximum cholesterol ingestion.
It is widely accepted that intracellular cholesterol ester
accumulation is catalysed by acyl-coenzyme A:cholesterol acyltransferase
activity, and, in the fibroblast, at least, is associated with an
increase in this enzyme's activity (106,121,123). However, there is no
absolute requirement for any enhancement of enzymic activity in order
to obtain the observed accumulation of cholesterol ester on increasing
the substrate supply to the enzyme if the enzyme is not saturated with
substrate, at the normal endoplasmic reticulum membrane cholesterol
concentration. Before the present work was undertaken it was not known
whether hepatic acyl-coenzyme A:cholesterol acyltransferase was
saturated with substrate at normal endoplasmic reticulum cholesterol
levels (that is, whether any observed changes in esterification rate
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could be fully accounted for by changes in substrate supply to the
enzyme), or whether changes in esterification rate were due to changes
in enzyme activity. As discussed above, of particular interest were
the possibilities that there might be a cyclical variation in activity
during a twenty-four hour period, associated with feeding, and that
there might be a stimulation of activity over a longer period on eating
a cholesterol-rich diet.
The experiments performed demonstrated that there does indeed appear
to be a diurnal variation in acyl-coenzyme A:cholesterol acyltransferase
activity, and this observation has been confirmed in subsequent experiments
r 14-,
using the assay based on LI- CJ-palmitoyl-coenzyme A. This result
contrasts with published results which claim to show that there is no
diurnal variation in the activity of acyl-coenzyme A:cholesterol acyl¬
transferase (252) . However, these authors based their conclusions on
assays for enzymic activity performed at midday and midnight. These
times were chosen to approximately coincide with the maxima and minima
in the diurnal rhythms in the rates of cholesterol and bile acid synthesis.
However, the experiment presented here (Section 6.2 and Figure 6.1)
showed the small peak and trough of acyl-coenzyme A:cholesterol acyl¬
transferase activity occurred somewhat later than these times, and that,
at the pair of times chosen by these authors, no difference in enzymic
activity would be expected. Indeed, from the description of hepatic
cholesterol metabolism presented above, it would appear quite reasonable
that any peak in esterification activity should follow, rather than
coincide with, peaks of cholesterol and bile acid synthesis.
It was also demonstrated that the increase in hepatic cholesterol
ester content on cholesterol feeding is accompanied by an increase in
acyl-coenzyme A:cholesterol acyltransferase activity. However, it was
shown that care was needed in the interpretation of this result,
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since feeding the olive oil-containing control diet also caused the
activity of this enzyme to increase. However, as is shown in Figure 6.15,
the activity of acyl-coenzyme A:cholesterol acyltransferase in the
liver microsomes of rats fed the 1% cholesterol, 10% olive oil diet was
greater than in those fed the 10% olive oil diet, but only significantly
greater at certain times. Within the relatively limited time-scale
that was studied, these times seemed to be defined by an early lag
phase before any increase in activity was detectable in the olive oil-
fed animals, and a later period when the enzymic activity of the
cholesterol-fed animals appeared to be increasing at a faster rate than
that of the olive oil-fed animals.
The results of these cholesterol-feeding experiments raise several
questions. These include the reason for the observed increase in
cholesterol esterification activity on olive oil-feeding, the failure
to accumulate cholesterol ester despite this increased activity, and
the lack of any observed decrease in activity on withdrawing the
cholesterol or olive oil diets.
The reason for an enhancement of microsomal cholesterol esterification
activity on feeding olive oil is not clear, but there are three main
alternative explanations. Firstly, for some as yet unexplainable reason,
there may be an enhanced induction of acyl-coenzyme A:cholesterol
acyltransferase on olive oil feeding, and the raised activity would then
be a consequence of an increase in the amount of this enzyme. Secondly,
feeding olive oil may alter the fatty acid composition of the phospholipids
of the microsomal membranes, and this may influence acyl-coenzyme A:
cholesterol acyltransferase activity through physico-chemical effects
on the environment of the enzyme. Thirdly, olive oil is particularly
rich in oleic acid and this is the favoured fatty acid for cholesterol
esterification by acyl-coenzyme A:cholesterol acyltransferase (248) .
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The increased esterification of cholesterol by incubations of microsomes
from olive oil-fed rats could therefore possibly be explained by an
increased supply of this cosubstrate. With reference to these
possibilities there is the observation, published since these experiments
were performed, that feeding rats diets of different fatty acid
composition results in a change in microsomal phospholipid fatty acid
composition, and also in altered acyl-coenzyme A:cholesterol acyl-
transferase activity (389-391). Although it was not proved, the
implication of this work was that the altered enzyme activity was in
some way caused by the changed physicochemical properties of the membranes.
The failure of the livers of olive oil-fed rats to accumulate
cholesterol ester despite the enhancement of measured esterification
activity is presumably explained by the lack of an increase in cholesterol
supply to the livers of these rats compared to the large increase in
supply to the livers of cholesterol-fed rats. This observation once
more serves to emphasise that the actual activity of enzymes such as
these is a function not only of measurable enzyme activity, but also of
the rate of supply of substrate to the vicinity of the enzyme.
In no experiment where a dietary stimulus resulted in an increase
in acyl-coenzyme A:cholesterol acyltransferase activity did removal of
that diet result in activity returning to basal levels. The effect of
olive oil feeding on the activity of this enzyme provides a satisfactory
explanation of these results. Thus, in the experiment described in
Section 6.4(a) and Figures 6.9-6.11, the animals were fed with the 10%
olive oil diet for seven days before transferring to the 1% cholesterol,
10% olive oil diet. In the light of the following experiment
(Section 6.4(b), Figures 6.12-6.15) this period of olive oil feeding
would be expected to result in little or no change in esterification
activity, and the activity on day 0 of the experiment was accordingly low.
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However, after feeding the 1% cholesterol, 10% olive oil diet for thirteen
days, the animals would have been eating a diet rich in olive oil for
twenty days, and any effect due to this component of the diet might be
expected to have stabilised. Thus, on removing the cholesterol from
the diet, there was a small decrease in activity, followed by a
relatively constant level of activity for the remainder of the duration
of the experiment.
If the effect of feeding olive oil on acyl-coenzyme A:cholesterol
acyltransferase activity is indeed mediated by changes in the microsomal
lipid composition, then these changes would be expected to be relatively
slow, as would their reversal on removing olive oil from the diet.
This probably explains the lack of any observable effect on acyl-
coenzyme A:cholesterol acyltransferase activity in the ten days
following the removal of either the 10% olive oil diet or the 1%
cholesterol, 10% olive oil diet (Section 6.4(b), Figures 6.12-6.15).
On no occasion was it possible to demonstrate an increase in
cholesterol 7a-hydroxylase activity on cholesterol feeding (Sections 6.4(a)
and 6.4(c), Figures 6.11 and 6.16), despite the known enhancement of
bile acid synthesis under these conditions (172,173), and the role of
cholesterol 7a-hydroxylase as the rate-limiting enzyme in this process
(392-397). This again reinforces the suggestion that substrate supply
as well as enzyme activity is important in the control of the activity
of this enzyme as well as that of acyl-coenzyme A:cholesterol acyl-
transferase. Thus, an increased rate of product formation appears to
be obtainable by increasing the supply of substrate in the absence of
increased amounts of enzyme activity. However, in the converse situation,
where, on cholestyramine feeding, an increase in enzymic product formation
is required in the absence of an increase in substrate supply, then an
increase in enzyme activity would be predicted to be necessary, and is,
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indeed, observed (146,288,289). It is of interest to contrast this
observation with the comparable situation where acyl-coenzyme A:
cholesterol acyltransferase activity is enhanced in the absence of
increased supply of substrate on olive oil feeding, when as yet no
increase in cholesterol ester formation (or, at least, accumulation)
has been detected.
(b) Hepatic cholesterol metabolism during the twenty-four hours following
bile duct liquation
Having examined in_ vivo conditions where the rate of cholesterol
supply to the liver was varied, a condition was sought where cholesterol
loss from the liver was prevented, at least in part. The two main
routes of loss of cholesterol from the liver are via lipoprotein
synthesis and secretion, and via the secretion of free cholesterol and
bile salts in the bile.
The former can be prevented by the use of drugs including protein
synthesis inhibitors and 4-aminopyrazolo-[3,4-d]-pyrimidine (31,130-132,
180,393-395). These compounds have considerable toxic effects both on
the whole animal and on the liver. It was therefore decided to prevent
cholesterol loss into the bile, by occlusion of the bile duct, since
the effects of this are likely to be less immediately deleterious to
the health of the animal, thus simplifying the interpretation of the
results obtained. Furthermore, bile duct occlusion wil'l raise hepatic
cholesterol levels, which might be expected to affect the activities of
cholesterol 7a-hydroxylase and acyl-coenzyme A:cholesterol acyltransferase,
and will also increase the hepatic contents of bile salts, which are
known, at least in vitro, to inhibit both these enzymes (178,272,396,397).
Whether the bile salt concentration ever reaches levels inhibitory to
these enzymes in vivo is not clear, because of the existence of cytosolic
bile salt-binding proteins in the hepatocytes (398). Because of the
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existence of these potentially antagonistic effects, it was decided
that it was of interest to examine the consequences of occluding the
bile duct by ligation.
The experiment described in Section 6.3 and Figures 6.3-6.8
demonstrated that microsomal free cholesterol levels did indeed increase
following bile duct ligation. The concentration of bile salts in the
systemic circulation also increased, and it is a reasonable assumption
that this was reflected by an increased hepatic concentration of bile
salts, although whether these were free or were protein-bound is not
clear.
The calculated size of the substrate pool for cholesterol 7a-
hydroxylase exhibited a diurnal variation that was in phase with the
variation in enzyme activity, as would be expected for cholesterol-fed
animals (176). The effect of ligating the bile duct appeared to be
to diminish the size of the variation in pool size with the result that
the pool size was usually somewhat greater than in sham operated
animals (Figure 6.6). Cholesterol 7a-hydroxylase activity was observed
to decrease on bile duct ligation despite this increase in substrate
supply, presumably because of the inhibitory effect of raised hepatic
bile salt levels (Figure 6.5).
If it is assumed that from the first time-point after bile duct
ligation onwards the inhibitory effect on cholesterol 7a-hydroxylase
of the increased bile salt concentration was constant, it is possible
usefully to plot cholesterol 7a-hydroxylase activity against substrate
pool size for both the sham operated and the bile duct ligated animals
(Figure 8.2(a)). This plot demonstrates a straight line relationship
between enzyme activity and substrate pool size for each group of
animals. (The usefulness of this plot tends to be confirmed by a plot
of enzyme activity against total microsomal free cholesterol, which
Figure 8.2(a)
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exhibits no obvious correlation at all (Figure 8.2(b)). The line
obtained for the group of animals with ligated bile ducts is displaced
to the right and has a steeper gradient. These observations are
consistent with the following model. Cholesterol 7a-hydroxylase is
not saturated with its substrate, and increasing the amount of cholesterol
in the vicinity of this enzyme therefore results in an increased
production of 7a-hydroxycholesterol. Cholesterol 7a-hydroxylase is
inhibited by bile salts, and this inhibition is of competitive type,
since it can be overcome by increasing the concentration of substrate.
The calculated size of the substrate pool for acyl-coenzyme A:
cholesterol acyltransferase increased both on sham operation and on
bile duct ligation, the increase being somewhat larger in the latter
case (Figure 6.8). There was relatively little change in acyl-coenzyme A:
cholesterol acyltransferase activity during the course of this experiment,
but twenty-four hours after ligation the enzyme activity was greater
in the bile duct ligated than in the sham operated animals (Figure 6.7),
this being due to a drop in activity in the sham operated controls rather
than to an increased activity in the bile duct ligated animals. Again,
enzyme activity can be plotted against substrate pool size (Figure
8.3(a)). A straight line is obtained for the plot of results from
bile duct ligated animals. No obvious relationship exists for the
sham operated animals, or for plots of enzyme activity against total
microsomal free cholesterol (Figure 8.3(b)).
8.5 The response of hepatic microsomal cholesterol metabolism to
in vitro alterations of the microsomal cholesterol content
The experiments performed in_ vivo having tended to support the
idea that changes in the activities of cholesterol 7a-hydroxylase
and acyl-coenzyme A:cholesterol acyltransferase could under some
Figure 8.2(b)
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circumstances be caused by changes in delivery of cholesterol to these
enzymes, a direct in vitro demonstration of this was sought.
Two types of approach to this problem are possible. The microsomal
preparation can be first delipidated, using either organic solvent or
detergent, and then reconstituted using lipid of known composition,
or alternatively, the lipid composition can be altered by exchange
processes with liposomes or serum lipoproteins. The former type of
technique allows lipids of completely defined composition to be used,
but often results in large losses of enzyme activity; the latter
approach, being less harsh, is less likely to cause loss of enzyme
activity, but does not so easily enable lipids of predetermined
composition to be used.
It was shown in Section 5.6 that detergent solubilisation destroys
microsomal cholesterol esterification activity (although it might be
anticipated that this activity could be at least in part restored on
reconstitution with liposomes (344)), and, furthermore, traces of
non-ionic detergents can be extremely difficult to remove from protein
preparations, and may influence enzymic activity or membrane properties.
Accordingly, the first approaches towards investigating the effects of
altered lipid composition on the activities of these enzymes utilised
extraction of freeze-dried microsomes with acetone.
The results of the experiment described in Section 7.2 and Figure
7.1 contain the suggestion that at least part of the difference in
cholesterol esterification activity between soft diet-fed and cholesterol-
fed animals was caused by some factor that was extracted with acetone.
However, the interpetation of results obtained using [4-14c]-cholesterol-
based assays was considerably complicated by the presence of additional
lipid pools created by the presence of the liposomes. This problem
could be completely circumvented by the use of an absolute assay for
acyl-coenzyme A:cholesterol acyltransferase.
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This was used in the following experiment where the cholesterol
content of the liposomes was varied (Section 7.3, Figures 7.2 and 7.3,
and Table 7.1). This unequivocally demonstrated that an increase in
the cholesterol supply to the enzyme resulted in an increase in the rate
of cholesterol esterification. However, enzyme activity was not restored
to the levels that existed before the acetone extraction.
The use of the gentler technique of incubation with cholesterol-
enriched serum was therefore tried, in collaboration with Dr. K.E.
Suckling. Again, the use of [4-"^c]-cholesterol-based assays yielded
results that proved difficult to interpret, but suggested that an
increase in cholesterol supply resulted in increased activities of
these two enzymes. This result tended to be confirmed by preliminary
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